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1. Introduction 
Due to the high sensitivity of detection and the non-invasive nature, luminescence techniques, 
and in particular fluorescence spectroscopy, have found a wide variety of applications in 
physical, chemical, biological, material and medical sciences.[1] Over the last decade, 
fluorescence methodologies were shown to be very promising tools for studying chemical 
processes and revealing mechanistic insights of molecular transformations.[2] In this respect, 
the high sensitivity of fluorescence detection perfectly suits the monitoring of catalytic species 
of transition-metal complexes, which (almost by definition) are present in very small 
concentrations during catalytic reactions. Pioneering work, which includes both ensemble[3] 
and single-molecule[4] experiments, has revealed the huge potential of fluorescence 
spectroscopy for the investigation of catalytic processes. One of the main requirements in such 
research is the labeling of transition-metal complexes with suitable fluorophores. Design and 
synthesis of novel fluorophore-tagged complexes would therefore greatly facilitate the 
development of this field of science. Except for mechanistic investigations, such complexes 
can be used as chemosensors,[5] triplet sensitizers,[6] biological sensing probes,[7] and even as 
therapeutic agents.[8] 
The current chapter covers briefly the phenomenon of luminescence and related processes, 
with a special focus on fluorescence emission, its characteristics, and quenching pathways. 
The full information on fluorescence techniques with numerous examples of application in 
biology can be found in the excellent book of Joseph Lakowicz “Principles of Fluorescence 
Spectroscopy” (Springer-Verlag, 2010).[9] More advanced description of the physical 
principles of fluorescence methods is given in “Molecular Fluorescence: Principles and 
Applications” by Bernard Valeur (Wiley-VCH, 2001).[10] The next section is dedicated to the 
synthesis of BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene), which was chosen as the 
most suitable fluorophore for labeling metal complexes. Finally, different examples of the 
application of BODIPY-tagged transition-metal complexes will be shown. 
1.1. Luminescence 
Emission of light by any substance, which is not caused by heating, is called luminescence. 
More general, luminescence is the emission of electromagnetic energy, which results from 
electronically excited states. Depending on the excitation mode different types of 
luminescence are known: mechanoluminescence, electroluminescence, chemiluminescence, 
bioluminescence, etc. If the excitation is caused by absorption of a photon, the subsequent 
emission is defined as photoluminescence. Depending on the spin state of the excited system 
photoluminescence is further divided into fluorescence and phosphorescence. Fluorescence is 
characterized by a singlet excited state. Return of the system to the ground state is spin 
allowed and, therefore, emission occurs very fast. Typical fluorescence lifetimes are in the 
range of 10 nanoseconds. Phosphorescence, in contrast, occurs from triplet excited state. Such 
a process is spin forbidden and displays much longer lifetimes (milliseconds to minutes). In 
case, when the excited state cannot be strictly determined as singlet or triplet, delayed 
fluorescence occurs. It is characterized by intermediate lifetimes. 
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Figure 1.1. Jablonski diagram; S0 – ground state, S1, S2 – singlet excited states, T1 – triplet excited state, IC – internal 
conversion, ISC – intersystem crossing. 
Photoluminescence and related processes can be illustrated by a Jablonski diagram (figure 
1.1). The singlet electronic states are depicted as S0 (ground state), S1, S2; triplet state – T1. 
With each electronic state many vibrational levels are associated. Absorption of a photon leads 
to the excitation of the system from the ground state S0 to the higher vibrational level of S1 or 
S2 states. Such transition, depicted with a vertical line, occurs very fast (10
-15 s), so no 
changes in nuclei arrangement are possible (Franck-Condon principle). The system in the 
excited state is normally rapidly relaxed (10-12 s) to the lowest vibrational level of S1 by a 
process called internal conversion. Finally, returning to the ground state can occur either by 
radiative process – fluorescence, which results in the emission of a photon, or by non-radiative 
internal conversion, which transforms excitation energy into the heat. Another possibility for 
the system in excited state S1 is spin conversion to the excited triplet state T1. This process is 
called intersystem crossing (ISC). The transition from T1 to S0 results in phosphorescence, 
which is characterized by longer wavelength (lower energy) than fluorescence emission. The 
presence of heavy atoms in the molecule normally facilitates ISC and subsequent 
phosphorescence. 
1.1.1. Characteristics of fluorescence emission 
The phenomenon of fluorescence emission is characterized by a number of different 
parameters, most of which can be quantitatively measured and analyzed. 
The amount of emitted photons by a given fluorophore defines the fluorescence intensity F, 
whose value strongly depends on the experimental conditions. The dependence of 
fluorescence intensity on wavelength gives an emission spectrum. The emission spectrum is 
generally independent of the excitation wavelength. The reason for this is that irrespective of 
the energy of absorbed light, the excited molecule is quickly relaxed to the lowest vibrational 
level of S1, from which fluorescence occurs. 
The wavelength, which corresponds to the maximum intensity of fluorescence emission 
(emission maximum, λem), is generally longer than the absorbance maximum (λabs) for a given 
fluorophore. This phenomenon is known as Stokes Rule (named after Sir G. G. Stokes) and is 
characterized by the Stokes shift – the difference between λem and λabs. The Stokes Rule 
reflects the fact that part of excitation energy is lost due to vibrational relaxation or by other 
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non-radiative processes. Therefore, fluorescence emission always has lower energy (longer 
wavelength) than excitation light. 
The efficiency of fluorescence emission is defined by the fluorescence quantum yield Φ. It is 
determined as the ratio between the number of emitted photons and the number of absorbed 
photons. A given fluorophore has a bright fluorescence emission if it is characterized by 
intense light absorbance and its quantum yield is larger than 0.9. In contrast, Φ values close 
to 0 mean no fluorescence occurs. The closely related parameter to quantum yield is 
fluorescence lifetime τ. It is defined as an average time the molecule spends in the excited 
state before return to the ground state, both by radiative and non-radiative processes. 
In some experiments, polarized light is used for excitation. In this case, only those molecules 
are excited, whose transition dipole is parallel to the electric vector of the excitation light. 
Subsequent fluorescent emission can be also polarized. The extent of its polarization is 
characterized by two interchangeable parameters: fluorescence anisotropy I and fluorescence 
polarization P. Small molecules in fluid solutions typically rotate very fast, so the orientation 
of polarized emission is quickly randomized, which led to the disappearance of anisotropy. 
However, in the case of macromolecules (or viscous solutions), fluorescence polarization can 
be observed, and its measurements can provide useful information about the rate of rotational 
diffusion. 
1.1.2. Mechanisms of fluorescence quenching 
Application of fluorescence techniques critically relies on the detection of parameters, 
described above. Detectable changes of fluorescence intensity (the most basic parameter) can 
provide useful information about the molecular processes, which cause such changes. In this 
section, the main processes, leading to the fluorescence quenching (decreasing of fluorescence 
intensity), are briefly discussed. 
Non-radiative deactivation of the excited-state fluorophore, which occurs upon collisional 
encounter with some other molecule (quencher), is known as collisional quenching. It 
requires molecular contact between fluorophore and quencher at the moment of excitation. 
Interacting molecules are not chemically modified in this type of process. A variety of 
compounds can act as collisional quenchers: oxygen, halogens, amines, amides, etc. 
Intersystem crossing (ISC) is a non-radiative transition from the singlet excited state to a 
triplet excited. Generally, such transition is forbidden but can be facilitated by the presence of 
heavy atoms (as parts of the fluorophore or as external molecules), which increases spin-orbit 
coupling. Subsequent deactivation of the triplet state normally occurs by non-radiative 
pathways, although radiative de-excitation – phosphorescence – is also possible. 
Quenching of fluorescence is often caused by photoinduced electron transfer (PET). Basically, 
it occurs due to the changes of redox properties of the fluorophore upon excitation. In the 
presence of another molecule, which can act as an electron donor (D) or acceptor (A) relative 
to the excited-state fluorophore, the charge transfer complex D+A- is formed, which 
subsequently returns to the ground state without emission. Depending on the direction of 
electron transfer reductive (acceptor-excited) or oxidative (donor-excited) types of PET are 
distinguished. As shown in figure 1.2, in case of reductive PET the fluorophore acts as an 
electron acceptor, whereas in oxidative PET it donates electrons. It should be also noted, that 
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both D and A are not necessarily different compounds, they can be also linked parts of the 
same molecule. 
 
Figure 1.2. Different types of PET: a) reductive (acceptor-excited) PET; b) oxidative (donor-excited) PET. 
The possibility of PET can be predicted based on the redox potentials of fluorophore and 
quencher. The energy change of PET is described by the Rehm-Weller equation: 
∆GPET = E1/2(D
+/D) – E1/2(A/A
-) – ∆E00 – C 
where E1/2(D
+/D) and E1/2(A/A
-) are reductive potentials for the respective processes; ∆E00 is 
the excitation energy of fluorophore corresponding to the S0→S1 transition; C – the coulombic 
attraction energy within formed ion pair D+A-. 
Another quenching process, which requires contact between the orbitals of donor and 
acceptor, is electron exchange or Dexter quenching. An electron from the LUMO of the 
excited-state donor (fluorophore) is transferred to the LUMO of the acceptor (quencher). 
Either in a stepwise or concerted manner, an electron from the HOMO of the acceptor is 
transferred to the HOMO of the donor. Such electron exchange results in the energy transfer 
to acceptor and quenching of donor. Dexter interaction occurs at high concentrations of 
fluorophore and quencher when the average distance between molecules is relatively short. 
Transfer of energy from an excited-state donor to an acceptor, which doesn’t involve direct 
interaction of electron orbitals, is known as fluorescence resonance energy transfer (FRET). It 
can be described as a long-range dipole-dipole interaction, which occurs without the 
appearance of the photon. It requires an overlap between the emission spectrum of the donor 
and the absorbance spectrum of the acceptor. The efficiency E of FRET is determined as the 
fraction of energy absorbed by the donor which is transferred to the acceptor. It can be 
calculated from the experimental data using the following expression: 
    
   
  
  
where FDA and FD are fluorescence intensities of the donor in the presence and in the absence 
of acceptor respectively. FRET efficiency depends on the fluorescence properties of the donor, 
the degree of spectral overlap, mutual orientation of fluorophores, solvent properties and a 
distance between donor and acceptor. Dependence of FRET on the distance is defined by a 
given formula: 
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where r is the distance between donor and acceptor; R0 – Förster radius –  corresponds to the 
distance of the transfer efficiency of 50%. This equation shows that FRET efficiency is very 
sensitive to the distance between donor and acceptor when r is comparable to R0. In general, 
FRET can be used as a very sensitive molecular tool for the distance measurements. Common 
fluorophore pairs have values of Förster radius typically in the range from 2 to 9 nm, which is 
comparable to the size of biomolecules. Because of this FRET is widely used in the biological 
research, for example, for determination of protein folding or for the investigation of 
membrane fusion/aggregation.[9] 
1.2. BODIPY fluorophores 
In recent decades, the interest towards BODIPY-based dyes has grown dramatically.[11] The 
most important areas of their applications include biolabeling and bioimaging,[12] 
chemosensing,[13] photodynamic therapy,[14] fluorescent switches,[15] laser dyes[16] and solar 
cell sensitizers.[17] Such a widespread usage of BODIPY is due to its exceptional photophysical 
properties, the most essential of which are: strong absorbance, sharp emission band, high 
fluorescence quantum yield, chemical and photostability, relative inertness of photophysical 
properties to the environment conditions (temperature, solvent polarity, and pH). Another 
key feature of BODIPY is the huge potential of its structure towards chemical modification.[18] 
The photophysical properties, which strongly rely on the chemical structure, can be thus easily 
tuned by introducing a variety of substituents in the different positions of the BODIPY core. 
1.2.1. BODIPY structure 
The structure of the simplest unsubstituted difluoroboron dipyrromethene (BODIPY) is 
represented in figure 1.3 (left). Nomenclature name of BODIPY is 4,4-difluoro-4-bora-3a,4a-
diaza-s-indacene, and the IUPAC numbering for this class of compounds is set similarly to the 
all-carbon tricyclic analog – indacene. The most chemically relevant positions are often 
specified as meso, α and β. The π-electron system is delocalized over the whole backbone as 
shown in figure 1.3 (right). 
 
 
Figure 1.3. Left: structure of BODIPY and its atom numbering scheme. Right: selected delocalized structures of 
BODIPY. 
BODIPY can be considered as a conformationally rigid monomethine cyanine dye, where both 
ends of the chain are held together with BF2 unit
[19] (figure 1.4). Restriction of the flexibility 
in dipyrromethene scaffold leads to the high quantum yield and sharp fluorescence band of 
the BODIPY fluorophore. 
 
Figure 1.4. The relationship between structures of cyanines and BODIPY dyes. 
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1.2.2. Synthesis of BODIPYs 
Synthesis of the first BODIPY derivative was reported by Treibs and Kreuzer in 1968.[20] After 
almost 50 years of vast synthetic efforts towards preparation, modification, and optimization 
of the structure, an enormous amount of various BODIPY-based fluorophores has been 
reported.[19, 21] Nonetheless, the synthesis of the simplest member of BODIPY family (figure 
1.3) has remained a challenging task for a long time and was successfully accomplished only 
in the last decade.[22] Most probably, the high sensitivity of “naked” BODIPY skeleton towards 
electrophilic attack causes the low stability of this compound and limits its accessibility. 
The general approach towards BODIPY synthesis typically includes condensation of α-free 
pyrrole with highly electrophilic carbonyl compounds (either aldehydes or acylium 
equivalents), followed by BF2 complexation, as shown in figure 1.5. 
 
Figure 1.5. The general scheme of the synthesis of BODIPY core. 
In case X = Cl, the condensation of pyrrole with an acid chloride leads to the formation of 
unstable dipyrromethene hydrochloride salt, which is normally not isolated and used directly 
for the next stage without purification.[16b] Subsequent treatment with BF3·OEt2 in basic media 
yields BODIPY (figure 1.6).[23] With this approach, both alkyl and aryl groups can be 
introduced into meso-position. Instead of acid chlorides, acid anhydride[24] or orthoester[25] 
can be also used as acylium equivalent. 
 
Figure 1.6. Synthesis of pentamethyl substituted BODIPY.[23] 
Burgess and coworkers have used this approach to synthesize 3,5-diaryl BODIPYs (figure 
1.7).[26] The reaction of different 2-arylpyrroles with 4-iodobenzoyl chloride proceeds through 
ketopyrrole intermediates and ends up with diarylpyrromethenes, which are subsequently 
converted to BODIPYs. The presence of halogen atom in meso-phenyl ring opens the way for 
further modification of the molecule via Pd-catalyzed cross-coupling reactions.[27] 
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Figure 1.7. Synthesis 3,5-diphenyl BODIPY by Burgess and coworkers.[26] 
In the case X = H (figure 1.5), an aldehyde (typically aromatic) reacts with pyrrole in the 
presence of a catalytic amount of Lewis acid to produce dipyrromethane. Subsequent 
oxidation with DDQ or p-chloranil leads to the formation of dipyrromethene, which is 
converted to BODIPY in the same way as described above. This methodology of BODIPY 
preparation is also known as Lindsey’s approach (figure 1.8).[27a] It allows obtaining BODIPYs 
lacking any α- or β- substituents, although an excess of pyrrole is needed to suppress 
polymerization and/or porphyrin formation.[28] 
 
Figure 1.8. Synthesis of meso-phenyl BODIPY by Wagner and Lindsey.[27a] 
If 2-substituted pyrroles (one of the α-positions is blocked) are used for the synthesis, the 
condensation reaction with aldehyde stops on the stage of dipyrromethane formation.[27a] 
Baruah et al. used[29] only two equivalents of 2-methylpyrrole (compare to aldehyde) in order 
to obtain meso-phenolic BODIPY (figure 1.9). Phenolic benzaldehyde was chosen as carbonyl 
component in this case since the application of acid chlorides would have introduced 
chemoselectivity problems. 
 
Figure 1.9. Synthesis of meso-phenolic BODIPY by Boens and coworkers.[29] 
The disadvantage of this approach is additional synthetic step – oxidation, which also raises 
the amount of undesired by-products. Nonetheless, a variety of functionalized aromatic 
substituents can be introduced into meso-position using this methodology.[30] Application of 
aldehydes other than aromatic is rather rare and proceeds only with low yield,[31] since the 
oxidation stage tends to fail in these cases. 
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Asymmetric BODIPYs can be prepared by condensation of ketopyrrole (obtained on a separate 
stage) with another pyrrole fragment in the presence of Lewis acid. Lee et al. have used this 
approach[32] to synthesize asymmetrical BODIPY shown in figure 1.10. 
 
Figure 1.10. Synthesis of asymmetrical BODIPY.[32] 
Similarly to the acid chloride approach, dipyrromethene hydrochloride salt is formed on the 
first stage. Again, the addition of base and BF3·OEt2 yields BODIPY. Boens and coworkers have 
utilized this procedure[33] to prepare conformationally restricted asymmetric BODIPY with 
fused carbocycle (figure 1.11). 
 
Figure 1.11. Synthesis of conformationally restricted asymmetric BODIPY.[33] 
In the described above synthetic pathways, preparation of the desired target BODIPYs was 
achieved by careful choice of starting pyrrole and carbonyl components. The precursors 
already possess all the substituents to be introduced into the BODIPY core. In other words, the 
starting materials have been prefunctionalized, and the general synthetic strategy can be 
considered as prefunctionalization of BODIPY. Nonetheless, because of the chemical 
robustness of BODIPY core, its structure can be also modified after creation of the 
boradiazaindacene framework. The postfunctionalization strategy[18, 21] dramatically extends 
the diversity of the BODIPY family and opens access towards new dyes, which could not be 
synthesized by another approach. Both methodologies have its advantages and drawbacks and 
should be considered as complementary rather than competitive synthetic pathways. 
Postmodification at meso-position is readily available by using 8-thiomethyl BODIPY, which 
was first prepared by Goud et al. (figure 1.12).[31] To synthesize this very important synthon, 
thiophosgene has been used instead of carbonyl compounds in the condensation reaction with 
pyrrole. The obtained thioketone was further reacted with methyl iodide to produce 
dipyrromethene hydroiodide (alkylation occurred at sulphur), following the common 
procedure to yield BODIPY. 
 
Figure 1.12. Synthesis of Bielmann’s BODIPY.[31] 
A variety of different groups can be introduced into meso-position of such BODIPY by using 
the Liebeskind–Srögl cross-coupling reaction (figure 1.13)[34] or via SNAr processes.
[35] 
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Figure 1.13. Cross-coupling of 8-thiomethyl BODIPY described by Peña-Cabrera and coworkers.[34] 
Meso-halogenated BODIPYs are also important substrates for postderivatization. In the 
synthesis reported by Leen et al.,[36] halogen is introduced through deoxygenative substitution 
on a dipyrrylketone. Reaction with phosphorus oxychloride (or oxybromide) leads to rapid 
formation of a dipyrrinium salt, which is subsequently treated with BF3·OEt2 in basic media to 
produce BODIPY. This methodology was not suitable for introducing iodine into meso-
position, and the respective 8-iodo-BODIPY was obtained from 8-chloro-BODIPY by modified 
Finkelstein procedure (figure 1.14). 
 
Figure 1.14. Synthesis of meso-halogenated BODIPYs by Dehaen and coworkers.[36] 
It was shown[36-37] that (like for 8-thiomethyl BODIPY) halogen in meso-position can be 
substituted by various nucleophiles in SNAr reactions; these substrates are also active in Pd-
catalyzed Suzuki, Stille, and Sonogashira cross-couplings (figure 1.15). 
 
Figure 1.15. Reactivity of meso-halogenated BODIPYs. 
Postfunctionalization at α position(s) of BODIPY core can be done by various techniques.[18] 
The most important ones include transformations of α-haloganated BODIPYs,[38] which can be 
prepared either from suitably halogenated pyrroles,[39] or by halogenation of dipyrromethane 
intermediate,[29, 40] or directly from BODIPY[41] (figure 1.16). 
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Figure 1.16. Synthetic pathways towards α-chloro-BODIPY. 
Similar to meso-chloro-BODIPY, α-chlorinated BODIPYs readily undergo SNAr substitution 
reactions (figure 1.17).[27b, 40, 42] Monosubstitution easily proceeds at room temperature, while 
for disubstitution higher temperatures and/or longer reaction times are required. A variety of 
substituents can be also introduced by Pd-catalyzed Stille, Suzuki, Heck, Sonogashira and 
Negishi cross-coupling reactions (figure 1.17).[43] Selectivity between monosubstitution and 
disubstitution in the latter case can be achieved by applying one or two equivalents of the 
respective coupling partner. 
 
Figure 1.17. Reactivity of α-chlorinated BODIPYs. 
To introduce different groups directly into α position(s) of 3,5-unsubstituted BODIPYs 
(avoiding halogenation step), some modern procedures have been developed: oxidative 
nucleophilic substitution,[44] vicarious nucleophilic substitution,[45] palladium-catalyzed C–H 
arylation,[46] radical C–H arylation.[47] 
In contrast to others, the β position of BODIPY core is often modified via electrophilic 
aromatic substitution reactions (SEAr): halogenation
[48], formylation[49] and sulfonation[50] are 
the most typical examples. Also as in other cases, a special role is devoted to 2,(6)-halo-
BODIPYs[38-39], which are active in Suzuki and Sonogashira cross-coupling reactions (figure 
1.18).[39, 51] In the same time SNAr processes for these substrates are not known. 
 
Figure 1.18. Pd-catalyzed cross-coupling reaction of 2-iodo-BODIPY described by Dehaen and coworkers. 
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1.3. Application of transition-metal complexes labeled with BODIPY 
Being at the intersection of organic and inorganic chemistry, organometallic compounds are a 
crucial part of modern chemical science. The special role in this field is devoted to transition-
metal complexes because of their exceptional chemical properties and reactivity.[52] Just as an 
example it is worth to mention the revolutionary impact of transition-metal catalysis on the 
development of modern organic chemistry awarded by various Nobel prizes. Nowadays, 
transition-metal organometallic complexes have found a wide variety of applications both in 
industry and academia. 
This chapter describes various reactions and applications of well-defined transition-metal 
complexes, which are tagged with BODIPY fluorophore. Such species can combine useful 
properties of the organometallic compounds and light absorbing/emitting capability of the 
dye. Besides the outstanding photophysical properties (e.g. high brightness and 
photostability), BODIPY has other unique characteristics, which makes it preferable to 
combine with transition metals. First of all, BODIPY core doesn’t contain functional groups 
suitable for complexation with transition metals and therefore remains sufficiently chemically 
inert to not interact with (active) transition-metal center. Another important point comes 
from the fact that the molecules of typical fluorophore and metal complex are in the same size 
range. The use of relatively small BODIPY ensures (or at least significantly reduced) possible 
steric interference between fluorophore part and transition-metal side. One more useful 
property of BODIPY is the possibility of versatile chemical modifications of its core, which 
facilitate tethering of this dye to a metal complex. Consequently, BODIPY is a very promising 
fluorophore for tagging transition-metal complexes. 
1.3.1. Study of catalytic processes (ensemble experiments) 
Understanding the mechanisms of catalytic processes is crucial for further improvements of 
catalytic systems towards better efficiency and selectivity. Nonetheless, direct observation of 
catalytically active species in solution represents a very challenging task, since the 
concentration level of such species is normally beyond the sensitivity range of common 
analytical techniques (for instance NMR). Being the most sensitive analytical tool, 
fluorescence spectroscopy is a promising method in the field of catalytic mechanisms study. 
For instance, it was used to clarify mechanistic details in ruthenium-mediated metathesis 
reactions[3a, 3b] or to observe palladium-catalyzed transformations.[3c] Dapoxyl and dansyl were 
used as fluorophores in these cases. 
The application of BODIPY-tagged complexes in similar experiments was first reported by Lin 
and Blum.[53] The aim of their fundamental work was to show the applicability of two-ligand 
FRET method for the study of transition-metal systems. To achieve this task, palladium 
complex 1.3 tagged with donor and acceptor BODIPY fluorophores has been synthesized by 
reacting palladium dimer 1.1 with BODIPY-tagged phosphine 1.2 (figure 1.19). Both ligands 
in such complex are coordinated to one metal center, and therefore donor and acceptor 
fluorophores are close enough to each other for FRET to occur. Indeed, a decrease in emission 
intensity of donor BODIPY with simultaneous increase of acceptor intensity was observed, and 
a FRET efficiency of 92% was established. It was shown, that emission intensity of donor and 
acceptor was proportional to the concentration of the complex 1.3 over the range from 3 × 
10-7 to 5 × 10-6 M. Measurements at lower concentration level were limited by the 
spectrometer sensitivity. At higher concentrations, the impact of intermolecular FRET or self-
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quenching became significant. Thus, together with other additional experiments, it was 
proven that at the concentration range of the experiments the changes in fluorescence 
intensities of donor and acceptor fluorophores occurred exclusively due to intramolecular 
FRET within complex 1.3. 
 
Figure 1.19. Synthesis of complex 1.3.[53] 
The formation of complex 1.3 can be observed directly in the cuvette of the spectrometer. 
Upon mixing of stoichiometric amounts of phosphine 1.2 and complex 1.1 in one portion, the 
rapid increase of acceptor emission intensity was observed. The final intensity level was 
almost the same as predicted for the full conversion. The addition of aliquots of phosphine 1.2 
to the solution of complex 1.1 resulted only in a partial increase of fluorescence intensity 
respectively to the rate of conversion. The changes of fluorescence intensity were monitored 
in real-time. The authors also stressed that the proposed analytical method can be performed 
at much lower concentration level with faster resolution time than is accessible for NMR 
spectroscopy. Based on the elementary ligand-exchange reaction, this groundwork has shown 
that fluorescence spectroscopy is a suitable analytical technique for the observation and 
quantification of the transformations of transition-metal complexes at the micromolar 
concentration level. 
Recently, Navarro et al. have shown[54] that cleavage of the triazolylidene palladium dimer 
1.4 with acridine led to the moderate (around 8%) decrease of fluorescence intensity of 
BODIPY fluorophore (figure 1.20). Addition of DMAP, instead of acridine, didn’t influence the 
fluorescent intensity, which defined DMAP as a spectator ligand. In the same time, being more 
donating, DMAP can substitute acridine in complex 1.5 to form complex 1.6, which led to an 
increase of fluorescence intensity. Based on this observation, the authors have suggested that 
fluorescence spectroscopy can be used for monitoring other ligand-exchange reactions of the 
complex 1.5 and, more generally, for investigation of catalytic transformations caused by this 
precursor. 
 13 
 
Figure 1.20. Transformations reported by Navarro et al..[54] 
Blum and coworkers have used fluorescence microscopy techniques to study various 
organometallic transformations. By imaging the location of the nascent polymers relative to a 
solid surface of single crystals of Grubbs II catalyst, metathesis polymerization was revealed to 
be solely homogeneous rather than heterogeneous or both.[55] Two-fluorophore experiments 
revealed the “dumbbell” polymer morphology, which was shown to be originated from 
physical strand aggregation/precipitation rather than chemical attachment.[56] In more recent 
work,[57] fluorescence microscopy has been applied to study the oxidative addition of 
organohalides to metallic zinc powder. Upon mixing of the model alkyl iodide 1.7 with zinc, 
the appearance of bright fluorescent spots on the surface of zinc particles was observed 
(figure 1.21). It was unambiguously established that the observed fluorescence was due to the 
formation of an oxidative addition product rather than nonspecific physisorption or Lewis 
acid/base coordination. Moreover, the role of lithium chloride, which is known to facilitate 
the formation of organozinc reagents,[58] was also revealed. It was shown that the addition of 
lithium chloride led to the solubilization of the formed organometallic species and re-
exposure of zinc surface for further substrate insertion. Concurrent complexation of both 
lithium and chloride was determined to be important for enhancing the solubility of the 
surface species. This work describes the first example of successful fluorescence spectroscopy 
application for the determination of the mechanistic role of a reagent in 
organic/organometallic synthesis. 
 
Figure 1.21. General schematic of the experiment reported by Feng et al..[57] 
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1.3.2. Study of catalytic processes (single-molecule experiments) 
Compared to ensemble experiments, which provide averaged spectra of billions of molecules, 
the main fundamental advantage of single-molecule fluorescence microscopy (SMFM) is the 
chance to record signal evolution of individual fluorophores.[9] As a consequence, it is possible 
to study reaction kinetics avoiding high-speed mixing or other synchronization methods. Also, 
in the case of macromolecules, fluctuations of their structure can be seen directly using 
SMFM, which is not possible in ensemble-averaged measurements. However, most single-
molecule techniques require immobilization of substrate, which limits SMFM application to 
the investigation of surface processes. 
Even though the first applications of SMFM for studying biological systems were reported 
almost 30 years ago,[59] its usage for monitoring transition-metal transformations started 
developing only in the last decade.[60] Cordes and Blum in their perspective[4] identified the 
following reasons for this lag: lower substrate specificity of transition-metal complexes 
compare to biomolecules, which complicates the elimination of non-specific background 
signals; absence of commercially available fluorophores designed specifically to probe 
chemical systems; more strict requirements for the experimental conditions in case of air-
sensitive transition-metal complexes, whereas biophysical systems normally tolerate ambient 
conditions. Despite the mentioned problems, noticeable progress in this area has been 
recently achieved.[4, 61] 
The first SMFM imaging of fluorophore-tagged transition-metal complex outside of biological 
systems was reported by Canham et al. in 2008.[62] BODIPY-tagged palladium (II) complex 
1.8 has been synthesized and immobilized on the surface of glass coverslip (figure 1.22). The 
covalent character of the immobilization was proven by polarization-modulation Fourier 
transform IR reflection-absorption spectroscopy (PM-FTIRRAS). Individual molecules of the 
complex 1.8 were successfully observed by using SMFM. This groundwork represents the first 
step in the development of the single-molecule study of transition-metal complexes. 
 
Figure 1.22. Immobilization of BODIPY-tagged palladium complex on a glass coverslip.[62] 
The next obvious step to try would be observing by SMFM an elementary event of transition-
metal catalysis – a ligand-exchange reaction. This was done by Esfandiari et al..[63] The 
concept, introduced by the authors, is shown in figure 1.23. The water molecule in BODIPY-
tagged platinum complex 1.9 can be easily substituted by sulphur-containing ligand. In case 
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this ligand is bonded to the surface, the formation of Pt–S bond would result in bonding of 
complex 1.9 to the surface as well. In the conditions of total internal reflectance fluorescence 
(TIRF) excitation mode, only surface-bonded species can be observed by SMFM. Therefore, 
only ligand-exchange events would produce signals, which indeed were successfully 
monitored at single-molecule level in real time. 
 
Figure 1.23. Schematic representation of the experiment reported by Esfandiari et al..[63] 
These experiments have also provided useful information about reactivity distribution on 
triethoxysilane-modified surfaces, which are used in industry as a catalyst support. Such type 
of information is not available by other traditional methods. Superlocalization techniques 
allowed to localize chemical processes on the surface with accuracy up to ±11 nm, i.e. below 
the diffraction limit. It was shown that the observed chemical transformations are 
uncorrelated which means the chemical reaction of one metal complex did not influence the 
location of a future chemical reaction of another metal complex. By using SMFM it was also 
possible to determine the kinetics of ligand-exchange reactions on the surface, and the 
biexponential first-order profile was found. Deconvolution strategy was applied to obtain this 
result. 
Surface-supported molecular catalysts attract the attention of chemists due to their ease of 
recovery and potential recyclability. However, kinetic investigations of this type of catalysts by 
common spectroscopic techniques are hampered because of surface heterogeneity and 
biphasic conditions. In 2016, Goldsmith and coworkers have shown[64] how SMFM can be 
applied to study the initiation dynamics of an operational surface-supported palladium 
catalyst. The prepared fluorescent complex 1.10 (figure 1.24) contained BODIPY moiety 
covalently bound to the pyridine ligand. Catalyst initiation upon base addition led to the 
release of the ligand, which then diffused quickly out of the excitation volume and didn’t 
longer emit. Therefore, loss of the fluorescence signal at a single complex can be correlated 
with the start of initiation at that individual complex. 
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Figure 1.24. General schematic of the experiment reported by Goldsmith and coworkers.[64] 
Analysis of the rate of signal loss during the catalyst initiation has revealed highly 
heterogeneous kinetics. This result was attributed to the presence of different local 
microstructures on the surface. Although their exact structures are still unknown, the obtained 
data allowed the evaluation of different hypotheses, resulting in a plausible 
structure−reactivity model. This work provided the first direct evidence that the many 
different physical surface microstructures detected in silyloxy tethered molecular complexes 
displayed different chemical reactivity. 
Despite the obvious progress in the imaging of transition-metal complexes and simple ligand-
exchange reactions, observation of subsequent catalytic transformations still remains a 
challenging goal. 
1.3.3. Fluorescent chemosensors 
The term fluorescent chemosensor describes abiotic compounds which are able to transform 
chemical information (e.g., presence and/or concentration of some particular species) into a 
useful fluorescence signal. BODIPY-based chemosensors have found a wide variety of 
applications in different areas of science.[13] Despite that, fluorophore-tagged transition-metal 
complexes have not been widely used for sensing purposes so far. One of the fields, where 
such compounds have promising sensing potential, is gas detection, in particular, carbon 
monoxide sensing.[5] 
The development of new CO sensors is driven by the high toxicity of this gas. The need of 
detection at very low concentration level (less than 50 ppm) represents a challenging task. 
Application of highly sensitive fluorescence techniques seems to be a very promising strategy 
to tackle this problem. Fluorogenic probes based on luminescence transition-metal 
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complexes[65] are very attractive for the development of new CO chemosensors.[66] The first 
BODIPY-based CO probe was reported by Chang and coworkers.[67] The initially quenched 
BODIPY-tagged palladium dimer 1.11 fell apart upon reaction with CO (figure 1.25). The 
released free BODIPY showed very bright fluorescent emission, which can be easily detected. 
 
Figure 1.25. BODIPY-based CO probe reported by Chang and coworkers.[67] 
BODIPY-tagged transition metal complexes for CO sensing, in which the fluorophore plays a 
spectator role, were developed by Plenio group. In 2015, Kos and Plenio have reported[68] 
[(NHC)MX(cod)] complexes 1.12-1.15 (M = Ir, Rh; X = Cl, I; figure 1.26), which contained 
a BODIPY moiety covalently bonded to the NHC ligand. Upon substitution of the labile cod 
ligand into stronger coordinated CO, the initially fluorescence quenched (“dark”) cod 
complexes 1.12-1.15 were irreversibly transformed to the very bright carbonyl complexes 
1.16-1.19. Based on this observation the reported complexes were recognized to be suitable 
for CO detection. A similar sensing principle was used by Chung and coworkers,[66c] although 
[Ru(phen)3]
2+-based subunits were used as luminescence labels in that case. 
 
Figure 1.26. Fluorescence-based CO chemosensors reported by Kos and Plenio.[68] 
High fluorescence emission of carbonyl complexes indicated that the heavy-atom effect was 
not a dominant quenching mechanism in this case. The authors proposed photoinduced 
electron transfer (PET) to be responsible for the observed fluorescence changes. This 
hypothesis was supported by cyclic voltammetry measurements, which established the metal 
center to be more electron-deficient in the case of the carbonyl rather than cod complexes. 
The best sensing results were observed for complex 1.14. In case ethyl acetate was used as a 
solvent, bubbling of CO gas through the micromolar solution of 1.14 led to an 80-fold 
increase of fluorescent intensity. Moreover, the reaction was extremely fast and led to 
completion within few seconds. Complex 1.14 had shown high sensitivity while exposed to 
the atmospheric air containing less than 100 ppm of CO. It should be also noted that the final 
fluorescence intensity was proportional to the amount of CO in the sample. 
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The main disadvantage of this approach was the small Stokes shift of the complexes (no more 
than 25 nm), which meant very similar wavelength for the reflected excitation light and 
fluorescence emission. Difficulties in distinguishing emitted and reflected light can possibly 
cause serious problems while applying the probe for sensing in real situations. To increase the 
difference between excitation and emission wavelength, Halter and Plenio have recently 
utilized[69] a strategy based on fluorescence resonance energy transfer (FRET). Newly 
prepared iridium complex 1.20 (figure 1.27) contained two BODIPY units constituting the 
FRET pair. It has shown virtual Stokes shift of almost 100 nm, which meant green excitation 
and red emission light. Despite this improvement, the addition of carbon monoxide solution 
to the solution of complex 1.20 gave a fluorescent gain (the relationship between final and 
starting fluorescence intensities) of only 1.7, which is not ideal for CO sensing. 
 
Figure 1.27. Fluorescence CO chemosensors reported by Halter and Plenio.[69] 
Since PET was shown to be the dominant quenching mechanism in such systems, the authors 
have proposed that modulation of the electron density at the metal center could result in 
improved sensing properties. Thus, stable thiolato complex 1.21 (figure 1.27) was prepared 
by reacting of complex 1.20 with para-nitrothiophenol in the presence of a base, which led to 
the substitution of chloride into thiolato residue. Because of donating properties of thiolates, 
such substitution reaction caused an increase in electron density on iridium, which in turn led 
to quenching of the fluorescence. The emission intensity of compound 1.21 was almost three 
times lower than for the starting complex 1.20, whereas upon reaction of 1.21 with CO 
fluorescence intensity has reached roughly the same level as in the case of 1.20 (figure 1.28). 
Hence, compared to complex 1.20, the fluorescent gain for 1.21 was considerably improved 
and determined to be 4.3. Impregnation of an indicator paper strip with a solution of complex 
1.21 allowed to obtain simple sensing device. Upon exposure to air containing 500 ppm of 
CO, a pronounced colour change of the fluorescent emission was observed within a few 
minutes. Chemosensor 1.21 has also shown excellent CO selectivity under ambient 
conditions. This work has introduced a fruitful strategy towards optimization of the 
fluorogenic probes, which is based on the fine-tuning of the electron density in fluorophore-
tagged transition-metal complexes. 
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Figure 1.28. Fluorescence–time trace for the reactions of 1.20 (c = 1.0×10-6 molL-1 in 1,2-dichloroethane) with 
HSC6H4NO2 (200 equiv) followed by CO (gain = 4.3; blue trace) or with CO (gain = 1.7) followed by HSC6H4NO2 (red 
trace) in the presence of Hünig base (200 equiv). The fluorescence intensity of 1.20 has been set to 1.0. Taken from 
reference [69]. 
A fluorescence-based sensing approach can be also applied for detection of hydrogen. 
Development of hydrogen-based economy creates demand for hydrogen sensing to properly 
address safety issues. In 2015 Kos and Plenio reported[70] the first chemosensors for H2 
(compounds 1.22 and 1.23, figure 1.29), which were based on Crabtree-type iridium 
complexes tagged with BODIPY fluorophore. As shown in figure 1.29 upon oxidative addition 
of hydrogen initially quenched complexes 1.22 and 1.23 were converted to much brighter 
1.24 and 1.25. The fluorescence gains were 11.7 and 9 respectively. Since oxidation state of 
iridium center increased during the reaction (from I to III), PET was established as the main 
quenching mechanism, which was in a good agreement with the above-mentioned works.  
The impregnated paper strips have shown excellent sensitivity for hydrogen detection (figure 
1.30). The distinguishable fluorescent brightness of paper strip was observed even at H2 
concentration of 4% – lower explosion limit. The fluorescent probes 1.22 and 1.23 were also 
used for monitoring of the catalytic hydrogenation reaction with different alkenes. The 
increase of fluorescence intensity during the reactions was very similar to the formation of 
dihydride species alone in the absence of alkene substrates. Based on this observation the 
authors assumed that the iridium dihydride species were the dominant ones in the catalytic 
reactions. Hence, probes 1.22 and 1.23 were shown to be not only efficient hydrogen 
chemosensors but also useful for the analysis of catalytic hydrogenation reactions. 
 
Figure 1.29. First hydrogen chemosensors described by Kos and Plenio.[70] 
 20 
 
Figure 1.30. Hydrogen-sensitive paper strips.[70] 
Nitroxyl (HNO), the one-electron reduced, protonated analogue of nitric oxide, is one of the 
reactive nitrogen species (RNS) relevant to biology.[71] Rosenthal and Lippard have 
reported[72] complex 1.26 (figure 1.31), which appeared to be the first fluorescent molecular 
probe with visible excitation and emission profiles for detecting HNO in living biological 
samples. Complex 1.26 was only weakly fluorescent (Φ = 0.01), which was attributed to PET 
from BODIPY to the bound Cu2+ ion. However, reduction of Cu2+ ion, for instance, with 
cysteine led to the restoring of fluorescence emission. Treatment of complex 1.26 with excess 
Angeli’s salt, which generates an equimolar ratio of nitroxyl and nitrite under physiological 
conditions, resulted in a 4.3 ± 0.6-fold increase in fluorescence intensity, demonstrating fast 
HNO turn-on detection. The ability of complex 1.26 to operate in live cells was also studied 
and an excellent selectivity for HNO over other biologically relevant RNS, including NO, was 
observed. 
 
Figure 1.31. Fluorescent molecular probe for nitroxyl reported by Rosenthal and Lippard.[72] 
Despite the need of further improvement, the BODIPY-tagged transition-metal complexes 
have been proven as promising fluorescent probes, in particular, for gas detection. It was 
shown that the changes in the electron density at the metal center, caused by ligand 
exchange, can be effectively translated into observable changes of the fluorophore brightness. 
1.3.4. Triplet photosensitizers 
Triplet photosensitizers (PSs) are compounds which upon photoexcitation efficiently generate 
a triplet excited state that is subsequently transferred to other compounds which have only a 
small intrinsic triplet state yield.[73] The main photophysical features of triplet PSs are the 
following: strong absorption of the excitation light; efficient intersystem crossing (ISC) from 
singlet to triplet states; a long triplet lifetime to ensure productive collisions with triplet 
energy acceptor. The unique properties of PSs have found wide application in photodynamic 
therapy (PDT),[74] photocatalytic reactions[75] and triplet-triplet annihilation (TTA) 
upconversion.[76] 
0 1 100 4 H
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Because of the excellent photophysical properties, BODIPY dyes are widely used as triplet 
photosensitizers.[77] The BODIPY core should be modified in order to enhance ISC to the 
triplet state. This is commonly achieved by introducing heavy atoms into its structure 
(bromine or iodine are typical examples),[14] although heavy-atom free photosensitizers are 
known as well.[78] Attachment of the BODIPY unit to the transition-metal complexes should 
also enhance formation of the triplet state.[6] The content of the current section is devoted to 
BODIPY-tagged transition-metal complexes, which show promising photosensitizing 
properties. The obtained conjugates were used for the singlet oxygen generation and TTA 
upconversion, so these topics are also briefly introduced. 
The lowest energy excited state of the molecular oxygen (so-called “singlet oxygen”) 
demonstrates significantly different chemical behaviour from that in the ground triplet 
state.[79] The most convenient method of singlet oxygen generation is based on electronic 
energy transfer from an excited state of PS molecule to a ground state of oxygen. Because of 
its unique characteristics, singlet oxygen still remains at the forefront of a wide range of 
scientific research.[80] Cytotoxic properties of singlet oxygen have found broad application in 
medicine for cancer treatment. The methodology, called photodynamic therapy (PDT),[74] is 
based on the photosensitized singlet oxygen production and can be applied to remove ailing 
tissue. The application of PDT relies on a combination of three key elements: light, active 
photosensitizer and molecular oxygen. The PS drug is delivered to the ailing region, which is 
subsequently irradiated with light to generate reactive oxygen species (mainly singlet 
oxygen), which destroy target diseases. Because of the low half-life of singlet oxygen, its 
therapeutic effect can be highly localized. 
Photon upconversion is defined as an anti-Stokes process in which the wavelength of emitted 
light is shorter than the excitation wavelength.[81] One of the possible mechanisms which 
allow upconversion to occur is triplet-triplet annihilation (TTA).[76] TTA upconversion is based 
on the combination of two different compounds: the triplet sensitizer (donor) and the triplet 
annihilator (acceptor). As shown in figure 1.32, at first light energy is accumulated in the 
triplet excited state of the sensitizer upon its excitation followed by ISC. Next, the acceptor is 
excited to the triplet state via triplet-triplet energy transfer (TTET) process from sensitizer. 
And finally, TTA occurs when excited acceptor molecules collide with each other to produce 
the singlet excited state of the acceptor, whose subsequent decay results in upconverted 
fluorescence. The efficiency of the described sequence critically relies on the relative 
arrangement of the energy levels both of donor and acceptor. The big advantage of TTA 
upconversion is the low energy density needed for sensitizing process. Even solar light can be 
used as the excitation source, which makes TTA upconversion very promising technique for 
application in various photophysical and photochemical processes. 
 
Figure 1.32. Generalized energy level diagram of the TTA upconversion processes. Solid lines represent radiative 
processes. GS is ground state, ES is excited state, ISC is intersystem crossing, TTET is triplet-triplet energy transfer, 
and TTA is triplet-triplet annihilation. Taken from reference [76b]. 
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For the first time BODIPY-based phosphorescence was observed in the BODIPY-tagged Ru(II) 
polypyridine complexes (figure 1.33, compounds 1.27-1.29), described by the research group 
of Raymond Ziessel.[82] Despite being hybrids of two well-known luminophores, the reported 
complexes 1.27-1.29 didn’t show any luminescence in solution at room temperature. 
However, nanosecond transient absorption spectroscopy revealed the formation of a long-
lived (microsecond timescale) excited state, which was identified as the BODIPY-based triplet 
state. In contrast to room temperature, at 77 K in a rigid matrix, the long-lived (millisecond 
lifetime) emission at about 770 nm was observed for these complexes. The authors have 
assigned the observed phosphorescence to be BODIPY-centered. It was proposed that BODIPY-
based phosphorescence has occurred due to the presence of the heavy ruthenium metal and 
closely lying metal-based 3MLCT level of the Ru(terpy)2-type subunits. It should be noted that 
the low-temperature fluorescence of BODIPY subunit was also observed, albeit with reduced 
lifetimes in comparison to the corresponding free ligands. 
 
Figure 1.33. BODIPY-tagged ruthenium (II) complexes described by Galletta et al..[82] 
The application of BODIPY as a visible light-harvesting ligand for Ru(II) complexes was 
further developed in the work of Wu et al..[83] They have reported the new complexes 1.30 
and 1.31 (figure 1.34), which contain both Ru(II) polyimine and BODIPY subunits connected 
however by different types of linkers. Thus, in the complex 1.30 the luminophores are joined 
via C≡C bridge, which enables π-conjugation between BODIPY and Ru(II) polyimine subunits, 
whereas in the complex 1.31 the BODIPY is tethered to the coordination framework of 
ruthenium by phenylethynyl moiety; therefore, no conjugation is possible in the latter case. 
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Figure 1.34. BODIPY-tagged ruthenium (II) complexes described by Wu et al..[83] 
Both complexes 1.30 and 1.31 showed strong absorption of visible light. Nonetheless, only in 
the case of complex 1.30, room temperature near IR (NIR) phosphorescence of BODIPY unit 
was observed (emission at 741 nm in deaerated solution). For Ru(II) complexes such a result 
was reported for the first time. It was proposed, that because of π-conjugation heavy atom 
effect in 1.30 was more significant than in 1.31, which resulted in more efficient ISC in 1.30. 
Fluorescence emission of both complexes was considerably quenched. In contrast, 
fluorescence of complex 1.30 totally disappeared at 77 K, although phosphorescence was 
preserved. For complex 1.30 no BODIPY phosphorescence emission was observed even at low 
temperature. This result is in agreement with previous work of Ziessel,[82] who observed low-
temperature phosphorescence only with terpyridine-based complexes 1.27-1.29, whereas 
analogous bipyridine-based complexes didn’t show any phosphorescence. 
Complexes 1.30 and 1.31 were tested as the triplet photosensitizers for singlet oxygen 
generation. Using 1,5-dihydroxynaphthalene as a scavenger, kinetics of singlet oxygen-
mediated photooxidation was followed. Determined singlet oxygen quantum yield for 
complex 1.30 was 0.93, while for complex 1.31 only 0.64. The higher level of singlet oxygen 
production in case of compound 1.30 was associated with more efficient ISC. This result 
further supports that π-conjugation between BODIPY and ruthenium coordination center 
greatly facilitates ISC. The reported work serves a nice example to show how properties of 
BODIPY-tagged transition-metal complexes can be adjusted by choosing suitable linker 
between fluorophore and metal coordination framework. A very similar approach was used 
for the preparation of highly efficient triplet photosensitizers based on Pt(II) complexes[84] 
and cyclometalated Ir(III) complexes.[85] 
Instead of Ru(II), other metal complexes were also linked to BODIPY. Nastasi et al. have 
reported[86] synthesis of novel BODIPY-tagged Pt(II) terpyridine complex 1.32 (figure 1.35). 
Compare to analogous Ru(II) species, the photophysical properties of the new complex were 
found to be different. In compound 1.32 fluorescence of BODIPY subunit is not significantly 
quenched both at room temperature and at 77 K. Although an oxidative photoinduced 
electron transfer is thermodynamically allowed, it is not so efficient, as in the case of Ru(II), 
because of unfavorable electronic factors due to the specific structural arrangement of the 
subunits. Under the same conditions, the luminescence of the Pt(terpy) part is almost 
quenched by energy transfer to the BODIPY triplet state. Analogously to Ru(II) complexes, 
compound 1.32 exhibited phosphorescence of BODIPY at 77 K. The reason for this is the 
presence of the heavy metal center. 
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Figure 1.35. BODIPY-tagged platinum (II) complex reported by Nastasi et al..[86] 
Based on the previous experience with Ru(II) complexes, Wu et al. have reported[87] new 
BODIPY-tagged Pt(II) complex, where the fluorophore and metal centers were connected 
directly with acetylide bonds in order to maximize the heavy-atom effect of platinum (figure 
1.36, compound 1.33). Complex 1.33 showed strong absorption in the visible-light range and 
a long-lived triplet excited state. Room-temperature NIR phosphorescence of BODIPY was also 
observed for this compound. The localization of triplet state on the BODIPY moiety was 
confirmed by steady-state and time-resolved spectroscopy, emission spectra at 77 K, and DFT 
calculations. Showing suitable photophysical properties, complex 1.33 was used as triplet 
photosensitizer for TTA upconversion. Upon excitation of compound 1.33 in the presence of a 
triplet acceptor (perylene), an intense blue emission can be observed even with naked eye. 
Irradiation of perylene alone did not produce the blue emission, which clearly supported the 
upconverted fluorescence. The upconversion quantum yield was determined as 5.2%. 
Concerning the intense absorption of complex 1.33, its overall upconversion capability was 
significant. 
 
Figure 1.36. BODIPY-tagged platinum (II) complexes reported by Wu et al..[87] 
In the following work Zhao and coworkers have described[88] symmetric and asymmetric 
BODIPY-tagged platinum(II) bis(phosphine) bis(aryleneethynylene) complexes 1.34-1.37 
(figure 1.37). The prepared compounds have shown strong visible light absorption profile, 
which was red-shifted in the case of binuclear complexes 1.36 and 1.37 compared to 
mononuclear complexes 1.34 and 1.35. The complexes 1.34-1.37 have exhibited fluorescence 
at room temperature, as well as weak phosphorescence. Nanosecond time-resolved transient 
difference absorption spectroscopy revealed long-lived BODIPY-localized triplet excited states 
for all complexes. This was supported by 77 K emission and spin density analysis. The 
compounds 1.34-1.37 were used as efficient triplet photosensitizers for TTA upconverted 
emission of perylene. Interestingly, for complexes 1.34 and 1.35 higher upconversion 
quantum yields were determined (19.0% and 14.3% respectively) than in the case of 1.36 
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and 1.37 (3.0% and 3.5%). It was proposed the energy differences between triplet excited 
states of perylene and Pt(II) complexes matched better for TTA upconversion in the case of 
compounds 1.34 and 1.35. 
 
Figure 1.37. BODIPY-tagged platinum (II) complexes described by Zhao and coworkers.[88] 
In order to expand the absorption wavelength range and thus additionally improve the 
sensitizer’s efficiency, Jia et al. have further developed[89] the structure of BODIPY-tagged 
Pt(II) complexes (compounds 1.38 and 1.39, figure 1.38). To achieve broadband absorption 
of visible light, a strategy was proposed to combine different fluorophores with different 
absorption profiles in one metal complex molecule. Complexes 1.38 and 1.39 contained three 
BODIPY subunits. Because of different coordination profiles, these subunits had different 
absorption wavelength. Indeed, for the complex 1.38, the absorption band was observed in 
the range 450-700 nm, which was clearly much broader than for the previously reported 
complex 1.36 with only one BODIPY moiety attached. Complex 1.39 showed two well-
separated absorption bands at 504 nm and 640 nm, which were assigned to the peripheral 4’-
phenyl coordinated BODIPY and the central coordinated BODIPY subunits respectively. The 
absorbed photoexcitation energy was subsequently transformed into the triplet excited state 
energy through intramolecular resonance energy transfer (RET) followed by ISC. Complex 
1.38 showed fluorescence emission and weak phosphorescence at room temperature. For 
complex 1.39 only fluorescence was observed. Long-lived triplet excited states were 
determined for both complexes. In the case of complex 1.38, triplet excited state was 
distributed on all BODIPY subunits, whereas in 1.39 it was localized only on the central 
BODIPY ligand. Complexes 1.38 and 1.39 were used for singlet oxygen generation and 
showed high quantum yields (76% and 78% respectively). Successful application in multi-
wavelength excitable TTA upconversion was also shown. 
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Winter and coworkers have described[90] complexes 1.40 and 1.41 (figure 1.39), where 
platinum atom was directly attached to BODIPY ligand via its meso-position. Complexes cis-
1.40 and cis-1.41 showed almost exclusively fluorescence (Φ values of 26% and 19.5%, 
respectively). The trans-configured complexes trans-1.40 and trans-1.41 showed dual 
emissions with bands centered at ca. 485 nm (fluorescence) and 640 nm (phosphorescence). 
The fluorescence quantum yield of trans-1.41 was reduced to 7.2%, whereas the 
phosphorescence quantum yield reached a value of 14.2%. The data for trans-1.40 were even 
more impressive: fluorescence quantum yield of 1.1% and phosphorescence quantum yield of 
31.2% were established. More efficient ISC in case of trans-1.40 and trans-1.41 was 
attributed to the shorter distance between Pt and BODIPY in these complexes according to 
single crystal X-ray analyses. Since the intensity of phosphorescence emission was very 
sensitive to the presence of oxygen, complex trans-1.40 appeared to be a very promising 
sensor for the ratiometric detection of oxygen up to the atmospheric level. 
 
Figure 1.39. BODIPY-tagged platinum (II) complexes reported by Winter and coworkers.[90] 
In the subsequent research, Winter and coworkers reported[91] new platinum (II) complexes 
1.42-1.44 (figure 1.40), which all contained two different dye ligands connected to the 
platinum atom by a direct σ bond. Additional fluorophore was found to act as an antenna that 
funnels the light absorbed by the dye with the higher excitation energy to the one absorbing 
at lower energy, providing fast and efficient energy transfer. All complexes show dual 
fluorescence and phosphorescence emission with a maximum phosphorescence quantum yield 
of 41% for complex 1.43, which is the highest value for room temperature phosphorescence 
from a BODIPY dye reported until now. Complex 1.43 was used for singlet oxygen generation 
and quantum yield of 36% for this process was found. 
 
Figure 1.38. BODIPY-tagged platinum (II) complexes reported by Jia et al..[89] 
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Figure 1.40. BODIPY-tagged platinum (II) complexes described by Geist et al..[91] 
The first Re(I) tricarbonyl chloride complexes attached to BODIPY were reported[92] by Zhao 
and coworkers (figure 1.41). A π-conjugation linker, a C≡C triple bond, was used to ensure 
efficient ISC. Attachment of electron-donating substituent to BODIPY moiety in complex 1.46 
resulted in the broader absorption band of this compound compared to complex 1.45. In the 
prepared complexes only fluorescence of the ligand was observed upon excitation, not the 
phosphorescence of the Re(I) coordination center. However, long-lived triplet excited states 
were identified. Nanosecond time-resolved transient absorption spectroscopy and DFT 
calculations have proven the triplet excited states of 1.45 and 1.46 to be localized on the 
BODIPY ligands. The quantum yield of singlet oxygen production for complex 1.45 was 
established to be 88%, which was significantly higher than for complex 1.46 (0.06%). Most 
likely, less efficient ISC in 1.46 is due to ligand bulkiness. The overall TTA upconversion 
capability (proposed by the authors as the product of extinction coefficient and upconversion 
quantum yield) was 15 times higher for complex 1.45 than for complex 1.46. 
 
Figure 1.41. BODIPY-tagged Re(I) tricarbonyl chloride complexes reported by Zhao and coworkers.[92] 
Rhenium bipyridine platforms were used for photocatalytic conversion of CO2 to CO.
[93] In 
order to expand the absorption profile of these compounds to visible region, Andrade et al. 
have prepared[94] BODIPY-tagged complex 1.47 (figure 1.42). However, photochemical 
activation of CO2 mediated by 1.47 with light of λex ≥ 495 nm resulted only in trace levels of 
CO production. This outcome was attributed to very poor electronic coupling between the 
BODIPY moiety and Re center due to rather long distance between the two. This work has 
clearly demonstrated the importance of linker between BODIPY and metal moieties for the 
efficient sensitizing process. 
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Figure 1.42. BODIPY-tagged Re(I) complex reported by Andrade et al..[94] 
The first phosphorescence BODIPY-tagged iridium complex 1.48 (figure 1.43) was described 
by Rachford et al..[95] As expected, the luminescence of this complex at room temperature was 
mostly quenched due to ISC. However, at 77 K complex 1.48 showed phosphorescence at 730 
nm, which was demonstrated to result from triplet state of BODIPY subunit. Such results were 
in a good agreement with previous investigations.[82] 
 
Figure 1.43. BODIPY-tagged iridium complex described by Rachford et al..[95] 
An interesting approach towards NIR photosensitizers was reported by Zhou et al.,[96] who 
designed and synthesized hybrid organic–metal complexes 1.49-1.52 (figure 1.44). The 
implemented strategy was based on the combination of the complementary advantages of 
aza-BODIPY dyes and iridium (rhodium) porphyrin complexes. Thus, the obtained compounds 
showed strong NIR absorption of the aza-BODIPY moieties together with long-lived triplet 
states of transition metal porphyrins. The photosensitizing capabilities of the conjugates were 
investigated by applying them for the singlet oxygen production. Ir(III) complexes 1.49 and 
1.50 showed high quantum yields of 0.85 and 0.79 respectively; efficiency of Rh(III) 
complexes 1.51 and 1.52 was lower, evaluated quantum yields were 0.27 for 1.51 and 0.19 
for 1.52. The authors have also noted remarkable photostability of the synthesized 
compounds. The reported results are very promising for the future developments. Thus, very 
recently, Xu et al. have reported[97] multi-dimensional Ni(II) and Zn(II) porphyrin-BODIPY 
hybrids, which might be suitable for mimicking the photosynthesis process or studying host-
guest chemistry. 
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Figure 1.44. BODIPY-tagged iridium and rhodium complexes reported by Zhou et al..[96] 
Very recently,        et al. have shown[98] for the first time that BODIPY-tagged gold (I) 
complexes can be also used as photoactive triplet sensitizers. Absorption and emission bands 
of the complex 1.53 (figure 1.45) were significantly red-shifted compared to its metal-free 
analogue, which clearly indicated a perturbation on the π-conjugation. A significant decrease 
of fluorescence quantum yield (almost 12 times compare to BODIPY acetylene) for complex 
1.53 as well as shorter fluorescence lifetime indicated ISC promoted by the internal heavy 
atom effect of Au(I). This was further proved in the singlet oxygen generation experiments. 
Quantum yield for the complex 1.53 was 0.84 – one of the highest values known so far. Such 
promising result has promoted investigation of cytotoxic properties of 1.53 in vitro against 
cancer cell lines. Significant decrease in viability was observed even at very low 
concentrations of complex 1.53 (EC50 = 2.5 nM). Weak fluorescence of 1.53 was sufficient for 
its visualization in the cellular medium. It was concluded that complex 1.53 passed through 
the cell membrane and localized particularly in the cytosol. The latter result was very 
interesting since it showed the reported gold complex can combine properties of both 
photosensitizer and theranostic (see section 1.3.6). 
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Figure 1.45. BODIPY-tagged gold complex prepared by        et al..[98] 
In general, attachment of BODIPY to certain transition-metal complexes – such as Ru(II), 
Pt(II), Ir(III), Rh(III) and Au(I) complexes – led in some cases to obtaining very efficient 
triplet photosensitizer. The main advantage of these compounds is intense absorption in the 
visible-light range, which is very crucial for their performance. Although the topic started to 
develop only recently, already obtained results showed huge potential for further 
development and application of this type of complexes. 
1.3.5. Biological imaging 
Radioimaging is a widely used technique for visualization of biological processes.[99] Although 
it allows sensitive detection of biological transformations deep within the body, its spatial 
resolution of a few millimeters is not suitable for imaging at cellular and subcellular levels. In 
contrast, another important imaging technique – fluorescence microscopy[100] – is 
characterized by the submicron resolution level, which allows accurate depiction of processes 
within cells. Therefore, a strategy, which is based on the complementary application of both 
methodologies, offers the unique opportunity to directly correlate in vitro and in vivo imaging 
studies. Implementation of this strategy critically relies on the development of novel 
radioimaging probes tagged with a fluorophore.[7] 
Application of BODIPY for dual imaging purposes was substantially described by Higham and 
coworkers. In 2012, Davies et al. have reported[101] synthesis of the BODIPY-tagged primary 
phosphanes 1.54 and 1.55 (figure 1.46). As predicted by the DFT-based model,[102] these 
compounds were found to be air-stable both in solution and in the solid state. Moreover, the 
introduction of the phosphino group didn’t alter significantly fluorescent properties of the 
BODIPY core. Variation of substituents at boron had a more pronounced effect. Fluorescence 
quantum yield of phosphane 1.55 was almost 8 times higher than of 1.54, indicating the 
lower impact of methyl groups at boron on photophysical properties of the molecules than in 
the case of phenyl groups. In the subsequent research[103] synthetic routes towards 1.54 and 
1.55 were optimized, which allowed multigram preparation of these compounds. 
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Figure 1.46. Chemical structures of phosphane 1.55[101] and its molybdenum and tungsten complexes.[104] 
Because of more favourable fluorescence properties phosphane 1.55 was chosen as the main 
substrate for further investigations. In order to determine how the BODIPY unit influenced the 
ability of phosphorus in 1.55 to coordinate to transition metals, and also to establish the 
effect of any complexation on photophysical properties of 1.55, its molybdenum and tungsten 
complexes 1.56-1.59 were prepared (figure 1.46).[104] Monosubstituted complexes 1.56 and 
1.57 were obtained by reacting 1.55 with [Mo(CO)6] and [W(CO)6] respectively in THF 
under UV irradiation. The disubstituted complex cis-1.58 was obtained by refluxing cis-
[Mo(CO)4(pip)2] and 1.55 in dichloromethane; reaction of two equivalents of 1.55 with cis-
[W(CO)4(pip)2] in toluene at 75 °C for 20 h led to formation of cis-1.59 as the major product. 
The complexes 1.56-1.59 were isolated and fully characterized. Structures of 1.56 and 1.58 
were proven by X-ray crystallography. Spectroscopic and crystallographic properties of the 
prepared compounds were consistent with those found for complexes of other primary 
phosphanes. Fluorescence of the complexes 1.56-1.59 was only slightly (for 1.58 and 1.59) 
or moderately (for 1.56 and 1.57) quenched compared to 1.55, despite the presence of the 
heavy metals. Hence, no essential influence of BODIPY incorporation on the reactivity of 
phosphane 1.55 and no significant changes of its photophysical properties upon complexation 
were observed. 
In medicinal diagnoses the most widely used radionuclide is 99mTc.[105] Its complexes are 
utilized as imaging agents in single-photon emission computed tomography (SPECT).[106] 
Because of the similar coordination profile, rhenium is frequently used as a mimic of 
99mTc.[107] To prepare fluorescent technetium and rhenium complexes Davies et al. have 
developed tridentate phosphine ligand 1.60 (figure 1.47).[101, 108] It was obtained by Pt-
catalyzed reaction of 1.55 with two equivalents of vinyldiphenylphosphane. Observed 
reactivity of 1.55 in this reaction was typical for primary phosphanes. Fluorescence properties 
of 1.60 were only slightly changed compared to 1.55, indicating no reductive PET (induced 
by the two additional phosphorus groups) has occurred. Upon refluxing of tripodal phosphane 
1.60 and mer-[ReCl(CO)3(PPh3)2] in toluene, a mixture of three stereoisomers 1.61-1.63 was 
generated (figure 1.47).[108] Subsequently, it was found that reflux of the same reagents at a 
higher temperature, in mesitylene, led to the formation of isomer 1.61 exclusively. 
Fluorescent technetium complex 1.64 was synthesized from 1.60 and readily available 
radioactive synthon fac-[99mTc(CO)3(OH2)3]
+.[109] To better correlate with the 99mTc 
experiments, additional rhenium complex 1.65 was synthesized by reaction of 1.60 and 
[Re(CO)5][OTf] in refluxing ethanol. The structures of all rhenium complexes were 
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characterized by X-ray diffraction. The fluorescence quantum yields of the complexes 1.61-
1.65 were only slightly lowered in comparison to free ligand 1.60, probably, due to ISC. 
Therefore, prepared probes appeared to have suitable photophysical properties for in vitro cell 
imaging. 
 
Figure 1.47. BODIPY-tagged phosphane 1.60[101] and rhenium and technetium complexes derived from it.[108] 
The authors reported that technetium complex 1.64 represented the first example of a 
phosphine-based, multi-functional imaging tool. The most prominent features of this complex 
are: a tridentate phosphine for kinetic stability; a fluorophore for in vitro imaging; a 
radioactive metal for in vivo imaging by SPECT. 
For a preliminary screening, the rhenium complexes 1.61 and 1.65 were imaged in prostate 
carcinoma (PC-3) cells by epi-fluorescence microscopy. Complex 1.61 enabled visualization of 
organelles without any apparent cytotoxicity, whereas for 1.65 some cytotoxic effect was 
observed. Nonetheless, both complexes have shown negligible cytotoxicity at the 
concentrations required for SPECT. Therefore, these complexes were concluded to be highly 
appropriate for application as imaging agents. 
Another imaging technique, used for tumor localization, is positron emission tomography. The 
copper isotope 64Cu is an attractive positron emitter because of its relatively long half-life.[107, 
110] Other group 11 metals radioisotopes – 199Au and 111Ag – have shown potential for medical 
application due to beta-emitting properties.[111] BODIPY-tagged coinage metals complexes 
were reported by Davies et al. (figure 1.48).[112] The authors have utilized fluorescent tertiary 
phosphines 1.66-1.69 as the ligands. Upon their complexation with [Cu(CH3CN)4][PF6] the 
copper(I) complexes 1.70-1.73 were formed. Interestingly, the metal center in these 
complexes is three-coordinated, although copper usually forms four-coordinated 
complexes.[113] Most probably, phosphine ligands 1.66-1.69 are too bulky for the four-
coordinate structure in this case. Analogously, silver (1.74-1.77) and gold (1.78-1.81) 
complexes were obtained by reaction of the phosphines with [Ag(η2:η2-cod)(hfa)] (hfa – 
hexafluoroacetylacetonat) and [AuCl(tht)] (tht – tetrahydrothiophene) respectively. The 
structures of most substances have been additionally confirmed by X-ray crystallography. 
Similar to the above-mentioned BODIPY-tagged phosphines 1.55 and 1.60 and their 
complexes, the newly prepared compounds 1.66-1.81 have shown only slight variation 
(mostly decrease) of the fluorescence quantum yields upon incorporation of phosphine moiety 
and following complexation. The phenyl rings at boron lowered fluorescence much more 
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significantly than methyl groups. Favourable photophysical properties made these compounds 
very attractive for applications in medicinal imaging. The authors have also suggested that the 
newly prepared fluorescent complexes 1.70-1.81 might display cytotoxic activity. 
Development and application of compounds, which combines both imaging and therapeutic 
modalities, is disclosed in more detail in the next section. 
 
Figure 1.48. BODIPY-tagged tertiary phosphines and derived complexes.[112] 
 
1.3.6. Theranostics 
Developing new drugs and improving existing ones can be largely facilitated if the 
mechanisms of their action are known. This knowledge can be obtained from a combination 
of various biological experiments. One of the recently developed strategies for solving this 
problem provides the tracking of therapeutic compounds directly in biological systems. This is 
possible due to the tagging of drugs with imaging probes (fluorophores or radionuclides). The 
newly obtained compounds are commonly called “theranostics”, or trackable therapeutic 
agents. Thus, theranostic is a single molecule, which enables both diagnosis and therapy. 
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Organometallic complexes, which have been widely used in medicine (for example, for cancer 
treatment[114]) are one of the most suitable targets in the context of this strategy.[8, 115] 
Organic fluorophores[116], luminescent complexes[117] or radioisotopes[118] can be used as 
imaging probes. 
Being very promising anticancer agents, organometallic-arene[119] and gold[120] complexes are 
very interesting substrates for theranostics development. In 2013, Bodio and coworkers 
reported the synthesis of new BODIPY-labeled phosphane 1.82.[121] By reacting this ligand 
with suitable metal precursors, respective Ru(II), Os(II) and Au(I) transition-metal complexes 
were obtained (figure 1.49). The syntheses of complexes 1.83-1.85 have been optimized to 
give an overall yield of 28-30% in 10 steps. Quantum yields of prepared compounds remained 
quite high, although being partially quenched in the case of ruthenium and osmium 
derivatives. 
 
Figure 1.49. Synthesis of theranostic agents reported by Tasan et al..[121] 
All three synthesized complexes have shown moderate cytotoxic properties compared to 
cisplatin but were much more active than posphane 1.82. The most active was gold complex 
1.85. Bearing BODIPY residue and being water soluble, complexes 1.83-1.85 were suitable 
for detection by fluorescence microscopy in vitro. They were shown to rapidly bind to the 
biological membranes, with no clear specificity. The authors suggested such distribution 
properties were defined mainly by BODIPY moiety. Thus, BODIPY-tagged transition-metal 
complexes were shown for the first time to be promising theranostic agents for optical 
imaging, worthy of further development. 
Based on the results above, Bodio and coworkers have continued to design new BODIPY-
tagged metal complexes[122] in order to obtain theranostics with improved properties. At first, 
previous research has shown the gold complexes possessing the best anticancer activity as 
well as the highest emission intensity. Therefore, for further developments only gold 
complexes were used. Secondly, the linker between the fluorophore and transition-metal 
moieties was changed in order to improve water solubility. And thirdly, different biovectors 
were introduced in order to target the compounds selectively on tumors and also to further 
improve water solubility. 
The reported new theranostics are shown in the figure 1.50. The gold complex 1.86 was 
easier to synthesize (three steps less and simpler purification) than one reported before 
(compound 1.85). It was further modified by introduction of vectors via metallic center: two 
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sugar derivatives (thioglucose analogues) and a peptide (modified bombesin). In this way, 
three theranostic agents 1.87-1.89 were easily obtained, by reacting complex 1.86 with the 
corresponding thiolate derivatives. The obtained gold complexes showed high fluorescence 
quantum yield (>85%), except the complex 1.89 (Φ = 21%). The authors have suggested the 
origin of this quenching effect is PET between the tryptophan residue of peptide and the 
BODIPY unit. 
 
Figure 1.50. New theranostics reported by Doulain et al. (BBN-SH – a bombesin-analog agonist).[122] 
The synthesized compounds appear to be cytotoxic. The authors suggested that application of 
biovectors allows selective targeting between cancer and healthy tissues. Despite the 
promising results, the application of theranostics for studies in vivo still remains a challenging 
task. 
Further improvement of theranostics, based on BODIPY-tagged gold complexes, was 
published recently.[123] The fluorescence brightness of the reported complexes (figure 1.51) 
was high enough to be suitable for detection even at a very low concentration. Compounds 
1.90 and 1.91 have shown strong cytotoxicity against breast, prostate, and colon cancer cell 
lines, and were much more active than previously reported complex 1.86, even though they 
contained two Au(I) centers. An investigation by confocal microscopy showed that complexes 
1.90 and 1.91 are accumulated and homogeneously distributed in the cytoplasm. Moreover, 
in addition to anticancer activity, compound 1.90 was also proven to be a promising anti-
inflammatory agent. Further research is directed towards introducing a vector on its gold 
atoms or on the BODIPY core in order to induce a selective targeting of tumors. 
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Figure 1.51. New theranostics reported by Trommenschlager et al..[123] 
Another class of organometallic compounds, interesting for theranostics development, are 
platinum-based complexes, which have been used as anticancer drugs for decades.[124] Sun et 
al. have prepared[125] BODIPY-tagged platinum complex 1.92 (figure 1.52) and studied its 
cellular distribution and cytotoxicities in human cervical carcinoma and human breast cancer 
cell lines. It was shown that the cytotoxic activity of complex 1.92 was lower than that of 
cisplatin. Nonetheless, by using fluorescence microscopy it was possible to image the 
distribution of platinum complex in living cells. Compound 1.92 was found to localize 
predominantly in the mitochondria. Thus, the synthesized platinum theranostic agent 1.92 
showed both cytostatic and imaging functionalities. 
 
Figure 1.52. Theranostics based on BODIPY-pyridyl ligands. 
It was shown recently that organometallic iridium (III) complexes also exhibit anticancer 
activity.[126] Zimbron et al. have described[127] synthesis and properties of new theranostic 
agents, based on cyclometalated half-sandwich iridium(III) complexes. Their structures are 
shown in figure 1.52 (compounds 1.93 and 1.94). Due to the potentially labile bond between 
BODIPY-pyridyl unit and iridium metal center, the stability of the complexes 1.93 and 1.94 
was tested. Full dissociation of both complexes was observed in the solution of DMSO (good 
coordinated solvent) after 2 days, whereas in the case of a weaker coordinated solvent such as 
methanol no solvolysis was noticed after 7 days. Compared to the emission intensity of free 
BODIPY-pyridyl ligand, fluorophores in complexes 1.93 and 1.94 were partially quenched due 
to complexation with iridium. Nonetheless, both complexes still displayed relatively high 
quantum yields (29% for 1.93 and 14% for 1.94). Being brighter (also in water medium), 
complex 1.93 was chosen for further investigations. Its photostability was tested: only 
negligible photodissociation and photobleaching were observed upon continuous irradiation, 
which confirms the suitability of this compound for cellular imaging studies by fluorescence 
microscopy. Complex 1.93 exhibited high antiproliferative activity on a range of cancer cell 
lines. Authors suggested the high cancer cell cytotoxicity of 1.93 can arise from its high 
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lipophilicity and stability toward hydrolysis. Cell imaging studies revealed very rapid cell 
internalization, which indicates the complex 1.93 was membrane-permeating. As in previous 
examples, application of a BODIPY tag provided useful information about the dynamics of cell 
uptake, accumulation, and distribution of the metallodrug in living cells. 
Silver has long been used as an antimicrobial agent for the treatment and prevention of 
infections of burns and difficult-to-treat wounds.[128] In order to follow the extent of active 
silver released to the wound, Mascharak and coworkers have developed[129] BODIPY-tagged 
silver complex 1.95 (figure 1.53). Fluorescence emission of BODIPY in this complex is 
quenched. However, the release of silver led to the restoring of fluorescence intensity. 
Therefore, complex 1.95 appeared to be suitable for tracking the delivery of silver to bacteria 
through turn-on fluorescence. Accompanied antibacterial efficacy arisen from silver delivering 
by complex 1.95 was comparable to that of silver nitrate. The authors have suggested that 
complex 1.95 can potentially be incorporated into a bandage material to treat burn wound 
infections with the advantage of real-time tracking of silver release. 
 
Figure 1.53. Silver complex reported by Pinto et al..[129] 
The field of trackable therapeutic metal-based drugs has started to grow only very recently. 
That’s why the current research in this area is still at its early stage, and the known 
theranostics are far from clinical application. Nonetheless, the observed results are very 
promising, which indicates a huge potential of this strategy. It should be noted, that tethering 
of a probe results in the formation of a new compound with modified therapeutic properties. 
Therefore, implementation of theranostics strategy should be done at the beginning of the 
research followed by the optimization process, which should be performed with the already 
tagged therapeutic compound. The wide variability of theranostics approach is likely to 
enhance the fast development of this research area. 
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2. Scope of the Dissertation 
The aim of this dissertation was to discover the potential of fluorescence spectroscopy for the 
investigation of transition-metal catalyzed transformations and to reveal mechanistic insights 
into such processes. The current work covers the synthesis of novel BODIPY-tagged transition-
metal complexes and their application in the ensemble fluorescence experiments as shown in 
the following scheme: 
 
Ligand-exchange reactions constitute elementary steps in catalytic transformations and are 
crucial in the chemistry of metal complexes. It was previously shown in our lab that 
substitution of cyclooctadiene ligand with CO molecules in BODIPY-tagged iridium complexes 
led to the increase in the fluorescence brightness. Concerning the fundamental importance of 
such observation, we decided to conduct the systematic study of this phenomenon. Chapter 
3.1 describes the application of various BODIPY-tagged NHC-gold complexes for the 
investigation of the relationship between electron density on metal center and fluorescence 
intensity of the attached fluorophore. The obtained results allowed us to establish the 
fundamental principle, which connects ligand exchange events and the intensity of 
fluorescence signal. 
Based on the knowledge gained in the first part we were able to design and prepare novel 
fluorescent complexes, which appeared to be very sensitive probes for the fluorescence 
investigations. Chapter 3.2 covers the synthesis of BODIPY-tagged phosphine ligands and the 
respective metal complexes. Sufficient stability and intermediate level of fluorescence 
intensity of gold(I) phosphine complexes made them very attractive tools for catalyst 
activation study. They were used for monitoring introductory steps in gold-catalyzed alkyne 
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transformations by means of fluorescence spectroscopy in a catalytically relevant 
concentration range. 
Ion-pairing plays an important role in catalytic processes of transition-metal complexes. A 
deeper understanding of counterion effect would greatly facilitate the development of novel 
catalytic systems with improved activity and selectivity. However, structure investigation of 
ion pairs is normally limited to NMR experiments. In this respect, we suggest the development 
of a novel approach based on fluorescence spectroscopy. The basic concept of application of 
fluorescence techniques for ion-pairing study is introduced in chapter 3.3. The initial 
experiments with BODIPY-tagged gold(I)-sulfonates have supported the idea and demonstrate 
the great potential of the proposed approach. 
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3. Results and Discussion 
3.1. Systematic modulation of the fluorescence brightness in boron-dipyrromethene 
(BODIPY)-tagged N-heterocyclic carbene (NHC)–gold–thiolates 
3.1.1. Modulation of the emission intensity 
During the last four decades,[130] a very large number of fluorescent molecular probes for the 
detection of cations, anions and small molecules have been developed.[131] To obtain potent 
molecular probes with excellent sensitivity, the interaction within the receptor-fluorophore 
pair needs to be optimized.[132] In this sense, Nagano et al. had shown for fluorescein and 
boron-dipyrromethene (BODIPY)[11a, 19] derivatives that the systematic manipulation of the 
electronic nature of an appended quencher enables excellent control over the brightness of 
the fluorophore (figure 1).[133] 
Based on this knowledge, the precise adjustment of the relative HOMO-LUMO energies of a 
1,2-diaminobenzene and a BODIPY dye led to the construction of a highly responsive 
bioimaging fluorescence probe for the detection of NO.[133c] In a conceptually related 
approach Park et al.[134] were able to rationally perturb the fluorescence quantum yield in 
emission-tunable fluorophores (Seoul-Fluors).[135] However, with a view to the structures 
displayed in figure 1, it is understandable that the covalent modification of organic 
fluorophores can be a tedious process, involving extensive synthetic work. 
 
Figure 1. Systematic modulation of substituents and electron density of a fluorescein and the influence on 
fluorescence brightness. 
Transition metal complexes with appended fluorophores can also experience significant 
changes in the fluorescence properties.[136] Chu et al. have reported[137] BODIPY-Fischer 
carbene dyads, where the fluorophore was attached to the metal-carbene group by an 
ethylenic bridge (figure 2a). The photophysical properties of such system depend on the 
extent of π-conjugation between BODIPY unit and carbene. In case of electron-deficient 
alkoxycarbene (X = OMe), the π-conjugation was maximized, which resulted in very 
pronounced quenching of fluorescence emission. In contrast, for electron-rich aminocarbene 
(X = NMe2) π-conjugation was diminished and the photophysical properties of BODIPY 
moiety were not altered significantly. Thus, it was demonstrated that fluorescence of BODIPY 
can be tuned by modifying electron-accepting properties of the metal-carbene unit. In the 
subsequent work[138] Chu et al. have shown that emissive properties of the system can be 
efficiently modulated even if the transition-metal fragment is not directly attached to the 
BODIPY core. Fluorescence intensity of BODIPY-Fischer carbene diads (figure 2b) experienced 
a noticeable substituent (R) effect. For π-donor groups (R = OMe, NMe2) higher emission 
intensities were observed than for π-acceptor groups (R = Br, CF3). The fluorescence 
properties of BODIPY can also be affected by cyclometallated Rh (Ir) fragments[139] (figure 
2c). When the fluorophore and transition-metal part are in close proximity to each other (n = 
0), BODIPY emission was completely suppressed. At a bigger distance (n = 1) the quenching 
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effect was less pronounced. The origin of the quenching was attributed to an acceptor-excited 
PET. 
 
Figure 2. BODIPY-tagged complexes used in the research of Sierra and coworkers. 
Modulation of fluorescence intensity of the fluorophore-tagged transition-metal complexes 
was used for monitoring cross-coupling reactions[3c] and olefin metathesis catalyst 
initiation.[3b] BODIPY-tagged complexes can be applied as molecular probes for the sensing of 
small molecules such as CO[68] or H2.
[70] In such complexes changes in the coordination sphere 
of the metal lead to diagnostic changes in the fluorescence brightness of the BODIPY 
fluorophore. This fluorescence modulation appeared to be related to the electron density at 
the transition metal.[68] This chapter represents the systematic study of the relationship 
between the electron density in a gold complex and the brightness of appended BODIPY 
fluorophores using a combined experimental and computational approach. 
3.1.2. Synthesis of BODIPY-substituted NHC-gold complexes 
The various [(NHC-BODIPY)AuX] (X = Cl, I) complexes 1, 2, 3a and 3b used in this study are 
displayed in figure 3. They are characterized by different distances between the BODIPY unit 
and the gold. Thus, in complex 1, fluorophore and imidazole ring of NHC ligand are 
separated with a phenyl ring. In the complex 2, this distance is extended by an additional 
CH2–CH2 chain, whereas complexes 3a and 3b represent an extreme case: the BODIPY unit is 
connected directly to the imidazole. 
 
Figure 3. BODIPY-tagged NHC-gold complexes employed in thiol fluorescence experiments. 
Complex 1 was reported previously.[68] To obtain complex 2, at first azolium salt 5 was 
prepared by cyclization of the known diamine[70] (figure 4). Subsequent in situ formation of 
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[(NHC)AgCl] species and transfer of the carbene to [AuCl(Me2S)] yielded complex 2.
[140] Due 
to the low solubility of salt 5 in CH2Cl2, acetonitrile was used as a solvent to generate 
intermediate silver complex; also prolonged reaction time was needed for complete 
conversion of the starting materials. 
 
Figure 4. Synthesis of the complex 2. Reaction conditions: a) NH4BF4, HC(OEt)3, HCOOH, 120°C, 24 h, then amberlite 
IRA, Cl-form; b) Ag2O, MeCN, 40°C, 3 h, then [AuCl(Me2S)], RT, 24 h. 
Synthesis of the complexes 3a and 3b appeared not to be a trivial task. All of the proposed 
synthetic approaches towards these compounds were based on the same starting material – 3-
chloro-BODIPY 6, which was prepared by the reaction of 2,2’-(p-tolylmethylene)bis(1H-
pyrrole)[28b] with N-chlorosuccinimide followed by chloranil and BF3·Et2O. A three step, one-
pot procedure involving two chromatographic purifications provides compound 6 in an 
acceptable overall yield of 19% (figure 5). An experimental procedure and spectroscopic data 
for this compound were reported only very recently.[41] Our procedure reported herein is 
based on the synthesis of the closely related 3,5-dichloro-BODIPY.[29] In the latter compound, 
the chlorine atoms are highly activated towards Pd-catalyzed cross-coupling reactions and 
nucleophilic substitution[46] and can be replaced with various nucleophiles (amines, alcohols, 
thiols, etc.) in good yields employing mild reaction conditions.[141] Hence, the diamine 7 was 
smoothly obtained by the reaction shown in figure 5. Attempts of its cyclization either by 
refluxing in triethyl orthoformate or by reacting with pentafluorobenzaldehyde were not 
successful. Most likely, decreased nucleophilicity of nitrogen atom attached directly to 
electron-withdrawing BODIPY restricts the cyclization reaction, whereas instability of 
unsubstituted BODIPY core facilitates alternative decomposition pathways to be realized. 
 
Figure 5. Synthesis of the diamine 7. Reaction conditions: a) N-chlorosuccinimide, -78°C, THF, followed by chloranil, 
followed by BF3·Et2O, NEt3; b) N
1-mesitylethane-1,2-diamine, NEt3, CH2Cl2, 40°C, 1 h. 
Therefore, it became clear, that imidazolium ring should be introduced directly into the 
BODIPY unit. Similarly to the reported procedure,[142] azolium salt 9 was smoothly prepared 
by reaction of 6 with imidazole and subsequent alkylation with isopropyl iodide (figure 6). 
Unfortunately, this approach was also not successful: the transfer of the respective carbene on 
gold via silver complex occurred only in a poor yield and, moreover, this synthesis was poorly 
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reproducible. Most probably, the key problem was the instability of the formed complexes due 
to insufficient steric bulk around metal center created by isopropyl group. 
 
Figure 6. Synthesis of complexes 3a and 3b. Reaction conditions: a) imidazol, MeCN, RT, 40 h; b) 2-iodopropane, 
MeCN, 70°C, 48 h; c) 1-mesityl-1H-imidazole, MeCN, RT, 60 h; d) 1-(2,6-diisopropylphenyl)-1H-imidazole, MeCN, RT, 
60 h; e) Ag2O, CH2Cl2, 40°C, 1 h, then [AuCl(Me2S)], RT, 2 h. 
To increase the stability of the metal complexes, aryl groups were introduced. Niu et al. have 
reported[143] the direct formation of azolium salt by the substitution reaction of α-chlorine of 
BODIPY with N-methyl imidazole. Using analogous one-step procedure, azolium salts 10a and 
10b were easily obtained from BODIPY 6 and 1-mesityl-1H-imidazole or 1-(2,6-
diisopropylphenyl)-1H-imidazole respectively (figure 6). In this case, silver salt approach led 
to the successful formation of the respective gold complexes 3a and 3b. The better yield of 3b 
reflects the higher bulkiness of 2,6-diisopropylphenyl group compared to mesityl. 
Simple chloro-to-thiolato ligand exchange at the transition metal enables the systematic 
manipulation of electron density with minimal synthetic effort.[68] Aryl thiolates are strong 
electron donors but were also chosen with a view to the high affinity of sulfur to gold. Nine 
different 4-substituted aryl thiols with R = NO2, CF3, COMe, Cl, H, Me, tBu, OMe, and NMe2 
were employed, covering the range from strongly electron-withdrawing groups (EWG) to 
strongly electron-donating groups (EDG).[144] For the monitoring of the fluorescence 
evolution, the full range of gold thiolates was generated in the cuvette only. In order to verify 
the identity of the respective [(NHC-BODIPY)Au(SC6H4R)] species, some of these complexes 
were isolated. Following the reported procedure,[145] the desired gold thiolates were 
synthesized by reaction of the respective [(NHC)AuX] (X = Cl, I) complexes with the different 
thiols in the presence of base (figure 7). The resulting gold thiolates are air-stable complexes. 
The identity of the gold thiolates was confirmed by NMR spectroscopy, and HR mass spectra 
and for [1(SC6H4NO2)] by X-ray diffraction analysis as well.
[146] 
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Figure 7. General synthesis of NHC-gold thiolates. Reaction conditions: a) thiol (1.1 equiv) and NaOH (1.2 equiv) in 
ethanol added to [(NHC-BODIPY)AuCl] (1.0 equiv) in CH2Cl2. 
 
3.1.3. Spectroscopic properties of the synthesized compounds 
As listed in table 1, the complexes 1, 2 and their derivatives display typically for BODIPY 
fluorophore absorption band near 510 nm.[68] Transformation of azolium salt 5 into complex 
2 doesn’t alter significantly emission and absorbance maxima of BODIPY. The same is true for 
the gold complexes and the corresponding thiolato derivatives. The latter compounds show 
lower quantum yields compared to the starting halide complexes. Such decrease of 
fluorescence emission qualitatively correlates with the intensity changes observed in the in 
situ generated fluorescence-time traces (see next section). 
Substituents in the α-position of BODIPY core have a strong influence on its optical properties. 
Derivatives of BODIPY 6 have diverse values of absorbance and emission maxima. 
Substitution of Cl with imidazole leads to a long-wave shift of the absorbance maximum, 
whereas for the compound 7 short-wave shift was observed. Introduction of the N-
substituents results in a decrease of quantum yield, most probably due to the PET quenching 
induced by nitrogen lone pair. In the case of derivative 8, the fluorescence quenching is less 
pronounced due to the lower donating properties of the imidazole nitrogen; tilting of the 
imidazole ring also reduces its interaction with BODIPY. 
Compound Φ Absorbance λmax [nm] Emission λmax [nm] 
1 0.61[a] 509 533 
2 0.50 509 523 
5 0.50 510 523 
[1(SC6H4NO2)] 0.44 509 533 
[2(SC6H4NO2)] 0.41 509 524 
6 0.093[b] 506 519 
7 0.018 490 (broad) 532 
8 0.036 518 533 
9 0.12 497 521 
10a 0.13 496 522 
10b 0.14 496 522 
3a 0.072 508 529 
3b 0.078 508 530 
[a] For this compound and below Φ values were determined in 1,2-dichloroethane versus rhodamine 6G (Φ = 0.95 
in EtOH) at RT with a concentration range of 0.25–1 µM; 
[b] For this compound and below Φ values were determined in 1,2-dichloroethane versus rhodamine 101 (Φ = 1.0 
in EtOH) at RT with a concentration range of 0.25–1 µM. 
Table 1. Spectroscopic properties of BODIPY derivatives. 
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BODIPY-azolium salts exhibit short-wave shift. Electron-accepting properties of the positively 
charged imidazole ring diminish PET, which leads to restoring of fluorescence. This situation 
is partially maintained for the complexes 3a and 3b, which are characterized by lower but still 
high enough fluorescence brightness to enable the fluorescence-time measurements with 
these complexes. 
3.1.4. Monitoring the fluorescence during the formation of the gold-thiolates 
To probe the effect of the halide-to-thiolate substitution in solution, the brightness of gold 
complexes 1, 2 and 3a[147] was monitored during the substitution reaction. The respective 
thiols were added to the 1,2-dichloroethane solutions of the respective gold halide complex (c 
= 1.0·10-6 mol·L-1) containing Hünig base. This approach is more precise than the 
determination of the fluorescence quantum yield of the isolated gold thiolates.[148] The 
formation of the gold thiolates always leads to a decrease in the brightness relative to the 
respective complexes 1–3. In table 2 the normalized intensities of the respective thiolato 
complexes are listed. 
complex 
R= 
1 
IAuS/IAuX 
2 
IAuS/IAuX 
3a 
IAuS/IAuX 
NMe2 0.0148 0.0668 - 
OMe 0.0274 0.323 - 
tBu 0.0711 0.687 - 
Me 0.0542 0.607 - 
H 0.127 0.820 <0.001 
Cl 0.199 0.903 - 
COMe 0.496 0.990 - 
CF3 0.961 0.999 <0.001 
NO2 0.750 0.814 - 
Table 2. Fluorescence intensities of the respective [(NHC-BODIPY)Au(SC6H4R)] complexes relative to the 
fluorescence level of the respective complexes 1–3. 
A typical set of fluorescence-time traces is shown in figure 8 for the reactions of complex 1. 
The rate of the halide-to-thiolate substitution depends on the nature of the R substituent. For 
electron-deficient and more acidic thiols the formation of the gold thiolates is ca. 20-50 times 
faster than for electron-rich thiols. The final intensities, which correspond to the complete 
conversion of the starting gold complex, also greatly depend on the nature of the thiol. For 
the gold thiolate with 4-R = CF3 derived from complex 1, the brightness is nearly the same as 
that of the halide complex with I(AuS)/I(AuX) = 0.96, while for R = NMe2 the fluorescence is 
65-times weaker. The fluorescence intensities of complex 1 derived [(NHC-
BODIPY)Au(SC6H4R)] nicely correlate with the Hammett parameters of the respective 
substituents R (figure 9). A linear fit was applied in this case. 
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Figure 8. Fluorescence-time traces upon addition of 100 equivalents of RC6H4SH (R = NO2, CF3, COMe, Cl, H, Me, 
tBu, OMe and NMe2) to complex 1 (c = 1.0·10
-6 mol·L-1) and Hünig base (100 equiv) in 1,2-dichloroethane solvent 
leading to the formation of the respective complexes [1(SC6H4R)]. The fluorescence intensity of complex 1 is set to 
1.0. 
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Figure 9. The plot of the p-Hammett plot and the relative fluorescence brightness of complexes [1(SC6H4R)]. 
Analogous fluorescence-time traces were obtained for the complex 2 (figure 10). The general 
trends are very similar to the previous example. Nonetheless, compared to complex 1, the 
brightness of the thiolato derivatives of complex 2 appeared to be less sensitive to the nature 
of R substituent. For instance, the formation of the gold thiolate with 4-R = CF3 derived from 
complex 2 is not accompanied by any changes in fluorescence brightness (I(AuS)/I(AuX) = 
0.999). Relative fluorescence intensities of the gold thiolates obtained from electronic-rich 
thiols are also much higher than for the complex 1 (table 2). The Hammett plot for the 
thiolates of complex 2 is fitted with an exponential function, with the log I(AuS)/I(AuX) 
values converging towards zero for the electron-deficient thiolates (figure 11). Most likely the 
bending of the fit only occurs for thiolates with highly EWG and is not visible in the data set. 
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Figure 10. Fluorescence-time traces upon addition of 100 equivalents of RC6H4SH (R = NO2, CF3, COMe, Cl, H) or 500 
eq of RC6H4SH (R = Me, tBu, OMe, NMe2) to complex 2 (c = 1.0·10
-6 mol·L-1) and Hünig base (100 equiv) in 1,2-
dichloroethane solvent leading to the formation of the respective complexes [2(SC6H4R)]. The fluorescence 
intensity of complex 2 is set to 1.0. 
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Figure 11. The plot of the p-Hammett plot and the relative fluorescence brightness of complexes [2(SC6H4R)]. 
The reaction of complex 3a with thiophenol leads to the complete quenching of fluorescence 
(figure 12). Moreover, even addition of electron deficient 4-CF3C6H4SH, which forms the 
brightest gold thiolates in case of complexes 1 and 2, leads to the same result (I(AuS)/I(AuX) 
was estimated at 0.001). Obviously, the addition of any other thiol would show the same 
pattern. This result indicates the very high sensitivity of the fluorescence brightness of 
complex 3a to the substituents on gold center. Unfortunately, it also prevents any 
rationalization of the relationship between fluorescence brightness and the nature of thiols. 
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Figure 12. Fluorescence-time traces upon addition of 100 equivalents of RC6H4SH (R = CF3, H) to complex 3a (c = 
1.0·10-6 mol·L-1) and Hünig base (100 equiv) in 1,2-dichloroethane solvent leading to the formation of the 
respective complexes [3a(SC6H4R)]. The fluorescence intensity of complex 3a is set to 1.0. 
The quantum yields of the complexes 1 and 2 were found to be independent of the nature of 
halide in the AuX unit. With the view to the exceptional sensitivity of the complex 3a, halide 
exchange reaction was tested. Chloro-to-iodo substitution in the complex 3a after excess 
addition of tetrabutylammonium iodide led to ca. 23% decrease in fluorescent intensity 
(figure 13). Most probably, electron-donating nature of iodide is responsible for this result. 
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Figure 13. Fluorescence-time traces upon addition of three aliquots of NBu4I (100 equiv; denoted by arrows) to a 
solution of 3a (c = 1.0·10-6 mol·L-1) in 1,2-dichloroethane. The fluorescence intensity of complex 3a is set to 1.0. 
In general, for thiols having EWG, the fluorescence level of the gold-thiolates derived from 
complexes 1 and 2 is close to that of the respective halide complex. The thiolates derived from 
complex 3a are characterized by very strong interactions of quencher and fluorophore, which 
was expected based on the very short distance of quencher and fluorophore. 
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Based on the data for complexes 1, 2 and 3a and the derived thiolato complexes, the electron-
density at the gold thiolates appears to be the dominant factor determining the fluorescence 
intensity. The lack of overlap between the absorption spectrum of the gold-thiolate and the 
emission spectrum of the BODIPY renders Förster and Dexter quenching unlikely.[9] In the 
complexes 1 and 2, the emission wavelength of the BODIPY unit is virtually independent of 
the nature of the NHC-metal complex.[68] The dominant quenching mechanism in the gold 
complexes thus appears to be photoinduced electron transfer (PET) instead.[9],[149]  
3.1.5. DFT-calculations 
The hypothesis described is supported by the results of the DFT calculations.[150] Thus, the 
occurrence of the PET mechanism can be roughly estimated by comparing the relative 
energies of the frontier molecular orbitals (FMO) of the fragments present in the dyads.[133c, 
139] As shown in figure 14, the HOMO of the thiolate fragment of complex 1 is higher in 
energy than that of the corresponding BODIPY moiety regardless of the R substituent. 
Therefore, upon photoexcitation, the BODIPY fragment behaves as an electron acceptor and 
its fluorescence is quenched by the acceptor-excited PET (a-PET) process. The extent of this 
quenching is directly related to the energy difference (E) between the involved orbitals 
(figure 14). Indeed, a similar linear correlation to that shown in figure 9 is found when 
plotting the E values versus the corresponding -Hammett substituent constants (figure 15). 
Concerning the fluorescence-time plots of complexes 1 and 2 a minor anomaly concerning the 
thiophenolato ligand with R = NO2 becomes apparent since the brightness of the respective 
thiolato complexes (table 2) is slightly lower than expected (based on the respective Hammett 
parameters). The nitro group is known to be a fluorescence quencher.[151] However, our DFT 
calculations do not support a d-PET mechanism for these complexes. 
 
Figure 14. Computed frontier molecular orbitals of the isolated chromophores present in compounds [1(SC6H4R)] 
(orbital energies are given in eV). 
N
B
N
Me
MeMe
Me
F F
–5.59
–2.54
–3.99
–0.78
LUMO
LUMO
HOMO
HOMO
Me
–4.23
–0.80
–4.39
–0.84
–4.48
–0.85
–4.61
–0.94
–4.84
–1.06
–5.16
–1.70
a-PET
N N
Me
Me
Au
Me
Me
S
R
R = NMe2 R = OMe R = Me R = H R = Cl R = COMe R = NO2
–4.87
–0.99
R = CF3
–4.44
–0.82
R = tBu
 50 
-0.9 -0.6 -0.3 0.0 0.3 0.6 0.9
0.4
0.6
0.8
1.0
1.2
1.4
1.6
HtBu
NO
2
E
H
(b
o
d
ip
y
) 
–
 E
H
(N
H
C
) 
/ 
e
V

p
 Hammett
NMe
2
OMe
Me
CF
3
Cl
COMe
 
Figure 15. Plot (R2= 0.98) of the p-Hammett constants and the energy difference (∆E) between the HOMO of the 
BODIPY and thiolate fragments in complexes [1(SC6H4R)]. 
 
3.1.6. The distance between fluorophore and quencher 
Förster resonance energy transfer (FRET) and photoinduced electron transfer (PET) are two 
distance-dependent processes which can modulate fluorescence brightness through 
interaction between a fluorophore and a quencher. FRET, being a dipolar, nonradiative 
process, is effective over long distances, typically between 2–8 nm. PET involves an electron 
transfer between fluorophore and quencher and requires contact interaction between the two. 
Therefore, PET is limited to much shorter distances of around 1 nm.[152] 
 
Figure 16. BODIPY-tagged gold complexes prepared by O. Halter. 
To better understand the effect of the distance between fluorophore and quencher on the 
fluorescence attenuation, additional gold complexes were prepared in our group by O. Halter 
(figure 16). In the gold thiolates derived from complexes 1, 2, 1-H and 2-H, the relative 
fluorescence brightness for R = H (table 2, bold, for 1 and 2; 0.612 for 1-H, 0.995 for 2-H) 
was plotted versus the distance of sulfur and boron atoms (d(B···S)) in the respective BODIPY. 
The choice of sulfur is justified since according to the DFT calculations the HOMO of the gold-
thiolate complexes is sulfur centered, whereas the boron atom is located close to the center of 
the BODIPY. Note that the d(B···S) values coming from DFT calculations are only approximate 
due to the conformational flexibility of the gold thiolates. Nonetheless, the data in figure 17 
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can be fitted reasonably well with an exponential function. Up to d(B···S) of 1.0 nm, the 
fluorescence attenuation due to the gold–thiolate quencher is pronounced, whereas for 
d(B···S) > 1.5 nm, the BODIPY fluorescence is virtually unperturbed. Both results make sense 
in the context of PET, the rate of which shows an exponential dependence of the distance 
between fluorophore and quencher.[152-153] 
Obviously, the d(B···S) in the complex 3a is shorter than in 1. Complete suppression of 
fluorescence brightness in [3a(SPh)] additionally supports PET mechanism. Nonetheless, 
unlike the complexes 1 and 2, where electron transfer occurs through space since no 
conjugation between BODIPY and metal center is possible, in case of 3a through-bond 
mechanism can be also realized. As shown in table 1 the quantum yields of BODIPY-imidazole 
derivatives greatly depend on the electron-withdrawing character of the imidazole ring. 
Chloro-to-thiolato substitution reduces electron-accepting properties of gold center, which 
results in releasing of electron density in NHC-ligand. This, in turn, facilitates PET quenching 
of BODIPY. Although the overall outcome is the same, in case of complex 3a PET occurs 
rather in an indirect manner. 
3.1.7. Redox potentials 
We attempted to determine the redox potentials of the model gold thiolates [4(SC6H4R)] (R 
= NO2, H, OMe) by cyclic voltammetry. Concerning the coordination sphere of gold, complex 
4 (figure 3) is similar to complex 1 but contains a 4-Me instead of the 4-(2-BODIPY) 
substituent to avoid overlap of the Au-thiolate and BODIPY oxidations. For the complexes 
studied, the oxidation of the gold thiolate was irreversible (only the oxidation wave was 
observed). Nonetheless, the observed oxidation potentials exhibit a very pronounced 
dependence on the nature of the thiolato ligand: Eox = +1.15 V (R = NO2), Eox = +0.81 V (R 
= H), Eox = +0.58 V (R = OMe) (figure 18). The observed electrochemical trend correlates 
with the computed energy of the corresponding HOMO: –5.23 eV (R = NO2) > –4.67 eV (R = 
H) > –4.46 eV (R = OMe), indicating that a less stabilized (i.e., less negative) HOMO is 
translated into a lower oxidation potential. Based on these data, the estimated free energy for 
the electron transfer was calculated using the Rehm-Weller equation.[154] This calculation is 
based on the assumption that the observed oxidation potentials E(ox) – 57/2 mV correspond 
to the reversible redox potentials E1/2. The GPET for [1(SC6H4R)] (GPET = –0.02 eV (R = 
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Figure 17. Plot of the distance between fluorophore and quencher (d(B···S)) versus the fluorescence attenuation. 
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NO2), –0.36 eV (R = H), –0.59 eV (R = OMe)) and [2(SC6H4R)] (GPET = 0.04 eV (R = 
NO2), –0.30 eV (R = H), –0.53 eV (R = OMe)) were calculated by employing the 
experimentally determined potentials for the oxidation of [4(SC6H4R)] (figure 18), the redox 
potential for the reduction of the BODIPY and the excitation energy (the electrostatic term can 
be neglected in 1,2-dichloroethane solvent). The four GPET for R = H and OMe are negative, 
while it is close to zero or even positive for R = NO2. This underlines the special behavior of 
the nitro-substituted complexes. 
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Figure 18. Fragments of cyclic voltammograms representing oxidation potentials in [4(SC6H4R)] (R = NO2, H, OMe). 
 
3.2. Observing initial steps in gold-catalyzed alkyne transformations by utilizing 
BODIPY-tagged phosphine-gold complexes 
3.2.1. Application of fluorescence spectroscopy for observing ligand-exchange 
reactions in metal complexes 
Understanding catalytic processes is of essential importance for enhancing catalysts and 
catalytic transformations.[155] Acquiring such an understanding critically relies on 
spectroscopic techniques, which are able to probe the status of the species under study with 
sufficient precision and sensitivity.[156] In this respect, fluorescence spectroscopy, due to its 
exceptional sensitivity, can be a useful method.[9] 
Ligand exchange reactions constitute elementary steps in the chemistry of metal complexes 
and are crucial in catalytic transformations. It thus appears highly interesting to synthesize a 
fluorescent reporter ligand for catalytically active metals, whose fluorescence properties are 
modulated by such elementary reactions. Only a few examples related to catalysis in single 
molecule studies[4, 60, 157] and in ensemble measurements in solution have been realized,[3c, 158] 
despite the fact that related approaches are very popular in photoluminescent sensing.[159] 
 53 
 
Figure 19. Examples for switched fluorescence (on/off) in transition metal complexes with an appended 
fluorophore (Mes = 2,4,6-trimethylphenyl, bdp = BODIPY, SIMes = 1,3-bis(2,4,6-trimethyl)phenyl-4,5-
dihydroimidazol-2-ylidene). 
The detection processes in such complexes so far are relatively simple, in that only two states 
are considered (signal on/off) depending on the presence or the absence of quencher. A 
transition metal and a ligand tagged with a fluorescent dye associate to form a fluorescent or 
a non-fluorescent complex whose brightness is reversed by some reaction. This principle has 
been put to good use to clarify mechanistic issues concerning the postulated release-return 
mechanism in olefin metathesis (figure 19a).[3b] Mirkin et al.[136a] reported a Pt-complex, 
whose BODIPY-centered fluorescence is reversibly modulated by an added ligand L (figure 
19b). This ligand L releases a nitrogen donor from the coordination sphere of platinum, which 
then quenches the fluorophore. It was recently shown that changes in the fluorescence signal 
of BODIPY-tagged N-heterocyclic carbene metal complexes also occur as a consequence of 
changes in the coordination sphere of a metal, despite the fact that the spatial relationship of 
fluorophore and transition metal remains unchanged. In this case, the substitution of a cod 
(1,5-cyclooctadiene) ligand in an Ir-complex by two CO molecules, converts an initially dark 
complex into a brightly fluorescent complex (figure 19c).[68] This modulated fluorescence 
intensity was attributed to changes in the electron-density at the transition metal and 
indicates that the PET mechanism appears to be primarily responsible for fluorescence 
quenching. The oxidative addition of H2 to a fluorophore-tagged Crabtree-type complex is 
another example of a fluorogenic reaction (figure 19d) useful for the detection of H2.
[70] 
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It was shown in the previous chapter that sensitivity of such probes critically relies on the 
distance between the fluorophore and the metal center. In order to enhance sensitivity, this 
distance should be minimized. This chapter is devoted to the synthesis of metal complexes of 
BODIPY-tagged phosphines, in which one phosphorus donor is directly connected to the 
BODIPY core. Thus, the BODIPY fluorophore and the metal center are separated by just one 
atom (phosphorus) – the smallest possible linker. The resulting phosphine should be dark, 
due to PET quenching by the phosphorus lone pair. However, coordination of this lone pair to 
a transition metal should restore fluorescence, when using metals which do not open other 
quenching pathways (for example heavy atom effect or via minor changes in the electronic 
structure).[131a, 160] Such a partially quenched fluorescence signal can be sensitive to subtle 
changes in the coordination sphere of the metal and translate such changes into an increase 
or a decrease of the BODIPY fluorescence. 
3.2.2. Synthesis of BODIPY-tagged phosphines 
Only a few examples of such phosphines have been reported in the literature.[161] Higham et 
al. recently synthesized several BODIPY-phosphines as well as metal complexes with coinage 
metals ions such as Cu, Ag, Au and with Re.[101, 112] Bodio et al. also reported such phosphines 
and the derived Ru, Os, and Au complexes[121] and Blum et al. a related Pd complex.[53] Most 
of the metal complexes previously reported are highly fluorescent, because the distance 
between the phosphorus (or the transition metal) quencher and the BODIPY is rather large. 
Our strategy is different, in that the phosphorus donor and the BODIPY core are to be 
connected directly, to initially generate fluorescence-quenched BODIPY-phosphines. 
We first tested the known 8-Ph2P-BODIPY (figure 20).
[16d] However, we learnt that this ligand 
and the respective gold complex show unfavourable properties (low fluorescence quantum 
yields, very broad emission band, and instability). Therefore, another synthetic approach 
leading to different BODIPY-phosphines was required. 
 
Figure 20. Synthesis and reaction conditions for BODIPY-phosphines: a) Ph2PH, CH2Cl2, 15 min; b) R2PH (R = Ph, Cy), 
Pd(OAc)2, Et3N, toluene. 
Reactions of 3-chloro-BODIPY 6 with Ph2PH or Cy2PH and base (Et3N) provide the respective 
BODIPY-phosphines 12a and 12b, but better yields (72–76%) were obtained, when the same 
reactions were carried out in the presence of catalytic amounts of Pd(OAc)2
[162] (figure 20). 
Additional phosphine for the activation of the palladium catalyst was not required and we 
assume that the secondary phosphine used as a reagent forms a sufficiently active cross-
coupling catalyst.[163] The BODIPY-phosphines 12a and 12b are slightly sensitive towards 
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oxidation and in a few reactions under ambient atmosphere, small amounts of phosphine 
oxide 13a were formed and separated by chromatography. 
3.2.3. Metal complexes of BODIPY-phosphines 
The new metal complexes of BODIPY-phosphines (figure 21), like [AuCl(11)] and [MX(12b)] 
(M = Cu, Ag, Au) were synthesized following established procedures for Ph3P-metal 
complexes for copper (X = I),[164] silver (X = Cl)[165] and gold (X = Cl).[166] The copper and 
the silver complexes with 12a and 12b are significantly less stable than the respective gold 
complexes. Solutions of the copper complexes decompose within a few hours, the silver 
complexes decompose once the solutions are exposed to ambient atmosphere. The most stable 
complexes are formed with the electron-rich phosphine 12b and gold. Nonetheless, NMR 
spectra of all Cu+, Ag+ and Au+ complexes could be recorded. However, based on the optical 
data, which are the same as those of phosphine 12a, [CuI(12a)] appears to dissociate at the 
low concentrations (c = 1.0·10-6 mol·L-1) used to record such spectra. Complex [PdCl2(12b)2] 
was synthesized from [PdCl2(MeCN)2] and 12b in 88% yield.
[167] 
 
Figure 21. Synthesis and reaction conditions for metal complexes of BODIPY-phosphines: a) [AuCl(Me2S)], CH2Cl2, 
rt, 30 min; b) CuI, MeCN, rt, 1 h; c) AgNO3, KCl, water/thf, rt, 3 h; d) [PdCl2(MeCN)2], CH2Cl2, rt, 12 h. 
 
3.2.4. NMR spectra 
The BODIPY-phosphines are characterized by the presence of several NMR active nuclei and, 
in particular, the 31P NMR spectra display interesting features. In the 31P spectra of 12a and 
12b, large 4J(31P-19F) coupling constants are observed (12a: J = 45.5 Hz; 12b: J = 52.4 Hz; 
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figure 22).[168] The same corresponding 4J(31P-19F) values are much smaller in the respective 
phosphine-metal complexes; for example, in the gold complex [AuCl(12a)], J is 15.4 Hz, and 
it is even smaller in [AuCl(12b)] (J < 2 Hz; figure 22). Our explanation for this observation is 
based on the Fermi contact term mechanism, which accounts for the coupling between 19F 
and 31P and the efficiency of which increases with increasing s-orbital participation in the 
bonds connecting the two nuclei.[169] In the phosphine, the phosphorus lone pair is partially 
delocalized into the electron deficient BODIPY -system. This leads to increased s-content in 
the respective P–C(BODIPY) bond. In the gold complexes, as well as in the other metal 
complexes, this lone pair is donated to the transition metal rather than to the BODIPY, leading 
to a decrease in the s-content of the P–C(BODIPY) bond and consequently to a decrease in the 
coupling constant. A related phenomenon concerning 19F-13C coupling constants was observed 
in fluorine-containing crown ether complexes, in which the magnitude of the coupling 
constants turned out to be an effective gauge of the fluorine-metal interactions.[170] 
In [AgCl(12b)] a 107,109Ag-31P coupling is detected, with a typical value for Ag-phosphine 
complexes of J = 617 Hz.[171] The 31P signal is severely broadened (1/2 = 150 Hz) and this 
line broadening prevents the determination of the individual 107Ag or 109Ag coupling with 31P. 
Such signal broadening is also observed for [CuI(12a)] and [CuI(12b)] and potential 31P-19F 
coupling could not be resolved. Such exchange-broadened 31P NMR signals are typical for Ag- 
and Cu-phosphine complexes and reflect the lability of such species in solution.[171] 
The coordination of BODIPY phosphines 12a and 12b to Au led to a significant deshielding of 
the 31P resonance from = -20.3 ppm for 12a to = 20.2 for [AuCl(12a)] and from = -
14.7 ppm for 12a to = 47.5 for [AuCl(12b)]. The more pronounced deshielding of the 31P 
NMR resonance in 12b (compared to 12a) upon metal coordination is in line with a more 
efficient donation of the phosphorus lone pair in [AuCl(12b)] to gold. 
  
 
Figure 22. 31P1H-NMR spectra of phosphines 12a (left up) and 12b (left down) and for complexes [AuCl(12a)] 
(right up) and [AuCl(12b)] (right down). Total range displayed for each spectrum is 300 Hz. 
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3.2.5. X-ray crystal structure analysis of [AuCl(12a)] 
Single crystals of [AuCl(12a)] were grown by slow evaporation of a cyclohexane/CH2Cl2 
solution (figure 23). The geometrical features of the complex are very similar to those of the 
related [AuCl(PPh3)] complex (Au–P 223.08(5) pm, Au–Cl 229.15(5) pm).
[172] Gold has a 
coordination number of two and adopts linear coordination geometry. The distance from gold 
to the nearest fluorine atom is 325.3(5) pm, which is too long to consider a significant Au···F 
interaction.[170a] 
 
Figure 23. X-ray crystal structure analysis[173] and ORTEP representation of X-ray crystal structure of [AuCl(12a)]. 
Thermal ellipsoids are set at 50 % probability (color coding: Au yellow, P orange, F greenish yellow, B pink, Cl green, 
N blue). Important bond lengths (pm) and angles (o): Au–P 222.7(2), Au–Cl 229.8(3), Au···F 325.3(5), 377.1(6), P–
Au–Cl 174.88(8). CCDC-1055648 contains the supplementary crystallographic data for this structure. 
 
3.2.6. Optical properties 
Fluorescence quantum yields and absorbance and emission maxima of the newly synthesized 
BODIPY compounds are summarized in table 3. All fluorophores reported herein display a 
strong UV/Vis absorbance at 506–552 nm and are characterized by small Stokes shift of 
approximately 15 nm. The small Stokes shifts point to a similar geometry of the excited and 
the ground state of the fluorophore.[11a] Replacing Cl with PPh2 or PCy2 leads to a long-wave 
shift of the absorbance maximum (= +13 or +25 nm); complexation of the phosphorus by 
group 10 metals leads to short-wave shift in the absorbance (and emission) maxima of 
approximately 10 nm. Like other 3-heteroatom-substituted BODIPY compounds, such as the 3-
amino-substituted BODIPY,[141] the BODIPY-phosphines 12a and 12b are essentially non-
fluorescent with fluorescence quantum yields  < 0.001. It is likely that the phosphorus lone 
pair engages in PET quenching of the excited state.[9] In case this is true, the respective 
complexes of 12a and 12b with transition metals coordinated through the phosphine electron 
lone pair can be expected to display brighter fluorescence unless the presence of the metal 
opens new relaxation pathways. Indeed, the respective metal complexes of Ag+ and Au+ are 
fluorescent with  close to 0.1, while that of Pd2+ is non-fluorescent. Spectroscopic reporter 
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groups are important since the d10 ions Cu+, Ag+, and Au+ do not show d-d transitions in the 
UV/Vis spectrum. Interestingly, the phosphine oxide 13a is fluorescent ( = 0.026) but less 
so than the metal complexes, which is consistent with the results of a study on fluorescent 
phospholes.[174] 
Compound [a] Absorbance max [nm] Emission max [nm] 
11 <0.001 529 - 
6 0.093 506 519 
12a <0.001 531 - 
12b <0.001 519 - 
13a 0.026 508 524 
[AuCl(11)] 0.008 552 567 
[CuI(12b)] 0.016 516 527 
[AgCl(12b)] 0.073 515 528 
[AuCl(12a)] 0.087 515 531 
[Au(NTf2)(12b)] 0.11 508 523 
[AuCl(12b)] 0.096 510 526 
[Au(CCPh)(12b)] 0.070[b] 510 526 
[PdCl2(12b)2] <0.001 540 - 
[a] Φ values were determined in 1,2-dichloroethane versus rhodamine 101 (Φ = 1.0 in EtOH) at RT with a 
concentration range of 0.25–1 µM. 
[b] estimated value, see experimental part. 
Table 3. Optical properties of BODIPY derivatives. 
 
3.2.7. Monitoring ligand substitution reactions by fluorescence spectroscopy 
In contrast to the bright BODIPY-NHC conjugates recently reported,[68, 70] the fluorescence in 
the BODIPY-phosphines described herein is largely quenched, probably due to PET-type 
quenching of the fluorophore. However, once the phosphorus lone pair is donated to a metal, 
an increase in the fluorescence quantum yields is likely, unless the metal itself opens new 
quenching pathways. Au(I) is normally a non-quenching metal ion and we, therefore, decided 
to study different ligand substitution reactions in the stable complex [AuCl(12b)]. This is 
especially interesting with a view to the prominent role that closely related complexes have 
played in homogeneous catalysis.[175] 
Gold-thiolato complexes. The addition of an alkanethiol (1-dodecanethiol) to [AuCl(12b)] 
leads to an exponential decrease in the fluorescence intensity within approximately two 
minutes; upon addition of base (Et3N), the fluorescence of this complex nearly vanishes 
(figure 24).[176] Upon addition of an arylthiol (thiophenol or thiocresol) to [AuCl(12b)] the 
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decrease in fluorescence is more pronounced, leading to an almost quenched complex; the 
addition of base produces only a small additional decrease in the brightness (figure 25). The 
addition of Et3N alone to [AuCl(12b)] does not have a significant influence on the 
fluorescence intensity, the fluorescence is only quenched once the thiol is added. This shows 
that the addition of thiol and Et3N leads to the formation of the well-established gold thiolato 
complexes,[177] with a significantly increased electron density at the gold. It is likely that this 
increase in electron density enhances the PET quenching of the fluorophore because the 
electron-rich gold is less willing to accept the phosphorus lone pair.[131a] Such conclusion is in 
line with the research on NHC–gold–thiolates described in the previous chapter. This 
hypothesis is additionally supported by work from Nagano et al. on organic fluorophores, who 
established a qualitative relationship between the electron density (rather the energy of the 
HOMO) of a quencher and the fluorescence quantum yield.[133a] 
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Figure 24. Fluorescence intensity vs. time plot for the reaction of thiol (dodecanethiol) with [AuCl(12b)] in 1,2-
dichloroethane (c = 1.0·10-6 mol·L-1) and base (Et3N). Order of addition of reactants: [AuCl(12b)] + Et3N then thiol 
(trace a) or [AuCl(12b)] + thiol then Et3N (trace b). 
 
 
 
 
 
 
 60 
0 60 120 180 240 300 360
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
fl
u
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 /
 a
.u
.
time / s
+thiol
+Et3N
 
Figure 25. Fluorescence intensity vs. time plot for the reaction of thiol (thiophenol) with [AuCl(12b)] in 1,2-
dichloroethane (c = 1.0·10-6 mol·L-1) and base (Et3N). Order of addition of reactants: [AuCl(12b)] + thiol then Et3N. 
It is not clear why the addition of alkanethiol leads to a smaller decrease in the fluorescence 
intensity than with the arylthiol, but the different acidities of alkanethiol and arylthiol might 
play an important role. Two explanations are considered: a) the thiol replaces the chloro 
ligand forming a cationic complex of the type [Au(RSH)(12b)]+Cl-; b) alternatively, an 
equilibrium of the type [AuCl(12b)] + RSH = [Au(SR)(12b)] + HCl is established. In order 
to probe hypothesis (a), the reaction of [AuCl(12b)] with thiophene was studied in the 
fluorescence spectrometer. No change in the fluorescence was observed upon addition of 
thiophene (figure 26) and therefore coordination of the thiol is less likely. 
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Figure 26. Fluorescence intensity vs. time plot for the reaction of thioether (tetrahydrothiophene) with [AuCl(12b)] 
in 1,2-dichloroethane (c = 1.0·10-6 mol·L-1). Order of addition of reactants: [AuCl(12b)] + thioether. 
To verify hypothesis (b), different amounts of thiol (50, 100, 200, 400 equiv) were added to 
[AuCl(12b)]. Depending on the amount of added thiol, a corresponding decrease in the 
fluorescence intensity was observed, with more thiol leading to successively weaker 
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fluorescence (figure 27). The fluorescence is always fully quenched upon addition of base to 
this reaction mixture. This observation is in line with shifting the equilibrium [according to 
(b)] upon addition of more alkanethiol to the product side. Based on this equilibrium, the 
much larger initial drop of brightness with aryl thiols as compared to alkyl thiols can be 
explained based on the much higher acidity of aryl thiols. 
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Figure 27. Fluorescence intensity vs. time plot for the reactions of [AuCl(12b)] (c = 1.0·10-6 mol·L-1) in 1,2-
dichloroethane with different amounts of dodecanethiol, added after ca. 80 s (black: +50 equiv dodecanethiol; red: 
+100 equiv; blue: +200 equiv; green: +400 equiv) to [AuCl(12b)], followed by addition of excess of triethylamine. 
The analogous experiments (addition of 1 equiv thiol and 1 equiv Et3N to [AuCl(12b)], albeit 
at ca. 10000 times higher concentration of gold complex) were carried out in NMR tubes. 
Resonances detected in the 31P NMR spectra of the nonfluorescent solutions show the clean 
transformation of [AuCl(12b)] ( 47.5 ppm) into [Au(SC12H25)(12b)] ( 49.6 ppm) or 
into [Au(SPh)(12b)] ( 50.5 ppm); no other peaks are observed in the 31P NMR spectra 
(figure 28). 
 
Figure 28. 31P-NMR spectra of [(3b)AuCl], and its thiol derivatives [(3b)AuSC12H25] and [(3b)AuSPh], formed directly 
in NMR tube upon addition of 1 equiv of the respective thiol and 1 equiv of Et3N to the solution of [(3b)AuCl] in 
CDCl3. 
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Gold complexes with weakly coordinating anions. Based on the results with Au thiolates, a 
decrease in the electron density at the transition metal could lead to enhanced brightness. We 
were therefore interested, whether it is possible to study the formation of “cationic” gold 
complexes at catalytically relevant concentrations using fluorescence spectroscopy. This was 
tested by replacing the strongly coordinating chloride in [AuCl(12b)] with weakly 
coordinating (donating) anions (wca), with the help of silver salts.[178] Such reactions are very 
important in gold catalysis, often constituting the crucial activating step in numerous gold-
catalyzed transformations.[179] Complexes such as [LAu(wca)] are generated in situ from 
[LAuX] (X = Cl, Br, I) through silver salt metathesis involving precipitation of AgX,[180] but 
may also be isolated and then used in catalysis.[181] The nature of the anion and of the solvent, 
in which such reactions are carried out, exert a very significant influence on the formation of 
solvent-separated ions (vs. close ion-pairs) and consequently on catalytic activity.[182] 
To a solution of [AuCl(12b)] in 1,2-dichloroethane were added aliquots corresponding to 0.5 
equivalents of [Ag(ONf)] (ONf = C4F9SO3
-) in the same solvent (figure 29). The fluorescence 
intensity of the solution increases following the addition of each aliquot and reaches 
saturation after adding approximately 2.5 equivalents of silver salt, corresponding to an 
increase in fluorescence brightness of approximately 20%.[183],[184] Addition of more silver salt 
(up to 20 equiv) does not lead to significant change in the fluorescence intensity. It is likely 
that the fluorescence increase is due to ONf- being less electron-donating than chloride. To 
test this, [Au(NTf2)(12b)] was synthesized and the fluorescence intensity was found to be 
almost the same as that of the in situ prepared gold nonaflate. However, for both 
[Au(wca)(12b)] complexes, the change in the fluorescence intensities is rather modest 
compared to those seen in the other reactions described herein. This may well mean that in 
the 1,2-dichloroethane solvent, cation and anion still form fairly close ion pairs, which is 
reasonable with a view to the very low donicity of 1,2-dichloroethane.[185],[186] The 
experiments clearly show that the reaction of the gold complex with [Ag(ONf)] requires 
superstoichiometric amounts of silver salt to form the gold nonaflate complex. When smaller 
amounts of silver salt intermediate species are used, presumably Au···Cl···Au species are 
formed.[187] This fits well with results reported by Echavarren et al., who showed that a 
significant excess of [Ag(OTf)] is required to produce the related [(JohnPhos)Au(OTf)] from 
[(JohnPhos)AuCl], as demonstrated by NMR studies.[187] Our studies confirm the results from 
Echavarren’s group; however, in our study, such information is obtained at catalytically 
relevant concentrations.[188] 
 63 
0 2 4 6 8 10
0.19
0.20
0.21
0.22
0.23
0.24
0.25
fl
u
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 /
 a
.u
.
time / min
 
Figure 29. Fluorescence intensity vs. time plot for the addition of six times 0.5 equiv aliquots of [Ag(ONf)] (denoted 
by arrows) to a solution of [AuCl(12b)] (c = 1.0·10-6 mol·L-1) in 1,2-dichloroethane. 
Gold-acetylene complexes. Next, we were interested to learn, whether the modulation of 
brightness could be used to probe the initial steps defining gold-catalyzed reactions with 
acetylenes. Key species in such reactions are -bonded acetylenes,[189] -bonded 
acetylides,[190] and the cationic digold species [(LAu)2(CCR)]
+.[190-191] Changes in the 
coordination sphere should influence the electron density at gold and lead to the 
characteristic modulation of the fluorescence intensity. 
To a solution of [AuCl(12b)] in 1,2-dichloroethane were added 1–30 equivalents of 
[Ag(ONf)]. The formation of [Au(ONf)(12b)] is accompanied by a modest increase in the 
fluorescence intensity (figures 29 and 30). To the in situ generated gold nonaflate were added 
1000 equivalents of phenyl acetylene, leading to a very pronounced increase in the brightness 
(figure 30). The amount of silver in the reaction mixture has a significant influence on the 
evolution of the fluorescence intensity. In the presence of large amounts of [Ag(ONf)] (> 10 
equiv) a very fast increase in the brightness is observed. When applying less silver salt, the 
reaction with acetylene is sluggish or does not take place. The need for a large excess of silver 
salt is not obvious since our previous experiments had shown that [Au(ONf)(12b)] is already 
formed with approximately 2.5 equivalents of silver salt. However, it is well known that for 
many Au-catalyzed reactions, a significant rate acceleration occurs in the presence of a large 
excess of silver salt.[180b, 182a, 192] Based on these results, we conclude that the coordination of 
the alkyne to the gold and alkyne deprotonation are critical steps. Consequently, the 
coordination of alkyne to excess silver salt appears to activate this substrate for the reaction 
with gold, leading to an overall faster reaction. 
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Figure 30. Fluorescence intensity vs. time plot for the reactions of [AuCl(12b)] (c = 1.0·10-6 mol·L-1) in 1,2-
dichloroethane with different amounts of [Ag(ONf)], added after ca. 1.5 min (trace f: +1 equiv [Ag(ONf)]; trace e: 
+5 equiv; trace d: +10 equiv; trace c: +15 equiv; trace b: +20 equiv; trace a: +30 equiv) to [AuCl(12b)], followed by 
addition of phenyl acetylene (1000 equiv added after 2.5–3.4 min). Traces a-f denote the fluorescence-time 
changes after addition of alkyne to gold complexes activated with different amounts of [Ag(ONf)]. 
The reactions of acetylenes with cationic gold complexes can lead to several different species, 
including a side-on bound complex [LAu(PhCCH)], a terminal acetylide complex 
[LAu(CCPh)], and a dinuclear species [(LAu)2(CCPh)]
+.[193] Based on the fluorescence 
intensity alone, it is not possible to identify the formed species. Nonetheless, we were able to 
gather sufficient evidence to overcome this problem. The side-on complex is a fragile species 
and only a few examples of such complexes have been reported.[189a] In the presence of a 
base, this complex is easily converted into the terminal acetylide.[194] However, in the 
reactions presented herein, the addition of an excess of base (Et3N) does not lead to 
significant changes in the brightness. The side-on complexes with PhCCH are characterized by 
modest formation constants,[190, 195] which render their presence in the 10-6 mol·L-1 solutions 
of Au complex less likely. To probe the potential formation of a side-on bound complex, the 
cationic gold complex was exposed to 1000 equivalents of 4-octyne, which is known to form 
more stable complexes with LAu+ than PhCCH.[195] However, no change in the fluorescence 
brightness was observed (figure 31) and based on this evidence we conclude that the side-on 
acetylene-gold complex is not formed in such dilute solutions. 
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Figure 31. Fluorescence intensity vs. time plot for the reaction of [AuCl(12b)] (c = 1.0·10-6 mol·L-1) in 1,2-
dichloroethane with [Ag(ONf)] (15 equiv) and 4-octyne (1000 equiv). 
The terminal acetylide complex is another potential reaction product. However, this neutral 
complex should not lead to the observed pronounced increase in the fluorescence level, but 
instead to a significant decrease. To further clarify this, [Au(CCPh)(12b)] was synthesized 
and the fluorescence quantum yield determined, which is much lower than that of 
[AuCl(12b)] (table 3). For this reason, we believe the species formed in our fluorescence 
experiments to be the dinuclear [((12b)Au)2(CCPh)]
+.[190-191] Closely related species with 
SIPr-type NHC ligands instead of 12b are well known.[189a] The cationic nature of this complex 
is in accord with the pronounced increase in fluorescence intensity. A reaction mixture 
containing the dinuclear species, based on a procedure by Widenhoefer et al.,[190] was probed 
by NMR spectroscopy (albeit at much higher concentration than in the fluorescence 
experiment). This experiment provides clear evidence for the formation of the dinuclear 
species. However, we were not able to isolate this complex in its pure state due to its 
instability. The phosphine ligand 12b is most likely insufficiently bulky to render a stable 
dinuclear complex. Furthermore, NMR signals are observed for the known vinyl triflate, which 
is the addition product of PhCCH and TfOH. Based on the fluorescence intensity of the in situ 
formed [((12b)Au)2(CCPh)], the fluorescence quantum yield of this complex is estimated to 
be close to  = 0.4. 
Finally, we were interested to find out whether the modulation of the electronic nature of the 
phenyl acetylene has an influence on the fluorescence intensity of the remote BODIPY unit. 
This was tested by using phenyl acetylenes with electron-withdrawing (R = NO2) and 
electron-donating groups (R = NMe2) in the 4-position. The respective digold complexes 
[((12b)Au)2(CCC6H4-R)]
+ were generated with the aid of Hünig’s base in the cuvette and the 
fluorescence intensity measured (figure 32). The fluorescence experiment proved to have 
excellent sensitivity, since even the remote 4-NMe2 substituent led to a significant decrease in 
the fluorescence brightness of the peripheral BODIPY unit, while the 4-NO2 group caused a 
small increase in the (already high) brightness of the fluorescence emission. 
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Figure 32. Fluorescence intensity vs. time plot for the reactions of [AuCl(12b)] (c = 1.0·10-6 mol·L-1) with [Ag(ONf)], 
Hünig’s base, and three different phenyl acetylene derivatives HCCC6H4R (1000 equiv; R = NO2, H, NMe2) yielding 
[((12b)Au)2(CCC6H4R)]
+ ONf- complexes in 1,2-dichloroethane. 
 
3.3. Ion-pairing in transition-metal complexes via PET and FRET 
3.3.1. Ion pairs in transition-metal catalysis 
The phenomenon of ion-pairing plays an important role in catalytic processes of transition-
metal complexes.[196] Nowadays, it is a matter of fact that the nature of weakly coordinating 
anion has a great influence on the activity of catalyst, as well as on its chemo-, regio- and 
stereoselectivity, which was observed in a variety of chemical transformations such as olefin 
polymerization,[197] Diels-Alder,[198] Heck,[199] hydrogenation,[200] carbonylation,[201] and many 
other catalytic reactions.[202] Concerning activity, in most cases, it has been found that the 
weaker the coordinating power of the anion, the higher the reactivity for a given cation.[203] 
The reason for such trend is that both the substrate and the anion compete for the reactive 
site of the cation, and the less coordinating anion would facilitate the coordination of 
substrate and subsequent catalytic transformations. At the same time, the influence of the 
counterion on the selectivity of the catalyst is still often the matter of debate. 
In reactions of transition-metal complexes, contact ion pairs play a decisive role. They are 
divided into two types: outer-sphere ion pairs (OSIPs) and inner-sphere ion pairs (ISIPs) 
(figure 33).[196] Since catalytic processes normally take place in solution, X-ray analysis may 
be only suitable for investigation of ISIPs, where strong interaction between cation and anion 
can be responsible for identical ionic orientation in the solid state and in solution; the 
structures of solvated OSIPs can be considerably different from that in the solid state. 
Therefore, the main tools used for the ion-pairing study in solution are NMR techniques, such 
as PGSE (pulsed field gradient spin-echo) and NOE (homo- and hetero-nuclear) NMR 
experiments.[204] 
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Figure 33. Schematic representation of OSIP (left) and ISIP (right). 
By using PGSE experiments it is possible to determine the hydrodynamic volume of the 
diffusing particles. Based on this, the degree of aggregation of catalytic species can be 
established, i.e. whether they exist as free ions, or ion pairs, quadruples, etc. Typically, the 
type of ionic species present in solution strongly depends on the nature of solvent and 
concentration of complexes.[205] 
NMR techniques based on NOE, which acts directly through space, can be used to establish 
the structures of ion pairs of transition-metal complexes in solution.[206] Although NOE is 
limited to the distance of max. 0.5 nm, it is suitable for investigation of intimate ion pairs, 
which affect the reactivity of catalysts the most. The obvious requirement for NOESY is that 
both ionic counterparts should contain magnetically nonequivalent NMR-active nuclei with 
high receptivity, for example, 1H and 19F nuclei. By investigation of 1H-NOESY and 19F,1H-
HOESY NMR spectra of several Fe(II),[207] Ru(II),[208] Os(II),[209] Pd(II),[210] Pt(II)[211] and 
Ir(III)[212] complexes ion pairs, Macchioni and coworkers have shown that in most cases there 
is a predominant relative anion-cation orientation, determined mainly by a gain in 
electrostatic interaction energy. Despite the successful qualitative NMR investigations, 
quantitative determination of the average interionic distances by NOESY faces some 
limitations. For a quantitative analysis, the correlation times of the reference distance and the 
distances of interest must be the same. This is not necessarily the case if we compare a pair of 
nuclei belonging only to one of the ions constituting ion pair (intramolecular distance) and 
the nuclei of the cation and those of the anion (interionic distance). Nonetheless, Zuccaccia et 
al. have shown[213] that in some cases quantification of interionic NOEs can be successfully 
carried out with the consequent possibility of estimating average interionic distances. 
Catalytic activity[214] and selectivity[215] of gold(I) cationic complexes are also greatly affected 
by the nature of counterion. For example, Macchioni and coworkers have shown[216] that 
properties of anion influence the catalytic performance of gold complexes in the alkoxylation 
reaction of alkynes by two reasons: on the one hand, the anion facilitates the reaction by 
deprotonation of methanol during the nucleophilic attack; on the other hand, its coordination 
to the metal center suppresses the catalytic activity by preventing alkyne coordination. Both of 
these factors have opposite dependence on basicity of the anion, and the medium basic OTs- 
was found to show the best catalytic activity. These results were further supported by the 
computational study.[217] In more general research, Zhdanko and Meier have shown[178b] that 
the overall anion effect is generally determined as superposition of the elementary effects 
such as hydrogen bond acceptor power, coordinating ability to gold, and affinity for a proton 
(basicity). The authors suggested OTf− to be an optimal counterion for the majority of cases 
in gold(I)-catalyzed hydroalkoxylation of alkynes. In another comprehensive study, Zuccaccia 
and coworkers have shown[218] that efficiency of gold(I) catalysts for a given process depends 
not only on the properties of anion and ligand alone but rather on their combination. 
Since gold(I)-alkene and -alkyne complexes are important intermediates in gold-catalyzed 
transformations,[219] Macchioni and coworkers have investigated ion-pairing in cationic 
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gold(I) catalysts bearing unsaturated hydrocarbons by combining NMR experiments with 
theoretical modelling.[189d, 220] Depending on the nature of ligand three specific anion-cation 
orientations were identified for most of the complexes[221] (figure 34): for phosphine ligands 
the anion preferentially located close to the substrate (orientation C) and/or above and below 
the metal (orientation B); in the case of NHC complexes the anion tends to stay near the 
ligand (orientation A). Within this general pattern, the ion-pairing can be finely tuned by the 
introduction of functional groups in the ligand. 
 
Figure 34. Three orientations, A, B, and C, of the counterion in gold(I)-alkene (-alkyne) complexes. 
In the subsequent work, Zuccaccia and coworkers have investigated[222] a relationship 
between the anion-cation relative orientation and the catalytic activity of gold complexes. For 
this reason, the authors have compared the structures of in situ prepared complexes P1, P2 
and P3 (figure 35) with their activity in the alkoxylation reaction of 3-hexyne directly in NMR 
tube. The difference in the number and the position of the OH and NH moieties (hydrogen 
bond donors) and also in the steric hindrance around them was designed with the deliberate 
purpose of influencing the ion pair structure of the catalyst. Thus, the anion in complex P1 in 
CDCl3 was found to localize predominantly near the ligand; the relationship of the relative 
orientations A and C (figure 34) was established to be 97:3. In fact, the interaction between 
BF4
- and the ligand in P1 was so strong that ion-pairing was not affected even by using more 
polar CD3OD as a solvent. Substitution of one NH hydrogen with bulky isopropyl group 
weakened the interaction between the anion and the ligand, so that for the complex P2 A:C = 
79:21, which indicates a higher relative abundance of the anion in the orientation C (closer to 
the alkyne side) compared to P1. In complex P3 the anion was predominantly localized near 
OH group; the impact of orientation A and C was negligible. 
 
Figure 35. Different N-acyclic carbene (NAC) gold complexes prepared by Biasiolo et al. 
The highest catalytic activity was observed for the complex P2 (catalyst loading 1 mol%), 
which showed 59% conversion of alkyne in 90 min using CDCl3 as a solvent, whereas for P1 
and P2 conversion was only 24-30% at the same time. This is consistent with the previously 
reported works,[178b, 216-217] according to which the anion has a beneficial role in activating the 
methanol by lowering the activation barrier of the attack: if a specific interaction keeps the 
anion far from the catalytic center, it cannot play its role of activator and the reaction slows 
down. By using methanol as a solvent for the reaction, catalytic activity of the complexes P2 
and P3 was found to be almost the same, since in more polar solvent both complexes exist as 
 69 
free ions. Hence, tuning of the preferential position of the counterion by careful ligand design 
opens the way to greater control over the properties and activity for the gold-mediated 
reactions in which the anion plays an important role during the catalysis. 
Concerning the important role of counterions in transition-metal catalysis, we decided to 
explore whether fluorescence spectroscopy can be used for the ion-pairing study. Compare to 
NMR techniques, it can operate at much lower concentration range – more relevant to the 
catalytic processes; also it requires relatively simple equipment, which can provide fast 
measurements, thus making possible “live” observation of chemical transformations. In the 
previous chapters, the design and application of PET-based molecular probes were shown. 
Another distance-dependent effect – FRET – is widely used in biology as a “spectroscopic 
ruler”[223] to measure the distances between different parts of macromolecules, etc. In this 
chapter, we have focused on designing transition metal complexes suitable for ion-pairing 
study by employing either PET or FRET quenching mechanisms. 
3.3.2. Ion-pairing via PET 
At first, we decided to probe whether PET effect is suitable for ion-pairing study. The general 
idea is schematically represented in figure 36. The lone pair(s) of the anion, connected to the 
fluorophore, should quench the fluorescence brightness because of PET. Once the anion is 
coordinated to the transition metal, the negative charge should be withdrawn towards the 
metal center, which plays a role of Lewis acid. As a consequence, fluorescence emission 
should increase. In contrast, the breakup of ion pair should lead to the quenching of 
fluorescence due to releasing of electron density on the anion. Hence, the intensity level of 
fluorescence emission was expected to provide useful information about the extent of 
association of counterions and their spatial arrangement. 
 
Figure 36. Investigation of ion-pairing based on PET effect. 
Gold(I) complexes are widely used in catalysis and were also chosen for our study because of 
non-quenching nature of gold metal. NHC-gold(I) complexes containing medium-coordinating 
tosylate counterion appeared to be very efficient in catalysis, for example, in alkoxylation of 
alkynes.[216-217] Therefore, to test our concept, we have synthesized gold sulfonate complex 
[AuIPr(14)] (figure 37). Since SO3 group is directly connected to the BODIPY core in this 
molecule, the influence of anion on the emission brightness of the fluorophore should be 
maximized. This complex was obtained from IPrAuCl and silver salt 14·Ag by the halide 
abstraction reaction. The salt 14·Ag was prepared in a similar way to the known BODIPY 
sulfonate sodium salts,[50] by using silver carbonate instead of sodium carbonate to quench the 
intermediate BODIPY sulfonic acid. Purification of the silver salt 14·Ag by silica column leads 
to an unclear result: although NMR shifts fit the ones observed in the spectrum of the crude 
product, the “purified” material doesn’t react with IPrAuCl anymore. Based on this we have 
concluded, that interaction with silica during purification leads to some chemical 
transformation, most probably, cation exchange. Therefore, salt 14·Ag was purified by 
precipitation with diethyl ether from DCM solution, thus avoiding silica column. 
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Figure 37. Synthesis of gold sulfonato complex [AuIPr(14)]. Reaction conditions: a) ClSO3H, DCM, -78 °C, 30 min, 
then RT, 1h, then MeOH, Ag2CO3, 12 h; b) IPrAuCl, DCM, RT, 12 h. 
We suggest that complex [AuIPr(14)] in toluene should exist predominantly in the form of 
intimate ion pairs. The increase of solvent polarity by addition of acetonitrile should lead to 
another extreme case – complete dissociation of ion pairs. Such chemical transformation 
should be characterized by the maximum change of fluorescence intensity. In other words, a 
difference of fluorescence emission between two states would define the range of values that 
can be useful for ion-pairing study. 
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Figure 38. Fluorescence intensity vs. time plot for the addition 50 µl aliquots of acetonitrile (denoted by arrows) to 
a solution of [AuIPr(14)] (c = 1.0·10-6 mol·L-1) in toluene. 
As shown in figure 38, the addition of acetonitrile to the solution of the complex [AuIPr(14)] 
in toluene led indeed to decrease of fluorescence intensity, which was in line with our 
prediction. Further increase of polarity has caused restoring of emission intensity, indicating 
suppression of PET at higher acetonitrile content. Most probably, it happened due to 
stabilization of the negative charge of the anion by solvation with a polar solvent. 
Nonetheless, the initial drop of fluorescence intensity was only ca. 11%, which shows the 
rather low sensitivity of the PET-based probe. Any other transformations should lead to even 
smaller intensity change, which can be difficult to detect. For example, the addition of phenyl 
acetylene was not accompanied by any observable change of emission intensity. Concerning 
the low stability of complex [AuIPr(14)] in solution, which limits its full characterization, we 
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have concluded that the PET-based probe is not suitable for ion-pairing study. Therefore, 
another quenching mechanism was considered. 
3.3.3. Ion-pairing via FRET: general concept 
FRET is another fluorescence quenching mechanism, which can be used for distance 
measurements in chemical systems. An interesting example of FRET application was described 
by Diederich and coworkers,[224] who have used fluorescence techniques for investigation of 
the vase–kite switching process in the quinoxaline-bridged resorcin[4]arene cavitands. In their 
research, the authors have prepared BODIPY-substituted cavitands shown in figure 39. 
Addition of trifluoroacetic acid caused the transition of cavitands from the vase state to the 
kite state, which was clearly demonstrated by FRET measurements: the donor intensity 
strongly increased and the acceptor intensity almost disappeared due to the increased 
distance between the two dyes. FRET was also applied for the determination of the average 
opening angle α of the cavitands in the vase conformation in solution. In general, to calculate 
the distance between the donor and acceptor fluorophores from the measured FRET 
efficiency, knowledge of Förster radius R0 is needed. Since R0 value depends on many factors, 
it should be determined for any particular system independently. Prepared cavitands (figure 
39) were different by the number of phenylethynyl units (n) in the linker which connects the 
fluorophores and the rest of the molecule. Assuming that α is constant for all cavitands at a 
certain temperature, the distance between the donor and acceptor BODIPYs (R) was 
expressed as a function of α and n. The brief mathematical description is given below. It 
should be also noted, that cavitand with n = 0 was not suitable for the investigations, since R0 
value for this compound was different than in the others cases (n = 1, 2, 3). Most probably, it 
was caused by the hindered rotation of the fluorophores, which resulted in a different 
orientation factor. 
The FRET efficiency can be calculated by the formula (1): 
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where IDA – measured emission intensity of the donor fluorophore in the presence of the 
acceptor fluorophore and ID – in the absence of the acceptor fluorophore. The dependence on 
distance is defined by the equation (2): 
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which can be rewritten in the following manner: 
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where R is a distance between two fluorophores, R0 – Förster radius. The distance R was also 
defined through trigonometric transformations: 
R = 2d + a = 2csin(α) + a = 2[(nb + e)sin(α)] + a = 2esin(α) + a + 2bsin(α)n     (5) 
where values a, b, c, d and α are defined as shown in figure 39, n – is a number of connecting 
phenylethynyl units, e = c when n = 0. When the expression for R from equation (5) was 
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substituted into equation (3), the authors have obtained an expression (6) for R/R0 that was a 
linear function of n. 
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The values of a, b and e were obtained from X-ray analysis. The values of R0 and α were 
unknown but were easily obtained by plotting R/R0 versus n. The plot was fitted linearly with 
a good correlation and from the slope and y-intercept of this line, values for the Förster radius 
and the average opening angle were calculated: R0 = 37 Å and α = 16°. 
 
Figure 39. BODIPY-substituted cavitands reported by Diederich and coworkers. 
We suggest that the similar approach as described above can be also applied for the ion-
pairing study. The very general concept is represented in figure 40. The FRET efficiency in the 
system, which consists of two counterions labeled with the FRET pair fluorophores, should 
depend on the average distance between the cation and anion. Hence, the ISIP should be 
characterized by the maximum FRET efficiency: the high intensity of acceptor fluorophore 
and almost absent emission of donor fluorophore (figure 40, a). In the case of OSIP, when 
cationic metal species are coordinated to the substrate, FRET efficiency should decrease 
leading to intermediate intensity values for both donor and acceptor fluorophores (figure 40, 
b). And, finally, solvation of ion pairs by a polar solvent and formation of free ions should 
lead to the complete disappearance of FRET and full restoring of donor emission (figure 40, 
c). The choice to connect acceptor fluorophore to cation and donor fluorophore to anion was 
arbitrary; the contrary connection doesn’t affect the overall concept. 
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Figure 40. The general concept of the FRET application for ion-pairing study: a) ISIP is characterized by the 
maximum FRET efficiency; b) OSIP – intermediate FRET efficiency; c) free ions – disappearance of FRET. 
More details of the proposed approach are revealed in figure 41. An acceptor fluorophore is 
connected to the ancillary ligand and a donor fluorophore to the anion moiety through 
properly designed linkers (figure 41, a). We can characterize relative 3D arrangement of ion 
pair components by using Cartesian coordinates and putting the origin on the metal center as 
shown in figure 41, b. In this case, we can define the average position of acceptor fluorophore 
by a vector  ⃗, which points from the origin to the fluorophore (strictly speaking to the middle 
of its transition dipole). To simplify the concept we assume that the value of vector  ⃗ depends 
only on the chemical structure of ligand and linker (and other macroscopic parameters such 
as solvent, temperature, etc.) and doesn’t depend on the type of ion pair (i.e. position of 
anion). In general, it is not necessarily true but can be achieved by careful design of the linker 
between ligand and acceptor fluorophore. Analogously to  ⃗, we can define position of donor 
fluorophore as a vector ⃗⃗ (figure 41, b), although in this case some additional requirements 
should be fulfilled. At first, positions of anion moiety and donor fluorophore can be easily 
correlated only if they are connected by a rigid (preferably straight) linker. And second, for 
such representation to be correct the whole anion should point towards the metal center. This 
requirement is more specific and must be considered separately for each particular case. 
 
Figure 41. Schematic representation of fluorophores-tagged ion pair (a); position determination of ion pair 
components using vectors (b). 
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The distance between two fluorophores R can be defined as a module of vector  ⃗ (figure 41, 
b), which equals to the difference between vectors  ⃗ and ⃗⃗. Based on equation (3) we can 
derive the following expression (7) for our system: 
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     (7) 
A vector can be defined through three parameters. For example, in spherical coordinates  ⃗ is 
completely characterized if its length | ⃗|, azimuthal angle θA, and polar angle ϕA are known 
(figure 41, b). To fully characterize the ion pair system we need to define two vectors  ⃗ 
and ⃗⃗, each of which is determined by three parameters, and establish Förster radius R0 – in 
total 7 unknown parameters. Hence, in most general case, it is necessary to determine FRET 
efficiency of at least 7 systems differing in the length of the linker(s) of donor and/or acceptor 
fluorophores by known length. This should be enough to make a system of 7 independent 
equations of general view as expression (7) and to solve it. Obviously, it is a very tedious 
work, especially from synthetic point of view. Also, in case of 7 different systems, which are 
characterized by 7 different distances R, it can be difficult to avoid the situation when for one 
of the systems R value appears to be too different from R0. In this case, FRET measurements 
may not be sensitive enough to determine the distance R with necessary accuracy. Therefore, 
we suggest that any particular ion pair system can be reasonably simplified. An example is 
described below. 
Our research was focused on NHC-gold(I) tosylate ion pairs. The coordinate system was 
chosen such that origin was located on metal center, z-axis was perpendicular to the line 
between two nitrogen atoms, and imidazole ring was lying in xz plane (figure 42). At first, we 
considered a situation without any substrate. Tosylate is known for its high affinity to 
gold,[178b] therefore, in a non-polar solvent like toluene, gold(I) tosylate should exist 
predominantly in a form of ISIP. Considering the linear structure of most gold(I) 
complexes,[188] we assume that in the chosen coordinate system anion is located along the z-
axis as shown in figure 42, a (vector ⃗⃗ is marked in green). In this case, θ = ϕ = 0, and | ⃗⃗| 
can be estimated with good accuracy by using computational methods as distance between 
gold and boron atoms. The acceptor fluorophore (BODIPYA) we propose to connect directly to 
imidazole ring of NHC ligand through alkoxy chain. Such connection ensures unhindered 
rotation of BODIPYA and is favourable synthetically. It is also important that linker is long 
enough to avoid any influence of metal center on the fluorescence intensity of BODIPYA via 
PET. Despite the flexibility of alkyl chain, we assume that BODIPYA is located in average in the 
plane of imidazole ring, i.e. in xz plane. Based on this we can reduce amount of unknown 
parameters by establishing θA = 0. Therefore, to define vector  ⃗ (marked in red in figure 42) 
we need to determine only its length | ⃗| and polar angle ϕA. Together with R0 we have only 3 
unknown parameters, which can be found by investigating 3 systems differing in value of n = 
1, 2, 3 (figure 42, a). 
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In the next situation, when a substrate is coordinated to gold (figure 42, b), the position of 
anion ( ⃗⃗) is no longer well-defined. Assuming the localization of  ⃗ has not been changed and 
all the parameters found in the previous situation remain the same, there are again only 3 
parameters to determine: | ⃗⃗|   θD, ϕD. Using the same systems (n = 1, 2, 3), it is possible to 
figure out the spatial structure of ion pair also in this case. Comparing to seven-component, 
such three-component approach seems to be more applicable and realistic. If all the 
simplifications were correct, it is possible to determine gold(I) tosylate ion pairs structures for 
variety of substrates using simple measurements of fluorescent intensity in three different 
systems. 
3.3.4. Synthesis of the complexes 
Our strategy towards BODIPY sulfonates was based on the condensation of sulfonated 
aromatic aldehydes with pyrroles. In this way, the target BODIPY sulfonates can be 
straightforwardly obtained in a couple of steps. For the monophenyl derivative, we have 
started from sodium 3-formylbenzenesulfonate 15·Na, which can be easily obtained by 
sulfonation of benzaldehyde. To increase the solubility in organic solvents sodium was 
exchanged by tetrabutylammonium cation (figure 43). Following the common procedure for 
the synthesis of BODIPYs, compound 16·NBu4(EtiPr2NH) was prepared in 30% yield. Finally, 
employment of ion-exchange resin yielded the target acid 16·H. It should be noted, that 
application of acidic resin leads to partial decomposition of BODIPY moiety. Fortunately, acid 
16·H can be easily purified by short silica column. 
 
Figure 43. Synthesis of BODIPY sulfonic acid 16·H. Reaction conditions: a) NBu4Br, DCM, H2O; b) 3-ethyl-2,4-
dimethylpyrrole, chloranil, iPr2NEt, BF3·Et2O, DCM; c) Amberlite IR-120 hydrogen form cation exchange resin, 
MeOH. 
 
Figure 42. Ion-pairing in NHC-gold(I) tosylates: a) in the absence of substrate – ISIP; b) in the presence of substrate 
– OSIP (a substrate is omitted for clarity). 
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To avoid additional step with silver carbonate, we decided to use the acid 16·H directly for 
the synthesis of NHC-gold(I) sulfonates. For this reason, we have prepared acetate complex 
[(17)-O-IPrAu(OAc)] by reaction of the respective halide complex [(17)-O-IPrAuCl] 
(prepared in our laboratory before by O. Halter) with silver acetate. Being much less acidic, 
acetate in [(17)-O-IPrAu(OAc)] was easily substituted by sulfonate in quantitative yield 
(figure 44). Analogously [IPrAu(16)] was prepared from 16·H and [IPrAu(OAc)]. 
 
Figure 44. Synthesis of BODIPYs-tagged NHC-gold(I) tosylate. Reaction conditions: DCM, RT, overnight. 
The synthesis of biphenyl sulfonates was started from the commercially available biphenyl-4-
carboxaldehyde, which can be selectively sulfonated as shown in figure 45. Subsequent cation 
exchange and condensation with 3-ethyl-2,4-dimethylpyrrole, followed by complexation with 
BF3·OEt2, led to the formation of BODIPY sulfonate 19a·EtiPr2NH. As in the case of the 
monophenyl sulfonate, employment of ion-exchange resin led to the partial decomposition, so 
the crude acid should be purified additionally by silica column. Unfortunately, in the case of 
biphenyl sulfonates, the “purified” product didn’t react with NHC-gold(I) acetate. At first, we 
concluded the low solubility of biphenyl moiety was the reason for such unexpected result. 
However, application of more soluble sulfonate 19b·NBu4 with longer hexyl side chains in the 
same reactions eventually led to a similar outcome. At this point, we realized that purification 
by silica column was the source of the problem. Most probably, the presence of some minor 
impurities in silica caused the substitution of the proton. We have already observed similar 
problem for the silver salt 14·Ag. Unlike the monophenyl acid 16·H, separation of the 
biphenyl acids from the byproducts was more complicated and the longer column was 
needed. Therefore, suppressing of undesirable effects by decreasing amount of silica was not 
possible in this case. To avoid decomposition during the ion-exchange step, we decided to try 
a less polar solvent. Application of DCM instead of methanol also led to the partial 
decomposition, although the byproduct, in this case, was different according to NMR spectra. 
Hence, preparation of pure biphenyl sulfonic acids and respective NHC-gold(I) sulfonates still 
remains a challenging task. 
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Figure 45. Synthesis of BODIPY biphenyl sulfonates. Reagents and conditions: a) oleum, 40°C; b) NBu4Br, DCM, 
H2O; c) pyrrole, chloranil, iPr2NEt, BF3·Et2O, DCM. 
 
3.3.5. FRET measurements 
To ensure the existence of sufficient amount of intimate ion pairs of complex [(17)-O-
IPrAu(16)] in the dilute solution we decided to use non-polar toluene as a solvent for our 
measurements. Upon excitation at 527 nm (absorbance maxima of donor fluorophore), we 
have clearly observed the emission band of acceptor fluorophore at 627 nm, which was 11.9 
times more intense than the donor emission band at 539 nm (figure 46). Furthermore, by 
measuring the fluorescence intensity of complex [IPrAu(16)] (which is lacking acceptor 
fluorophore) under the same conditions and using equation (1), the FRET efficiency was 
established to be 96%. The appearance of strong FRET clearly indicates the existence of ISIPs 
in toluene solution, which is fully consistent with the proposed concept (figure 40, a). 
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Figure 46. Emission spectrum of complex [(17)-O-IPrAu(16)] (c = 1.0·10-6 mol·L-1) in toluene (λexc = 527 nm). 
Next, we have examined the influence of more polar solvents on the system. Addition of 
acetonitrile led to a steep decrease of acceptor to donor intensity relationship (figure 47, left). 
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Combining the results of measurements for both complexes [(17)-O-IPrAu(16)] and 
[IPrAu(16)] we were able to plot FRET efficiency versus acetonitrile content (figure 47, 
right). The obtained results clearly showed that at acetonitrile content of 25 vol% there are no 
ion pairs anymore in solution, which was indicated by full disappearance of the FRET. 
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Figure 47. FRET measurements of toluene solutions of complex [(17)-O-IPrAu(16)] (c = 1.0·10-6 mol·L-1). Left: 
dependence of acceptor to donor intensity relationship on acetonitrile content. Right: dependence of FRET 
efficiency on acetonitrile content. 
Addition of 1,2-dichloroethane (DCE) also led to decrease of FRET efficiency (figure 48). 
However, it was not so steep in this case and the full disappearance of FRET was achieved at 
higher solvent content – approximately 63 vol%. Although it can be predicted based on the 
different polarity of the solvents, this result quantitatively showed higher solvation power of 
acetonitrile relative to 1,2-dichloroethane towards gold cationic species. 
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Figure 48. FRET measurements of toluene solutions of complex [(17)-O-IPrAu(16)] (c = 1.0·10-6 mol·L-1). Left: 
dependence of acceptor to donor intensity relationship on 1,2-dichloroethane content. Right: dependence of FRET 
efficiency on 1,2-dichloroethane content. 
Dependence of energy transfer efficiency on polar solvent content (figures 47 and 48, right) is 
very similar to the FRET dependence on distance (equation (2)). It can be understood in the 
way that the higher polar solvent content corresponds to the larger average distance between 
counterions because of ion pairs dissociation to free ions. 
Finally, we have explored the reaction of complex [(17)-O-IPrAu(16)] with the alkyne 
substrate. Addition of excess amount of phenyl acetylene led to the increase of donor intensity 
with the simultaneous decrease of acceptor intensity (figure 49). It is reflected in the overall 
decrease of acceptor to donor intensity relationship, which becomes close to zero after 
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approximately 10 min. The most probable outcome of the reaction is the formation of gold 
dinuclear species, which were observed in the fluorescence experiments described in chapter 
3.2.7. The complete disappearance of FRET means that the digold species and tosylate anions 
exist as separated ions rather than ion pairs at a concentration level of the experiment. 
Remote localization of anion can be a reason of the high cationic character of gold dinuclear 
species, which explains a significant increase of fluorescence intensity shown in figure 30 
(chapter 3.2.7). 
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Figure 49. Left: fluorescence intensity vs. time plot for the reaction of complex [(17)-O-IPrAu(16)] (c = 1.0·10-6 
mol·L-1) in toluene with phenyl acetylene (1000 equiv). Right: dependence of acceptor to donor intensity 
relationship on time over the course of the reaction. 
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4. Summary and Conclusions 
In the following paragraphs, the most important aspects of my work are presented as a short 
summary. 
1. The reaction of the newly synthesized NHC-gold complexes 1, 2 and 3a with various aryl 
thiolates was monitored in situ by means of fluorescence spectroscopy (figure 50). 
 
Figure 50. NHC-gold complexes used in reactions with various thiophenols. 
2. The substitution of halide by various substituted aryl thiolates at the gold leads to a 
decrease in the brightness of the appended fluorophore. The extent of the decrease depends 
on the electronic nature of the thiol: the reaction with electron-rich thiolates leads to a strong 
decrease of fluorescence emission, whereas with electron-deficient thiolates the intensity drop 
was much less pronounced (figure 51). 
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Figure 51. Left: fluorescence-time traces upon addition of 100 equivalents of RC6H4SH (R = NO2, CF3, COMe, Cl, H, 
Me, tBu, OMe and NMe2) to complex 1 (c = 1.0·10
-6 mol·L-1) and Hünig base (100 equiv) in 1,2-dichloroethane 
solvent leading to the formation of the respective complexes [1(SC6H4R)]. Right: the plot of the p-Hammett 
parameter and the relative fluorescence brightness of complexes [1(SC6H4R)]. 
The fluorescence brightness of a BODIPY fluorophore attached to NHC–gold complexes can be 
easily tuned by changing the electron density at the transition metal. 
3. DFT calculations, conducted in cooperation with Prof. Dr. Israel Fernandez (Universidad 
Complutense de Madrid), suggest that fluorescence quenching occurs predominantly by the a-
PET-mechanism, despite the presence of a 5d transition metal ion and heavy atom halides 
(figure 52). 
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It was firmly established that fluorescent dyes can be used as highly sensitive probes for the 
determination of electron density at transition metals, thus being valuable tools for 
investigations in organometallic chemistry and homogeneous catalysis. 
4. Novel BODIPY-tagged phosphines 12a and 12b and the derived transition-metal complexes 
were prepared (figure 53). 
 
Figure 53. Transition-metal complexes containing BODIPY-tagged phosphine ligands. 
The synthesized compounds are characterized by very different fluorescence properties: 
phosphines 12a and 12b and the respective Pd complex are strongly quenched (Φ < 0.001); 
 
Figure 52. Computed frontier molecular orbitals of the isolated chromophores present in compounds [1(SC6H4R)] 
(orbital energies are given in eV). 
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the Cu complex was only partially quenched (Φ = 0.016), whereas Au and Ag complexes 
exhibited an intermediate level of fluorescence intensity (Φ ≈ 0.10). 
5. It was demonstrated that fluorescence spectroscopy on BODIPY-tagged phosphines can be 
used to monitor introductory steps in gold-catalyzed alkyne transformations in a catalytically 
relevant concentration range. The reactions involving [AuCl(12b)] show that changes in the 
electron density at the transition metal, resulting from ligand substitution reactions, translate 
into characteristic changes in the brightness of the BODIPY reporter group. An increase in the 
electron density at gold leads to a decrease in the brightness, whereas lower electron density 
at gold results in an increase in the fluorescence brightness. In suitably designed complexes, 
the fluorophore is highly sensitive to changes in the environment of the gold and even remote 
substituents in the periphery lead to pronounced changes in the brightness (figure 54). 
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Figure 54. Fluorescence intensity vs. time plot for the reactions of [AuCl(12b)] (c = 1.0·10-6 mol·L-1) with [Ag(ONf)], 
Hünig’s base, and three different phenyl acetylene derivatives HCCC6H4R (1000 equiv; R = NO2, H, NMe2) yielding 
[((12b)Au)2(CCC6H4R)]
+ ONf- complexes in 1,2-dichloroethane. 
6. The in situ fluorescence spectroscopic studies reveal subtle details of the reaction of 
[AuCl(12b)] with [Ag(ONf)] and different acetylenes. It was shown that activation of gold 
complexes through silver salt metathesis requires superstoichiometric amounts 
(approximately 2.5 equivalents) of [Ag(ONf)]. However, to accelerate the subsequent reaction 
with the alkyne even a larger excess (>15 equiv) of silver salt is needed (figure 55, traces a-
c); addition of less silver salt leads to sluggish or no reaction (figure 55, traces d-f). This may 
explain why several gold-catalyzed reactions perform better in the presence of excess silver 
salt – even though the “cationic” species are already formed with approximately 2.5 
equivalents of silver salt. Hence, the nature of the silver additive appears to be important both 
as an activator to generate the “cationic” gold complex and as an activator of the alkyne. 
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Figure 55. Fluorescence intensity vs. time plot for the reactions of [AuCl(12b)] (c = 1.0·10-6 mol·L-1) in 1,2-
dichloroethane with different amounts of [Ag(ONf)], added after ca. 1.5 min (trace f: +1 equiv [Ag(ONf)]; trace e: 
+5 equiv; trace d: +10 equiv; trace c: +15 equiv; trace b: +20 equiv; trace a: +30 equiv) to [AuCl(12b)], followed by 
addition of phenyl acetylene (1000 equiv added after 2.5–3.4 min). 
7. The general concept of the application of fluorescence spectroscopy for the investigation of 
ion-pairing in transition metal catalysis was introduced. The proposed approach is based on 
the distance-dependent FRET effect. Measurement of FRET efficiency in suitably fluorophore-
tagged metal complexes is suggested to provide useful information about ion-pairing at 
catalytically relevant concentration range. 
8. A pair of NHC-gold(I) tosylate complexes suitable for FRET efficiency measurements was 
prepared (figure 56). 
 
Figure 56. BODIPY-tagged NHC-gold(I) tosylates. 
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9. Energy transfer efficiency in complex [(17)-O-IPrAu(16)] appeared to be very sensitive to 
the average distance between counterions. Thus, the addition of acetonitrile or 1,2-
dichloroethane to the toluene solutions of [(17)-O-IPrAu(16)] led to the dissociation of ion 
pairs to free ions, which was nicely indicated by the decrease of FRET efficiency (figure 57). 
The initial measurements revealed the great potential of fluorescence spectroscopy for ion-
pairing study. 
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Figure 57. Dependence of FRET efficiency of toluene solutions of complex [(17)-O-IPrAu(16)] (c = 1.0·10-6 mol·L-1) 
on acetonitrile content (left) or 1,2-dichloroethane content (right). 
 
In this thesis, it was shown that the observation of the modulated fluorescence intensity in 
(catalytically active) transition metal complexes with suitable fluorescent tags renders a 
highly useful tool for the analysis of chemical transformations. 
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5. Zusammenfassung der Ergebnisse 
In den folgenden Abschnitten werden die wichtigsten Aspekte meiner Arbeit als kurze 
Zusammenfassung dargestellt. 
1. Die neuartigen NHC-Gold-Komplexe 1, 2 und 3a wurden mit diversen 
Arylthiolverbindungen umgesetzt. Fluoreszenz-Spektroskopie wurde dabei in situ eingesetzt, 
um den Reaktionsfortschritt zu überwachen (Abbildung 58). 
 
Abbildung 58. Umsetzung der NHC-Gold-Komplexe mit diversen Thiophenolen. 
2. Werden die Halogenliganden am Goldzentrum durch diverse substituierte Arylthiole 
ersetzt, beobachtet man eine Abnahme der Helligkeit des an die Komplexe gebunden 
Fluorophors. Das Maß der Helligkeitsabnahme korreliert mit den elektronischen 
Eigenschaften des Thiols: Während der Umsatz mit elektronenreichen Thiolen zu einer 
signifikanten Abnahme der Fluoreszenz-Emission führt, wird bei elektronenarmen Thiolen 
lediglich ein geringer Intensitätsabfall beobachtet (Abbildung 59). 
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Abbildung 59. Links: Fluoreszenz-Zeit-Verläufe nach Zugabe von 100 Äquivalenten RC6H4SH (R = NO2, CF3, COMe, 
Cl, H, Me, tBu, OMe and NMe2) zum Komplex 1 (c = 1.0·10
-6 mol·L-1), welcher in 1,2-Dichlorethan gelöst und mit 
Hünig-Base (100 eq) versetzt wurde. Bei den Umsätzen werden die entsprechenden Komplexe [1(SC6H4R)] 
gebildet. Rechts: Auftragung des Hammett-Parameters p gegen die relative Fluoreszenz-Helligkeit des 
entsprechenden Komplexes [1(SC6H4R)]. 
Die Fluoreszenzhelligkeit des BODIPY-Fluorophors, welches an den NHC-Gold-Komplex 
gebundenen ist, lässt sich leicht einstellen, indem die Elektronendichte am Übergangsmetall 
variiert wird. 
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3. DFT-Berechnungen, die in Zusammenarbeit mit Prof. Dr. Israel Fernandez (Universidad 
Complutense de Madrid) durchgeführt wurden, weisen darauf hin, dass trotz der Gegenwart 
eines 5d-Übergangmetallions und schwerer Halogenatome die Löschung der Fluoreszenz 
hauptsächlich nach dem a-PET-Mechanismus abläuft (Abbildung 60). 
Es wurde dezidiert bewiesen, dass Fluoreszenzfarbstoffe als hochsensible Sonden verwendet 
werden können, um die Elektronendichte am Übergangsmetall zu bestimmen. So erweisen 
sich die Fluorophore als wertvolle Werkzeuge für Untersuchungen in der Organometallchemie 
und der homogenen Katalyse. 
 
 
 
 
 
 
 
 
 
 
Abbildung 60. Berechnete Grenzmolekülorbitale des isolierten Chromophors, welcher in den Verbindungen 
[1(SC6H4R)] enthalten ist (Orbitalenergien sind in eV angegeben). 
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4. Die bislang literaturunbekannten BODIPY-markierten Phosphine 12a and 12b und die 
davon abgeleiteten Übergangsmetall-Komplexe wurden synthetisiert (Abbildung 61). 
 
Abbildung 61. Übergangsmetall-Komplexe mit BODIPY-markierten Phosphin-Liganden. 
Die hergestellten Verbindungen zeichnen sich durch signifikant unterschiedliche Fluoreszenz-
Eigenschaften aus: So weisen die Phosphine 12a and 12b und die entsprechenden 
Palladiumkomplexe eine weitgehend gelöschte Fluoreszenz auf (Φ < 0.001). Die Fluoreszenz 
des Kupferkomplexes wurde hingegen lediglich abgeschwächt (Φ = 0.016), wohingegen die 
Gold- und Silberkomplexe ein mittlere Fluoreszenzintensität aufweisen (Φ ≈ 0.10). 
5. Es wurde nachgewiesen, dass die Fluoreszenz-Spektroskopie BODIPY-markierter Phosphine 
genutzt werden kann, um die einführenden Schritte goldkatalysierter Alkin-Transformationen 
im für die Katalyse relevanten Konzentrationsbereich zu verfolgen. Bei Reaktionen mit dem 
Komplex [AuCl(12b)] wurde die Elektronendichte am Übergangsmetall durch Substitution 
von Liganden variiert. Dabei konnte gezeigt werden, dass eine Variation der Elektronendichte 
am Übergangsmetall mit einer charakteristischen Änderung der Helligkeit der BODIPY-Gruppe 
einhergeht. Ein Anstieg der Elektronendichte am Gold führt zu einer Abnahme der 
Fluoreszenzhelligkeit, wohingegen eine geringere Elektronendichte am Gold einen Anstieg der 
Helligkeit bewirkt. In entsprechenden Komplexen ist das Fluorophor hochsensibel für 
Änderungen in der Umgebung des Goldzentrums. Sogar der Austausch von Substituenten, die 
sich in der Peripherie des Komplexzentrums befinden, führt zu einer signifikanten Änderung 
der Helligkeit (Abbildung 62). 
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Abbildung 62. Auftragung der Fluoreszenz-Intensität gegen die Zeit für die Reaktionen, bei denen [AuCl(12b)] (c = 
1.0·10-6 mol·L-1) mit [Ag(ONf)], Hünig-Base und drei verschiedenen Phenylacetylenderivativen HCCC6H4R (1000 eq; 
R = NO2, H, NMe2) in 1,2-Dichloroethan zu [((12b)Au)2(CCC6H4R)]
+ ONf--Komplexen umgesetzt werden. 
6. Die Studien mittels in situ Fluoreszenzspektroskopie liefern Erkenntnisse zu subtilen Details 
der Reaktionen von [AuCl(12b)] mit [Ag(ONf)] und verschiedenen Acetylenverbindungen. Es 
wurde gezeigt, dass zur Aktivierung von Goldkomplexen durch Silbersalz-Metathese 
überstöchiometrische Mengen (etwa 2.5 Äquivalente) von [Ag(ONf)] benötigt werden. Ein 
noch größerer Überschuss (>15 Äquivalente) von Silbersalz ist erforderlich, um die 
Folgereaktion mit dem Alkin zu beschleunigen (Abbildung 63, Spuren a-c). Wird der 
Goldkomplex mit weniger Silbersalz versetzt, findet die Reaktion nicht oder nur verlangsamt 
statt (Abbildung 63, Spuren d-f). Dies würde erklären, warum diverse goldkatalysierte 
Reaktionen in der Gegenwart eines Überschusses an Silbersalzen besser ablaufen – auch wenn 
„kationische“ Spezies schon bei etwa 2.5 Äquivalenten Silbersalzen vorliegen. Folglich scheint 
die Natur des Silberadditivs eine wichtige Rolle zu spielen, da es sowohl den „kationischen“ 
Goldkomplex generiert, als auch das Alkin aktiviert. 
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Abbildung 63. Auftragung der Fluoreszenz-Intensität gegen die Zeit für jene Reaktionen, bei denen [AuCl(12b)] (c 
= 1.0·10-6 mol·L-1) in 1,2-Dichlorethan mit verschiedenen Mengen an [Ag(ONf)] umgesetzt wurde. [AuCl(12b)] 
wurde nach etwa 1.5 Minuten mit Ag(ONf) versetzt (Spur f: +1 eq [Ag(ONf)]; Spur e: +5 eq; Spur d: +10 eq; Spur c: 
+15 eq; Spur b: +20 eq; Spur a: +30 eq). Nach 2.5–3.4 min erfolgte die Zugabe von 1000 Äquivalenten 
Phenylacetylen. 
7. Die Anwendung der Fluoreszenz-Spektroskopie für die Untersuchung von Ionenpaaren in 
der Übergangsmetall-Katalyse wurde als grundlegendes Konzept neu eingeführt. Die Messung 
der FRET-Effizienz in geeigneten Fluorophor-markierten Metallkomplexen könnten Aufschluss 
über die Ionenpaarung in katalytisch relevanten Konzentrationsbereichen geben. 
8. Zwei literaturunbekannte NHC-Gold(I)-Tosylat-Komplexe, die sich für die FRET-Effizienz-
Messungen eignen, wurden hergestellt (Abbildung 64). 
 
Abbildung 64. BODIPY-markierte NHC-Gold(I)-Tosylate. 
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9. Die Effizienz des Energietransfers im Komplex [(17)-O-IPrAu(16)] scheint sehr sensibel für 
die durchschnittliche Distanz zwischen zwei Gegenionen zu sein. Demzufolge führte die 
Zugabe von Acetonitril beziehungsweise 1,2-Dichlorethan zu den Toluol-Lösungen von [(17)-
O-IPrAu(16)] zur Dissoziation der Ionenpaare zu freien Ionen. Anhand der Abnahme der 
FRET-Effizienz konnte die Dissoziation eindeutig nachgewiesen werden (Abbildung 65). Diese 
ersten Messungen im Rahmen meiner Arbeit weisen auf das große Potential der 
Fluoreszenzspektroskopie hin, um die Ionenpaarbildung zu untersuchen. 
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Abbildung 65. Abhängigkeit der FRET-Effizienz der in Toluol gelösten Komplexe [(17)-O-IPrAu(16)] (c = 1.0·10-6 
mol·L-1) vom Acetonitril- (links) beziehungsweise 1,2-Dichlorethan-Gehalt (rechts). 
 
In dieser Arbeit konnte gezeigt werden, dass die Beobachtung modulierter 
Fluoreszenzintensitäten in (katalytisch aktiven) Übergangsmetall-Komplexen mittels 
geeigneter Fluoreszenzmarker ein sehr nützliches Werkzeug darstellt, um chemische 
Transformationen zu analysieren. 
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6. Experimental Part 
General experimental. All reactions involving transition metal complexes were conducted in 
oven-dried glassware. Reactions were performed in Schlenk flasks under a positive pressure of 
argon or nitrogen. The flasks were fitted with rubber septa and gas-tight syringes with 
stainless steel needles or double-cannula were used to transfer air- and moisture-sensitive 
liquids. 
Materials. All chemicals were purchased as reagent grade from commercial suppliers and 
used without further purification unless otherwise noted. CH2Cl2 (99.5) and pentane (99) 
were obtained from Grüssing GmbH, toluene from Sigma-Aldrich (Lab. Reagent grade, 
99.3%). These solvents were dried and degassed by using a column purification system from 
Innovative Technology Inc. Tetrahydrofuran was dried under sodium and distilled under 
argon atmosphere. All solvents were stored over molecular sieves (4 Å). Preparative 
chromatography was performed using Merck silica 60 (0.063–0.2 mm). 
Instrumentations. 1H, 19F, 31P and 13C-NMR spectra were recorded on a Bruker DRX 500 or 
Bruker ARX 300 spectrometer. The chemical shifts are given in parts per million (ppm) on the 
delta scale (δ) and are referenced to tetramethylsilane (1H, 13C-NMR = 0.0 ppm), the residual 
peak of CDCl3 (
1H-NMR = 7.26 ppm, 13C-NMR = 77.23 ppm), DMSO-d6 (
1H-NMR = 2.50 
ppm, 13C-NMR = 39.51 ppm), C6D6 (
1H-NMR = 7.16 ppm, 13C-NMR = 128.39 ppm), CD2Cl2 
(1H-NMR = 5.32 ppm), hexafluorobenzene (19F-NMR = -164.90 ppm) or H3PO4 (
31P-NMR = 
0.0 ppm). Abbreviations for NMR data: s = singlet; d = doublet; t = triplet; q = quartet; sep 
= septet; m = multiplet; bs = broad signal. Mass spectra were recorded on the Finnigan 
MAT95 spectrometer using electron ionization (EI). UV-Vis spectra were recorded on Analytik 
Jena Specord 600 UV-Vis spectrometer, fluorescence spectra were recorded on J&M TIDAS 
S700/CCD UV/NIR 2098 spectrometer combined with J&M TIDAS LSM monochromator with 
75 W Xenon light source and thermo-controlled cuvette holder. Samples for emission and 
absorption measurements were contained in 1 cm × 1 cm quartz cuvette (Hellma Analytics, 
Lot.: 111-10-40). Cyclic voltammetry was performed using a standard electrochemical 
instrumentation consisted of an EG&G 273A-2 potentiostat-galvanostat. A three-electrode 
configuration was employed. The working electrode was a Pt disk (diameter 1 mm) sealed in 
the soft glass with a Pt wire as a counter electrode. The pseudo reference electrode was a Ag 
wire. Potentials were calibrated internally against the formal potential of ferrocene (+0.46 V 
vs. Ag/AgCl) or octamethylferrocene (-0.01 V vs. Ag/AgCl). All cyclic voltammograms were 
recorded in dry CH2Cl2 under an atmosphere of argon, supporting electrolyte NnBu4PF6 (c = 
0.1 mol/L). 
 
6.1. Experimental Procedures and Compounds Characterization 
Synthesis of salt 5 
BODIPY-C2H4-diamine (50 mg, 0.088 mmol, 1 
eq) and ammonium tetrafluoroborate (9.2 mg, 
0.088 mmol, 1 eq) were suspended in triethyl 
orthoformate (3 ml) and 2 drops of formic acid 
were added. The reaction mixture was stirred at 
120 °C for 24 h. After cooling down to room 
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temperature the content of the flask was poured into 10 ml of diethyl ether and the mixture 
stirred for 1 h. The formed precipitate was collected by filtration, washed with diethyl ether 
and dried. The product was dissolved in acetone/methanol mixture and amberlite IRA, Cl-
form (1 g) was added. The mixture was stirred overnight and the ion-exchange resin was 
removed by filtration. The volatiles were evaporated under reduced pressure. The residue was 
triturated with diethyl ether, filtered, washed with diethyl ether and dried in vacuo. Product 
was obtained as an orange powder (40 mg, 74% yield). 
1H NMR (500 MHz, DMSO-d6) δ 9.04 (s, 1H), 7.15 (s, 2H), 7.09 (s, 2H), 6.19 (s, 1H), 4.46 (s, 
4H), 2.64 (s, 3H), 2.63 (s, 3H), 2.42 (s, 3H), 2.39 (s, 3H), 2.38–2.34 (m, 16H), 2.33 (s, 3H), 
2.29 (s, 3H). 13C NMR (126 MHz, DMSO-d6) δ 160.21, 152.57, 151.42, 143.36, 141.75, 
140.48, 139.60, 138.24, 135.44, 135.32, 131.30, 131.18, 131.09, 130.82, 129.85, 129.39, 
128.95, 120.70, 50.89, 35.39, 25.38, 20.50, 17.17, 17.13, 16.78, 16.34, 14.05, 13.92, 12.14. 
19F NMR (282 MHz, DMSO-d6) δ -145.50 – -146.50 (m). HRMS (ESI): m/z calcd. for 
C36H44BF2N4
+ [M-Cl]+ 581.3622, found 581.3632. 
Synthesis of complex 2 
A 10 ml flame-dried Schlenk flask equipped with 
a stirring bar was charged with the salt 5 (20 
mg, 0.032 mmol, 1 eq), Ag2O (4.1 mg, 0.018 
mmol, 0.55 eq) and acetonitrile (2 ml). The 
reaction mixture was stirred at 40 °C for 3 h. 
[AuCl(SMe2)] (9.5 mg, 0.032 mmol, 1 eq) was 
added and the obtained suspension was stirred 
at room temperature for 24 h. Insoluble material was removed by filtration and the volatiles 
were evaporated under reduced pressure. Product was obtained as an orange powder (21 mg, 
80% yield). 
1H NMR (500 MHz, CDCl3) δ 6.95 (s, 2H), 6.86 (s, 2H), 6.02 (s, 1H), 3.99 (s, 4H), 2.70–2.64 
(m, 4H), 2.60 (s, 3H), 2.51 (s, 3H), 2.43 (s, 3H), 2.41 (s, 3H), 2.32 (s, 6H), 2.31 (s, 6H), 2.30 
(s, 3H), 2.12 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 195.34, 153.49, 152.43, 142.47, 141.49, 
140.31, 139.22, 138.92, 135.97, 135.69, 135.46, 134.76, 132.27, 132.07, 130.04, 129.94, 
129.64, 120.93, 50.91, 36.37, 25.99, 21.29, 18.18, 17.56, 17.17, 15.02, 14.57, 12.68. 19F 
NMR (282 MHz, CDCl3) δ -149.55 (q, J (
19F-11B) = 32.2 Hz). HRMS (APCI): m/z calcd. for 
C36H43AuBClFN4 [M-F]
+ 793.2914, found 793.2949 (100%); m/z calcd. for C36H43AuBF2N4 
[M-Cl]+ 777.3209, found 777.3242 (20%). 
Synthesis of complex 4 
3-isopropyl-1-mesityl-1H-imidazol-3-ium iodide (100 mg, 0.281 mmol, 
1 eq) was dissolved in CH2Cl2 (5 ml) and Ag2O (32.5 mg, 0.141 mmol, 
0.5 eq) was added. The reaction mixture was stirred for 1 h at 40 °C. 
[AuCl(SMe2)] (83 mg, 0.281 mmol, 1 eq) was added and the stirring 
was continued for another 1 h at room temperature. The formed 
precipitate was removed by filtration and the filtrate was evaporated under reduced pressure. 
Product was obtained as a white powder (110 mg, 85% yield). 
1H NMR (500 MHz, CDCl3) δ 7.18 (d, J = 1.8 Hz, 1H), 6.95 (s, 2H), 6.87 (d, J = 1.7 Hz, 1H), 
5.20 (hept, J = 6.7 Hz, 1H), 2.32 (s, 3H), 2.00 (s, 6H), 1.55 (d, J = 6.8 Hz, 6H). 13C NMR 
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(126 MHz, CDCl3) δ 171.38, 139.82, 135.16, 135.00, 129.60, 122.52, 116.71, 53.78, 23.64, 
21.31, 17.98. HRMS (EI): m/z calcd. for C15H20N2Au
35Cl [M]+ 460.0975, found 460.0977. 
Synthesis of gold-thiolate complexes 
General procedure. The respective thiol (1.1 eq) was dissolved in ethanol and 0.1 M NaOH in 
ethanol (1.2 eq) was added. The formed mixture was added to the solution of gold complex 
((NHC)AuCl, 1 eq) in CH2Cl2. The reaction mixture was stirred for 3 h at room temperature. 
The volatiles were evaporated under reduced pressure. The residue was dissolved in CH2Cl2 
and the remaining insoluble material was removed by filtration. The solvent was evaporated 
under reduced pressure and the crude product was triturated with a small amount of 
methanol, filtered and dried. 
Complex [4(SC6H4NO2)] was obtained as a yellow powder (23 mg, 
73% yield) from complex 4 (25 mg, 0.054 mmol), 4-nitro-thiophenol 
(9.3 mg, 0.060 mmol) and 0.1 M NaOH in ethanol (650 µl, 0.065 
mmol). 
1H NMR (500 MHz, CDCl3) δ 7.70 (d, J = 8.9 Hz, 2H), 7.22 (d, J = 
1.9 Hz, 1H), 7.15 (d, J = 8.8 Hz, 2H), 7.06 (s, 2H), 6.95 (d, J = 1.9 
Hz, 1H), 5.09 (hept, J = 6.8 Hz, 1H), 2.43 (s, 3H), 2.06 (s, 6H), 1.60 
(d, J = 6.8 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 181.60, 158.06, 
143.56, 140.15, 135.47, 135.36, 131.84, 129.57, 122.74, 122.41, 116.95, 53.59, 23.74, 
21.42, 18.00. HRMS (EI): m/z calcd. for C21H24O2N3AuS [M]
+ 579.1249, found 579.1255. 
Complex [4(SPh)] was obtained as a white powder (19 mg, 65% 
yield) from complex 4 (25 mg, 0.054 mmol), thiophenol (6.1 µl, 
0.060 mmol) and 0.1 M NaOH in ethanol (650 µl, 0.065 mmol). 
1H NMR (500 MHz, CD2Cl2) δ 7.27–7.21 (m, 1H), 7.09 (d, J = 6.9 
Hz, 2H), 7.05 (s, 2H), 6.97–6.93 (m, 1H), 6.91–6.80 (m, 3H), 5.12 
(hept, J = 7.0 Hz, 1H), 2.38 (s, 3H), 2.06 (s, 6H), 1.58 (d, J = 6.7 
Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 182.84, 143.33, 139.65, 
135.47, 135.37, 132.34, 129.49, 127.65, 122.65, 122.17, 116.62, 53.39, 23.70, 21.41, 18.04. 
HRMS (EI): m/z calcd. for C21H25N2AuS [M]
+ 534.1398, found 534.1397. 
Complex [4(SC6H4OMe)] was obtained as a white powder (18 mg, 
59% yield) from complex 4 (25 mg, 0.054 mmol), 4-methoxy-
thiophenol (7.4 µl, 0.060 mmol) and 0.1 M NaOH in ethanol (650 µl, 
0.065 mmol). 
1H NMR (500 MHz, CD2Cl2) δ 7.23 (d, J = 1.9 Hz, 1H), 7.05 (s, 2H), 
6.96 (d, J = 7.6 Hz, 2H), 6.95 (d, J = 1.8 Hz, 1H), 6.49 (d, J = 8.5 
Hz, 2H), 5.11 (hept, J = 6.8 Hz, 1H), 3.70 (s, 3H), 2.39 (s, 3H), 2.06 
(s, 6H), 1.57 (d, J = 6.8 Hz, 6H). 13C NMR (126 MHz, CD2Cl2) δ 
182.88, 156.67, 140.04, 136.06, 135.86, 133.14, 129.71, 122.64, 117.28, 113.95, 55.77, 
53.87, 23.79, 21.56, 18.14. HRMS (EI): m/z calcd. for C22H27ON2AuS [M]
+ 564.1504, found 
564.1518. 
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Complex [1(SC6H4NO2)] was obtained as an orange 
powder (5 mg, >95% yield) from complex 1 (5 mg, 
0.006 mmol), 4-nitro-thiophenol (1.1 mg, 0.007 
mmol) and 0.1 M NaOH in ethanol (80 µl, 0.008 
mmol). 
1H NMR (500 MHz, CDCl3) δ 7.71 (d, J = 8.8 Hz, 2H), 
7.31 (d, J = 8.8 Hz, 2H), 7.28 (d, J = 1.8 Hz, 1H), 
7.09 (s, 2H), 7.04 (d, J = 1.7 Hz, 1H), 6.11 (s, 1H), 
5.16 (hept, J = 6.5 Hz, 1H), 2.64 (s, 3H), 2.55 (s, 3H), 2.48 (s, 3H), 2.45 (s, 3H), 2.26 (s, 
3H), 2.16 (s, 6H), 1.63 (d, J = 6.8 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 181.54, 158.02, 
154.95, 151.07, 143.62, 142.42, 142.13, 136.88, 136.55, 136.33, 135.65, 133.04, 132.00, 
131.79, 130.87, 122.93, 122.36, 122.05, 117.22, 53.75, 23.78, 18.24, 17.73, 17.12, 15.77, 
14.76, 13.49. 19F NMR (282 MHz, CDCl3) δ -149.64 (q, J (
19F-11B) = 32.1 Hz). HRMS (ESI): 
m/z calcd. for C34H37AuBF2N5NaO2S [M+Na]
+ 848.2287, found 848.2283. 
Complex [2(SC6H4NO2)] was obtained as an 
orange powder (6 mg, 81% yield) from 
complex 2 (6.5 mg, 0.008 mmol), 4-nitro-
thiophenol (1.4 mg, 0.009 mmol) and 0.1 M 
NaOH in ethanol (96 µl, 0.0096 mmol). 
1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 
8.6 Hz, 2H), 7.03 (s, 2H), 6.93–6.88 (m, 
4H), 6.03 (s, 1H), 4.04 (s, 4H), 2.70 (s, 4H), 
2.60 (s, 3H), 2.51 (s, 3H), 2.41 (s, 3H), 2.39 (s, 3H), 2.37 (s, 6H), 2.35 (s, 6H), 2.34 (s, 3H), 
2.21 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 204.22, 153.49, 152.72, 143.45, 142.65, 141.24, 
140.43, 139.49, 138.36, 136.23, 136.16, 135.39, 134.82, 131.67, 130.01, 129.58, 126.66, 
122.58, 121.06, 51.22, 51.10, 36.39, 26.05, 21.37, 18.21, 17.58, 17.11, 14.81, 14.59, 12.58. 
19F NMR (282 MHz, CDCl3) δ -149.57 (q, J (
19F-11B) = 32.2 Hz). HRMS (APCI): m/z calcd. for 
C42H47AuBFN5O2S [M-F]
+ 912.3188, found 912.3197. 
Synthesis of 3-chloro-BODIPY 6 
2,2'-(p-tolylmethylene)bis(1H-pyrrole) (4.00 g, 16.93 mmol) was dissolved 
in 150 ml of THF and cooled to -78 °C. To the cooled solution N-
chlorosuccinimide (2.26 g, 16.93 mmol) was added in one portion and 
reaction mixture was stirred at -78°C for 3 h. The reaction mixture was left 
in a fridge (-40°C) overnight. After warming to room temperature water 
(100 ml) was added and the reaction mixture was extracted with CH2Cl2 (3 
× 100 ml). The combined organic layers were dried over anhydrous MgSO4, 
filtered, and evaporated under reduced pressure. The crude product was 
dried and dissolved in CH2Cl2 (200 mL). Chloranil (5.0 g, 20.34 mmol) was added to the 
solution in one portion and the mixture was stirred for 2 h at room temperature. 
Triethylamine (23.6 ml, 169.20 mmol) was added and the mixture was stirred for an 
additional 30 min. BF3·Et2O (31.3 ml, 253.61 mmol) was added dropwise over 30 min and 
the resulting mixture was stirred for 4 h at room temperature. The resulting dark solution was 
washed with water (3 × 100 ml), dried over anhydrous MgSO4, filtered, and evaporated 
under reduced pressure. The crude product was charged on top of a flash chromatography 
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column (400 × 40 mm, 0.015-0.040 mm silica gel). Using cyclohexane / CH2Cl2 (1:1) 
mixture as the eluent, the desired product was collected as the second orange band (TLC: Rf 
= 0.30). A second chromatography is needed to obtain higher than 98% purity product 
(without di- and unsubstituted by-products). Evaporation of solvent afforded product as an 
orange powder (1.02 g, 19% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.92 (s, 1H), 7.42 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 7.9 Hz, 2H), 
6.92 (d, J = 4.1 Hz, 1H), 6.90 (d, J = 4.3 Hz, 1H), 6.57–6.54 (m, 1H), 6.41 (d, J = 4.3 Hz, 
1H), 2.47 (s, 3H). 13C-NMR (126 MHz, CDCl3) δ 146.26, 144.32, 141.69, 134.91, 134.18, 
131.97, 131.62, 130.77, 130.51, 129.45, 118.95, 118.43, 21.66. 19F-NMR (282 MHz, CDCl3) δ 
-150.26 (q, J (19F-11B) = 28.3 Hz). HR-MS (EI), m/z: 316.07758 [M]+▪, calcd. 316.0746 (Δ = 
3.0 mmu). 
Synthesis of BODIPY-diamine 7 
To the solution of 3-chloro-BODIPY 6 (50 mg, 0.158 
mmol, 1 eq) in DCM (5 ml) N1-mesitylethane-1,2-
diamine (56 mg, 0.316 mmol, 2 eq) and triethylamine 
(110 μl, 0.790 mmol, 5 eq) were added. The reaction 
mixture was stirred at 40°C for 1 h. The crude product 
was purified by column chromatography using DCM as 
an eluent. The product was obtained as an orange powder (65 mg, 90%). 
1H NMR (300 MHz, CDCl3) δ 7.46 (s, 1H), 7.39 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 
6.96 (d, J = 4.9 Hz, 1H), 6.84 (s, 2H), 6.66 (s, 1H), 6.48 (d, J = 3.4 Hz, 1H), 6.35 (dd, J = 
3.6, 2.4 Hz, 1H), 6.15 (d, J = 5.0 Hz, 1H), 3.58 (q, J = 5.9 Hz, 2H), 3.23 (t, J = 5.8 Hz, 2H), 
2.44 (s, 3H), 2.28 (s, 6H), 2.24 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 161.77, 139.48, 
136.25, 134.08, 133.56, 132.92, 131.96, 131.69, 130.92, 130.52, 129.97, 129.12, 120.60, 
113.75, 110.09, 48.37, 44.74, 21.57, 20.81, 18.47. HRMS (ESI): m/z calcd. for 
C27H29BF2N4Na [M+Na]
+ 481.23455, found 481.23558 (100%); m/z calcd. for C27H30BF2N4 
[M+H]+ 459.25261, found 459.25349 (10%). 
Synthesis of BODIPY-imidazole 8 
To the solution of 3-chloro-BODIPY 6 (50 mg, 0.158 mmol, 1 eq) in 
acetonitrile (5 ml) imidazol (54 mg, 0.790 mmol, 5 eq) was added and 
the reaction mixture was stirred at room temperature for 40 h. After 
evaporation of the solvent under reduced pressure the crude product was 
purified by column chromatography (eluent: DCM/methanol 50:1). The 
product was obtained as a pink powder (50 mg, 91% yield). 
1H NMR (500 MHz, CDCl3) δ 8.22 (s, 1H), 7.90 (s, 1H), 7.69 (s, 1H), 7.46 
(d, J = 8.1 Hz, 2H), 7.35 (d, J = 7.8 Hz, 2H), 7.23 (s, 1H), 7.00 (d, J = 
4.4 Hz, 1H), 6.96 (d, J = 4.1 Hz, 1H), 6.58 (dd, J = 4.2, 1.8 Hz, 1H), 
6.49 (d, J = 4.4 Hz, 1H), 2.48 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 147.82, 147.27, 144.08, 
141.78, 138.13, 134.62, 133.39, 132.72, 131.43, 130.81, 130.71, 130.46, 129.50, 120.37, 
119.21, 112.22, 21.68. 19F NMR (282 MHz, CDCl3) δ -144.41 (q, J (
19F-11B) = 30.2 Hz). 
HRMS (APCI): m/z calcd. for C19H16BF2N4 [M+H]
+ 349.14306, found 349.14340. 
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Synthesis of imidazolium salt 9 
To the solution of BODIPY-imidazole 8 (50 mg, 0.144 mmol, 
1 eq) in acetonitrile (5 ml) 2-iodopropane (144 μl, 1.44 
mmol, 10 eq) was added and the reaction mixture was 
stirred at 70 °C for 48 h. After evaporation of the solvent 
under reduced pressure the crude product was purified by 
column chromatography (eluent: DCM/methanol 20:1). The 
product was obtained as a red powder (65 mg, 87% yield). 
1H NMR (500 MHz, CDCl3) δ 10.52 (s, 1H), 8.13 (s, 1H), 8.01 (s, 1H), 7.60 (s, 1H), 7.48 (d, J 
= 7.8 Hz, 2H), 7.42–7.35 (m, 3H), 7.15 (d, J = 3.8 Hz, 1H), 7.02 (s, 1H), 6.70 (d, J = 3.0 
Hz, 1H), 5.25 (hept, J = 6.5 Hz, 1H), 2.50 (s, 3H), 1.74 (d, J = 6.1 Hz, 6H). 13C NMR (126 
MHz, CDCl3) δ 149.85, 148.00, 142.93, 140.59, 136.98, 136.04, 134.96, 133.44, 131.23, 
131.06, 130.02, 129.82, 123.95 (t, J = 6.9 Hz), 121.31, 119.87, 114.16, 54.58, 23.23, 21.77. 
19F NMR (282 MHz, CDCl3) δ -143.52 (q, J (
19F-11B) = 30.5 Hz). HRMS (ESI): m/z calcd. for 
C22H22BF2N4 [M-I]
+ 391.19001, found 391.19061. 
Synthesis of imidazolium salts 10a and 10b. 
General procedure. To the solution of 3-chloro-BODIPY 6 (1 eq) in acetonitrile, the respective 
N-aryl imidazole (5 eq) was added and the reaction mixture was stirred at room temperature 
for 60 h. After evaporation of the solvent under reduced pressure, the crude product was 
purified by column chromatography (eluent: DCM/methanol 10:1). 
Imidazolium salt 10a was obtained as a dark orange 
powder (70 mg, 88% yield) from BODIPY 6 (50 mg, 
0.158 mmol) and 1-mesityl-1H-imidazole (147 mg, 
0.790 mmol) in acetonitrile (5 ml). 
1H NMR (500 MHz, , CDCl3) δ 10.36 (s, 1H), 8.82 (t, J 
= 1.8 Hz, 1H), 7.97 (s, 1H), 7.65 (d, J = 4.4 Hz, 1H), 
7.53 (t, J = 1.8 Hz, 1H), 7.45 (d, J = 8.1 Hz, 2H), 7.35 (d, J = 7.8 Hz, 2H), 7.12 (d, J = 4.0 
Hz, 1H), 7.05–6.99 (m, 3H), 6.68 (dd, J = 4.4, 1.8 Hz, 1H), 2.47 (s, 3H), 2.32 (s, 3H), 2.18 
(s, 6H). 13C NMR (126 MHz, CDCl3) δ 149.78, 147.76, 142.81, 141.76, 140.54, 138.26, 
135.92, 134.85, 134.52, 133.43, 131.46, 130.98, 130.57, 130.10, 129.96, 129.72, 125.42, 
124.04, 121.21, 114.72, 21.68, 21.26, 17.76. 19F NMR (282 MHz, CDCl3) δ -143.39 (q, J (
19F-
11B) = 31.0 Hz). HRMS (ESI): m/z calcd. for C28H26BF2N4 [M-Cl]
+ 467.22131, found 
467.22225. 
Imidazolium salt 10b was obtained as a dark orange 
powder (73 mg, 85% yield) from BODIPY 6 (50 mg, 
0.158 mmol) and 1-(2,6-diisopropylphenyl)-1H-imidazole 
(180 mg, 0.790 mmol) in acetonitrile (5 ml). 
1H NMR (500 MHz, CDCl3) δ 10.10 (s, 1H), 9.49 (s, 1H), 
7.96 (s, 1H), 7.86 (s, 1H), 7.57 (t, J = 7.7 Hz, 1H), 7.52 
(s, 1H), 7.47 (d, J = 7.5 Hz, 2H), 7.38–7.29 (m, 4H), 
7.13 (d, J = 3.4 Hz, 1H), 7.08 (s, 1H), 6.69 (d, J = 2.2 Hz, 1H), 2.55–2.45 (m, 5H), 1.26 (d, 
J = 6.3 Hz, 6H), 1.20 (d, J = 6.3 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 149.85, 147.57, 
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145.65, 142.88, 140.73, 137.38, 135.87, 134.82, 133.55, 132.39, 131.90, 131.01, 130.03, 
129.98, 129.76, 126.34, 125.19, 125.04, 123.68, 121.17, 115.00, 28.91, 24.46, 21.72. 19F 
NMR (282 MHz, CDCl3) δ -143.27 (q, J (
19F-11B) = 31.3 Hz). HRMS (ESI): m/z calcd. for 
C31H32BF2N4 [M-Cl]
+ 509.26826, found 509.26859. 
Synthesis of complexes 3a and 3b 
General procedure. A 10 ml flame-dried Schlenk flask equipped with a stirring bar was charged 
with the respective imidazolium salt 10a or 10b (1 eq), Ag2O (0.5 eq) and dichloromethane. 
The reaction mixture was stirred at 40 °C for 1 h. [AuCl(SMe2)] (1 eq) was added and the 
obtained suspension was stirred at room temperature for 2 h. Insoluble material was removed 
by filtration and the volatiles were evaporated under reduced pressure. The crude product 
was purified by column chromatography using DCM as an eluent. 
Complex 3a was obtained as an orange powder (15 
mg, 36% yield) from 10a (30 mg, 0.060 mmol), Ag2O 
(6.9 mg, 0.030 mmol) and [AuCl(SMe2)] (17.6 mg, 
0.060 mmol) in DCM (2 ml). 
1H NMR (500 MHz, CDCl3) δ 7.96 (s, 1H), 7.95 (d, J = 
2.0 Hz, 1H), 7.52 (d, J = 8.0 Hz, 2H), 7.38 (d, J = 7.8 
Hz, 2H), 7.09 (d, J = 4.2 Hz, 1H), 7.06 (d, J = 2.0 Hz, 1H), 7.02 (d, J = 4.3 Hz, 1H), 7.00 
(d, J = 4.5 Hz, 1H), 6.99 (s, 2H), 6.64 (dd, J = 4.3, 1.7 Hz, 1H), 2.50 (s, 3H), 2.34 (s, 3H), 
2.12 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 174.54, 149.13, 146.70, 146.28, 142.26, 140.14, 
135.65, 135.00, 134.67, 133.59, 133.28, 130.98, 130.47, 129.73, 129.62, 123.55 (t, J = 6.4 
Hz), 122.05, 120.26, 115.66, 21.75, 21.35, 17.98. 19F NMR (282 MHz, CDCl3) δ -145.18 (q, J 
(19F-11B) = 29.9 Hz). HRMS (APCI): m/z calcd. for C28H25AuBClFN4 [M-F]
+ 679.15050, found 
679.15079. 
Complex 3b was obtained as an orange powder (13 mg, 
48% yield) from 10b (20 mg, 0.037 mmol), Ag2O (4.3 
mg, 0.018 mmol) and [AuCl(SMe2)] (10.8 mg, 0.037 
mmol) in DCM (2 ml). 
1H NMR (500 MHz, CDCl3) δ 7.99 (s, 1H), 7.98 (d, J = 
2.0 Hz, 1H), 7.52 (d, J = 8.0 Hz, 2H), 7.49 (t, J = 7.8 
Hz, 1H), 7.38 (d, J = 7.8 Hz, 2H), 7.28 (d, J = 7.8 Hz, 
2H), 7.10 (d, J = 2.0 Hz, 1H), 7.09 (d, J = 4.2 Hz, 1H), 7.06 (d, J = 4.3 Hz, 1H), 7.01 (d, J 
= 4.3 Hz, 1H), 6.65 (dd, J = 4.3, 1.7 Hz, 1H), 2.57 (hept, J = 6.7 Hz, 2H), 2.50 (s, 3H), 1.33 
(d, J = 6.8 Hz, 6H), 1.19 (d, J = 6.9 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 175.22, 149.08, 
146.64, 146.28, 145.94, 142.25, 135.61, 134.09, 133.58, 133.29, 130.95, 130.45, 129.62, 
124.55, 123.28, 123.18, 120.26, 115.69, 28.68, 24.63, 24.53, 21.76. 19F NMR (282 MHz, 
CDCl3) δ -145.20 (q, J(
19F-11B) = 30.0 Hz). HRMS (APCI): m/z calcd. for C31H31AuBClFN4 [M-
F]+ 721.19745, found 721.19914. 
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Synthesis of BODIPY-phosphine 11 
meso-ChloroBODIPY (50 mg, 0.221 mmol) was loaded into a 25 mL flame-
dried Schlenk flask equipped with a stirring bar, followed by addition of 
CH2Cl2 (5 mL). Ph2PH (46.11 µl, 0.265 mmol) was added and the reaction 
mixture was stirred for 10 min at room temperature. Solvent was evaporated 
under reduced pressure and the crude product was purified by short silica 
column using cyclohexane / CH2Cl2 (1:1) mixture as the eluent. The BODIPY-phosphine was 
collected as the red band (TLC: Rf = 0.22). Evaporation of the solvent afforded product as a 
red powder (27 mg, 33% yield). The obtained phosphine is slowly oxidized in air and should 
be stored under an inert atmosphere. 
1H-NMR (500 MHz, CDCl3) δ 7.81 (s, 2H), 7.51–7.46 (m, 4H), 7.44–7.37 (m, 6H), 6.89 (d, J 
= 4.2 Hz, 2H), 6.33 (dd, J = 4.2, 1.2 Hz, 2H). 13C-NMR (126 MHz, CDCl3) δ 150.37 (d, J = 
36.8 Hz), 144.04, 138.63 (d, J = 15.5 Hz), 134.64 (d, J = 9.5 Hz), 133.97 (d, J = 21.1 Hz), 
131.98 (d, J = 11.9 Hz), 130.19, 129.40 (d, J = 7.8 Hz), 118.64. 19F-NMR (282 MHz, CDCl3) 
δ -148.70 (q, J (19F-11B) = 28.8 Hz). 31P-NMR (121 MHz, CDCl3) δ -7.62. HR-MS (EI), m/z: 
376.1114 [M]+▪, calcd. 376.1113 (Δ = 0.1 mmu). 
Synthesis of complex [AuCl(11)] 
The BODIPY-phosphine 11 (6.0 mg, 0.016 mmol) was dissolved in CH2Cl2 
(3 ml) and [AuCl(SMe2)] (4.7 mg, 0.016 mmol) was added to the solution. 
After 30 min of stirring the solvent was evaporated under reduced pressure. 
The residue was dissolved in a small amount of CH2Cl2 (0.1 ml) and poured 
into pentane (3 ml). The formed precipitate was filtered, washed with 
pentane (3 × 1 ml) and dried. The product was obtained as a purple 
powder (9.0 mg, 93% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.87 (s, 2H), 7.84–7.77 (m, 4H), 7.66–7.61 (m, 2H), 7.57–7.52 
(m, 4H), 6.63 (d, J = 4.4 Hz, 2H), 6.33 (d, J = 4.3 Hz, 2H). 13C-NMR (126 MHz, CDCl3) δ 
146.64, 137.14 (d, J = 45.1 Hz), 136.66 (d, J = 12.4 Hz), 135.05 (d, J = 15.4 Hz), 133.52 
(d, J = 1.7 Hz), 132.45, 130.17 (d, J = 12.7 Hz), 128.66 (d, J = 63.3 Hz), 120.13. 19F-NMR 
(282 MHz, CDCl3) δ -148.99 (q, J (
19F-11B) = 27.8 Hz). 31P-NMR (121 MHz, CDCl3) δ 27.94. 
MS (EI): calcd for C21H16BF2N2PClAu (M) 608, found 608. (HR-MS could not be obtained). 
Synthesis of BODIPY-phosphine 12a 
3-Chloro-BODIPY 6 (150 mg, 0.474 mmol), Pd(OAc)2 (10.6 mg, 0.047 
mmol) and Ph2PH (164.9 µl, 0.948 mmol) were loaded into 25 mL flame-
dried Schlenk flask equipped with a stirring bar, followed by addition of 
toluene (10 mL). The mixture was degassed (2 cycles of freeze-pump-
thaw). Triethylamine (330.5 µl, 2.369 mmol) was added and the reaction 
mixture was stirred overnight at room temperature. After evaporation of 
solvent under reduced pressure, the residue was filtered through a short 
silica gel pad using cyclohexane/CH2Cl2 (1:1) mixture for eluting. The 
collected deeply colored fractions were evaporated under reduced 
pressure and the crude product was purified by flash chromatography column (400 × 20 mm, 
0.015-0.040 mm silica gel), using cyclohexane / CH2Cl2 (1:2) mixture as the eluent. The 
desired product was collected as the pink band (TLC: Rf = 0.25). Evaporation of the solvent 
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afforded product as a dark red powder (159 mg, 72% yield). The obtained phosphine is 
oxidized in air and should be stored under an inert atmosphere. 
1H-NMR (500 MHz, CDCl3) δ 7.88 (s, 1H), 7.47–7.40 (m, 6H), 7.38–7.34 (m, 6H), 7.32 (d, J 
= 7.8 Hz, 2H), 6.90 (d, J = 4.0 Hz, 1H), 6.85 (d, J = 4.1 Hz, 1H), 6.51 (d, J = 3.2 Hz, 1H), 
6.13 (d , J = 4.1 Hz, 1H), 2.47 (s, 3H). 13C-NMR (126 MHz, CDCl3) δ 159.68 (d, J = 23.4 
Hz), 146.54, 144.71, 141.41, 138.84, 136.08 (d, J = 9.0 Hz), 135.42, 134.09 (d, J = 20.6 
Hz), 131.45, 131.33, 130.79, 130.48, 129.32 (d, J = 5.6 Hz), 128.74 (d, J = 7.3 Hz), 125.32, 
118.97, 21.66. 19F-NMR (282 MHz, CDCl3) δ -143.89 (dq, J (
19F-31P) = 45.5 Hz, J (19F-11B) = 
30.5 Hz). 31P-NMR (121 MHz, CDCl3) δ -20.34 (t, J (
31P-19F) = 45.5 Hz). HR-MS (EI), m/z: 
466.15601 [M]+, calcd. 466.1582 (Δ = -2.2 mmu). 
Synthesis of BODIPY-phosphine 12b 
3-Chloro-BODIPY 6 (150 mg, 0.474 mmol), Pd(OAc)2 (10.6 mg, 0.047 
mmol) and Cy2PH (191.8 µl, 0.948 mmol) were loaded into 25 mL flame-
dried Schlenk flask equipped with a stirring bar, following by addition of 
toluene (10 mL). The mixture was degassed (two cycles of freeze-pump-
thaw). Triethylamine (330.5 µl, 2.369 mmol) was added and the reaction 
mixture stirred for 8 h at 50 °C. After evaporation of solvent under 
reduced pressure, the residue was filtered through a short silica gel pad 
using cyclohexane/CH2Cl2 (1:1) mixture for eluting. The collected deeply 
colored fractions were evaporated under reduced pressure and the crude 
product was purified by flash chromatography column (400 × 20 mm, 0.015-0.040 mm silica 
gel), using cyclohexane/CH2Cl2 (1:2) mixture as the eluent. The desired product was collected 
as the red band (TLC: Rf = 0.27). The evaporation of solvent afforded product as an orange 
powder (172 mg, 76% yield). The obtained phosphine is oxidized in air and should be stored 
under an inert atmosphere. 
1H-NMR (500 MHz, CDCl3) δ 7.90 (s, 1H), 7.46 (d, J = 8.0 Hz, 2H), 7.31 (d, J = 7.8 Hz, 2H), 
6.93 (d, J = 4.2 Hz, 1H), 6.86 (d, J = 4.0 Hz, 1H), 6.69 (d, J = 4.2 Hz, 1H), 6.50 (d, J = 3.0 
Hz, 1H), 2.47 (s, 3H), 2.03–1.90 (m, 4H), 1.83–1.76 (m, 2H), 1.75–1.61 (m, 6H), 1.37–1.15 
(m, 10H). 13C-NMR (126 MHz, CDCl3) δ 162.39 (d, J = 34.1 Hz), 145.60, 143.65, 141.10, 
137.57, 134.88, 131.41, 130.71, 130.51 (d, J = 14.9 Hz), 129.18, 123.74, 118.38, 35.14 (d, J 
= 12.6 Hz), 30.38 (d, J = 26.8 Hz), 30.35, 27.33 (d, J = 8.0 Hz), 27.29 (d, J = 12.0 Hz), 
26.48, 21.58. 19F-NMR (282 MHz, CDCl3) δ -140.21 (dq, J (
19F-31P) = 52.7 Hz, J (19F-11B) = 
30.1 Hz). 31P-NMR (121 MHz, CDCl3) δ -14.66 (t, J (
31P-19F) = 52.4 Hz). HR-MS (EI), m/z: 
478.24988 [M]+▪, calcd. 478.2521 (Δ = -2.2 mmu). 
Synthesis of complex [AuCl(12a)] 
BODIPY-phosphine 12a (50 mg, 0.107 mmol) and [AuCl(SMe2)] 
(31.5 mg, 0.107 mmol) were loaded into 25 mL Schlenk flask 
equipped with a stirring bar, followed by addition of CH2Cl2 (5 mL). 
After 30 min of stirring the solvent was evaporated under reduced 
pressure. The residue was dissolved in CH2Cl2 (0.5 ml) and poured 
into excess of pentane (5 ml). The formed precipitate was filtered, 
washed with pentane (3 × 1 ml) and dried. The product was 
obtained as a red powder (65 mg, 87% yield). 
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1H-NMR (500 MHz, CDCl3) δ 8.01 (s, 1H), 7.74–7.64 (m, 4H), 7.57–7.52 (m, 2H), 7.50–7.43 
(m, 6H), 7.35 (d, J = 7.8 Hz, 2H), 7.06 (d, J = 4.1 Hz, 1H), 6.78 (d, J = 3.6 Hz, 1H), 6.62 
(d, J = 4.1 Hz, 1H), 6.09–6.04 (m, 1H), 2.48 (s, 3H). 13C-NMR (126 MHz, CDCl3) δ 150.07, 
148.47, 142.32 (d, J = 65.02 Hz), 142.29, 140.12 (d, J = 7.2 Hz), 137.04, 134.88, 134.76 
(d, J = 14.9 Hz), 132.25, 130.91, 130.75, 129.60, 129.20 (d, J = 12.4 Hz), 129.03, 128.51, 
128.15 (d, J = 7.3 Hz), 126.13 (d, J = 9.8 Hz), 121.79, 21.73. 19F-NMR (282 MHz, CDCl3) δ -
139.97 (dq, J (19F-31P) = 15.5 Hz, J (19F-11B) = 30.7 Hz). 31P-NMR (121 MHz, CDCl3) δ 20.15 
(t, J (31P-19F) = 15.4 Hz). MS (EI): calcd for C28H22BF2N2PAuCl 698 (M), found 698. (HR-MS 
could not be obtained). 
Synthesis of complex [AuCl(12b)] 
BODIPY-phosphine 12b (50 mg, 0.105 mmol) and [AuCl(SMe2)] (31 
mg, 0.105 mmol) were loaded into a 25 mL Schlenk flask equipped 
with a stirring bar, followed by addition of CH2Cl2 (5 mL). After 30 
min of stirring the solvent was evaporated under reduced pressure. 
The residue was dissolved in small amount of CH2Cl2 (0.5 ml) and 
poured into pentane (5 ml). The formed precipitate was filtered, 
washed with pentane (3 × 1 ml) and dried. The product was 
obtained as an orange powder (67 mg, 90% yield). 
1H-NMR (500 MHz, CDCl3) δ 8.09 (s, 1H), 7.47 (d, J = 8.1 Hz, 2H), 
7.36 (d, J = 7.9 Hz, 2H), 7.29 (t, J = 4.7 Hz, 1H), 7.11 (d, J = 4.3 Hz, 1H), 6.86 (d, J = 3.8 
Hz, 1H), 6.70 (d, J = 4.1 Hz, 1H), 2.99–2.89 (m, 2H), 2.49 (s, 3H), 2.14–2.07 (m, 2H), 1.89–
1.82 (m, 2H), 1.73–1.63 (m, 6H), 1.53–1.40 (m, 4H), 1.35–1.23 (m, 6H). 13C-NMR (126 
MHz, CDCl3) δ 148.91, 148.45, 142.75, 142.37, 140.45 (d, J = 4.1 Hz), 136.42, 134.61, 
133.59 (d, J = 24.3 Hz), 130.94, 130.62, 129.55, 128.64 (d, J = 11.0 Hz ), 121.43, 36.64 (d, 
J = 33.2 Hz), 32.67 (d, J = 5.2 Hz), 30.63, 26.44 (d, J = 11.6 Hz), 26.32 (d, J = 9.4 Hz), 
25.70, 21.67. 19F-NMR (282 MHz, CDCl3) δ -143.29 (q, J (
19F-11B) = 31.0 Hz). 31P-NMR (121 
MHz, CDCl3) δ 47.49 (s). HR-MS (EI), m/z: 710.18508 [M]
+▪, calcd. 710.1872 (Δ = -2.1 
mmu). 
Synthesis of complex [Au(NTf2)(12b)] 
[Ag(NTf2)] (8.6 mg, 0.022 mmol) and [AuCl(12b)] (15 mg, 
0.021 mmol) were loaded into a 10 mL Schlenk flask equipped 
with a stirring bar, followed by addition of CH2Cl2 (2 mL). The 
mixture was stirred for 1 h at room temperature protected from 
light. Formed precipitate of silver chloride was separated by 
centrifuge and the solvent was evaporated under reduced 
pressure. Obtained material was carefully washed with pentane 
(3 × 0.2 ml) and dried. The product was obtained as a light 
orange powder (19 mg, 94% yield). 
1H-NMR (500 MHz, CD2Cl2) δ 8.14 (s, 1H), 7.50 (d, J = 8.1 Hz, 
2H), 7.39 (d, J = 7.9 Hz, 2H), 7.19 (d, J = 4.4 Hz, 1H), 7.13 (t, J = 4.4 Hz, 1H), 6.93 (d, J 
= 3.5 Hz, 1H), 6.76 (d, J = 4.3 Hz, 1H), 2.93–2.82 (m, 2H), 2.49 (s, 3H), 2.19–2.11 (m, 2H), 
1.94–1.85 (m, 2H), 1.77–1.66 (m, 4H), 1.63–1.57 (m, 2H), 1.52–1.35 (m, 4H), 1.31–1.17 (m, 
6H). 13C-NMR (126 MHz, CD2Cl2) δ 149.87, 149.59, 143.18, 141.02, 139.57, 139.11, 137.28, 
 101 
135.74, 132.76 (d, J = 21.6 Hz), 131.50, 130.95, 130.01, 128.94 (d, J = 10.9 Hz), 122.41, 
120.03 (q, J = 322.6 Hz), 36.86 (d, J = 34.4 Hz), 33.10 (d, J = 3.6 Hz), 31.28, 26.91 (d, J = 
11.0 Hz), 26.79 (d, J = 9.0 Hz), 26.22, 21.85. 19F-NMR (282 MHz, CD2Cl2) δ -78.31 (s), -
141.81 (q, J (19F-11B) = 28.3 Hz). 31P-NMR (121 MHz, CD2Cl2) δ 45.06 (s). Mass spectrum 
could not be obtained. 
Synthesis of complex [AuCCPh(12b)] 
10 ml flame-dried Schlenk flask equipped with a stirring bar 
was charged with 3 ml of THF, followed by addition of 
phenylacetylene (139 µl, 1.266 mmol). The obtained mixture 
was cooled down to -78 °C and n-BuLi (507 µl of 2.5 M solution 
in hexane, 1.268 mmol) was added in one portion. The reaction 
mixture was stirred at low temperature for 30 min. The cooling 
bath was removed allowing mixture warming up to room 
temperature. After 1 h of additional stirring the solution of 
lithium phenylacetylide (0.42 M) was obtained. [(12b)AuCl] 
(20 mg, 0.028 mmol) was loaded into Schlenk flask, followed by addition of THF (2 ml). The 
reaction mixture was cooled down to -78 °C and the previously prepared lithium 
phenylacetylide solution (75 µl, 0.032 mmol) was added in one portion. Stirring was 
continuing for 1 h. After removing of cooling bath reaction mixture was stirred for additional 
30 min. The reaction was stopped by adding 3 drops of water. The solvent was evaporated 
under reduced pressure. The remaining residue was dissolved in CH2Cl2 (5 ml) and washed 
with water (3 × 3 ml). The organic layer was dried over anhydrous MgSO4, filtered, and 
evaporated under reduced pressure. The remaining product was carefully washed with 
pentane, filtered and dried. The obtained red precipitate appears to be the mixture of product 
and starting material (ratio 3/1 according to 31P-NMR). Further purification was not possible 
due to the instability of product. 
19F-NMR (282 MHz, CD2Cl2) δ -142.08 (q, J (
19F-11B) = 30.6 Hz). 31P-NMR (121 MHz, 
CD2Cl2) δ 49.57 (s). MS (APCI): calcd for C36H39BF2N2PAu (M) 776.3, found 777.5 (M + H). 
(HR-MS could not be obtained). 
Synthesis of complex [PdCl2(12b)2] 
BODIPY-phosphine 12b (25 mg, 0.052 mmol) and [PdCl2(CH3CN)2] 
(7.0 mg, 0.027 mmol) were loaded into a 25 mL Schlenk flask 
equipped with a stirring bar, following by addition of CH2Cl2 (5 
mL). The reaction mixture was stirred overnight and the solvent 
was evaporated under reduced pressure. The residue was dissolved 
in small amount of CH2Cl2 (0.5 ml) and poured into excess of 
pentane (5 ml). The formed precipitate was filtered, washed with 
pentane and dried. The product was obtained as a red powder (26 
mg, 88% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.98 (s, 1H), 7.47 (d, J = 7.9 Hz, 2H), 
7.30 (d, J = 7.7 Hz, 2H), 7.09–7.03 (m, 1H), 6.91 (d, J = 3.6 Hz, 1H), 6.87 (d, J = 3.8 Hz, 
1H), 6.56–6.51 (m, 1H), 3.12–3.03 (m, 2H), 2.58–2.50 (m, 2H), 2.46 (s, 3H), 2.10–2.02 (m, 
2H), 1.86–1.58 (m, 12H), 1.46–1.35 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 150.28 (t, J = 
14.1 Hz), 146.64, 144.79, 141.24, 139.21, 135.23, 131.43 (d, J = 4.9 Hz), 130.95, 130.26, 
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129.58, 129.12, 119.18, 34.95 (d, J = 9.3 Hz), 34.87 (d, J = 10.0 Hz), 30.95, 29.91, 27.72 
(d, J = 4.6 Hz), 27.68 (d, J = 5.1 Hz), 27.52 (d, J = 6.2 Hz), 27.47 (d, J = 6.3 Hz), 26.56, 
21.61. 19F-NMR (282 MHz, CDCl3) δ -140.88 (q, J (
19F-11B) = 26.2 Hz). 31P-NMR (121 MHz, 
CDCl3) δ 28.34 (s). MS (ESI): calcd for C56H68B2F4N4P2Pd (M – 2Cl) 1062.4, found 1063.6 (M 
– 2Cl + H). (HR-MS could not be obtained). 
Phosphine oxide 13a 
The phosphine oxide was obtained as the by-product from other reactions 
involving phosphine 12a. Different fractions were collected and purified 
by flash chromatography using ethyl acetate as the eluent. The residue 
was dissolved in small amount of CH2Cl2 and poured into an excess of 
pentane. The precipitate was filtered, washed with pentane and dried. 
The product was obtained as an orange powder. 
1H-NMR (500 MHz, CDCl3) δ 8.00 (s, 1H), 7.88–7.75 (m, 4H), 7.59–7.52 
(m, 2H), 7.51–7.42 (m, 6H), 7.34 (d, J = 7.6 Hz, 2H), 7.08–7.01 (m, 
1H), 6.80 (s, 1H), 6.62–6.56 (m, 1H), 6.47 (s, 1H), 2.48 (s, 3H). 13C-NMR 
(126 MHz, CDCl3) δ 149.56, 148.87, 147.21, 146.34, 142.03, 139.37 (d, J = 9.9 Hz), 136.85, 
134.46, 132.98, 132.37 (d, J = 10.1 Hz), 132.11, 130.97, 130.87, 129.45, 128.35 (d, J = 
12.8 Hz), 127.93 (d, J = 9.2 Hz), 126.81 (d, J = 15.5 Hz), 121.40, 21.65. 19F-NMR (282 
MHz, CDCl3) δ -143.01 (q, J (
19F-11B) = 29.0 Hz). 31P-NMR (121 MHz, CDCl3) δ 20.03 (s). 
HR-MS (EI), m/z: 482.15183 [M]+▪, calcd. 482.1531(Δ = -1.3 mmu). 
Synthesis of complex [CuI(12b)] 
To a stirred solution of CuI (2.0 mg, 0.010 mmol) in CH3CN (1 ml) the 
BODIPY-phosphine 12b (5.0 mg, 0.011 mmol) dissolved in 1 ml of 
CH3CN was added. Stirring was continued for 1 h. After evaporation of 
the solvent under reduced pressure, product was obtained as a violet 
powder (7.0 mg, >95% yield). 
1H-NMR (500 MHz, CDCl3) δ 8.02 (s, 1H), 7.46 (d, J = 8.1 Hz, 2H), 
7.37–7.30 (m, 3H), 7.00 (d, J = 4.1 Hz, 1H), 6.88 (d, J = 3.8 Hz, 1H), 
6.60 (dd, J = 4.2, 1.4 Hz, 1H), 2.87–2.74 (m, 2H), 2.48 (s, 3H), 2.13–
2.06 (m, 2H), 1.86–1.76 (m, 4H), 1.71–1.63 (m, 4H), 1.60–1.56 (m, 
2H), 1.44–1.24 (m, 8H). 13C-NMR (126 MHz, CDCl3) δ 149.47, 147.63, 146.64, 141.79, 
139.49, 135.85, 132.99, 131.14, 130.97, 130.59 (d, J = 16.9 Hz), 129.94 (d, J = 7.1 Hz), 
129.40, 129.02, 120.20, 35.91 (d, J = 19.4 Hz), 30.83 (d, J = 9.9 Hz), 29.81, 27.08 (d, J = 
27.0 Hz), 27.07, 26.07, 21.71. 19F-NMR (282 MHz, CDCl3) δ -141.99 (br s). 
31P-NMR (121 
MHz, CDCl3) δ 1.91 (br s). MS (ESI): calcd for C28H34BCuF2N2P (M – I) 541.2, found 541.5. 
(HR-MS could not be obtained). 
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Synthesis of complex [AgCl(12b)] 
BODIPY-phosphine 12b (5.0 mg, 0.010 mmol) was loaded into a 10 
mL Schlenk flask equipped with a stirring bar, following by addition 
of THF (1 mL) and saturated aqueous solution of KCl (1 ml). To the 
vigorously stirred two-phase mixture AgNO3 (17 mg, 0.10 mmol) was 
added in few portions. After 3 h of stirring protected from light 
reaction mixture was filtered from AgCl and extracted with CH2Cl2 (3 
× 2 ml). Combined organic fractions were dried over anhydrous 
MgSO4, filtered, and evaporated under reduced pressure, giving 
product as a red powder (6.0 mg, 92% yield). 
1H-NMR (500 MHz, C6D6) δ 8.20 (br s, 1H), 7.73 (s, 1H), 6.83 (d, J = 8.1 Hz, 2H), 6.78 (d, J 
= 7.9 Hz, 2H), 6.65 (d, J = 3.8 Hz, 1H), 6.50 (d, J = 4.2 Hz, 1H), 5.92 (dd, J = 4.2, 1.2 Hz, 
1H), 3.26 (br s, 2H), 2.30–2.09 (m, 4H), 2.00 (s, 3H), 1.91–1.76 (m, 6H), 1.68–1.63 (m, 2H), 
1.58–1.46 (m, 4H), 1.41–1.32 (m, 4H). 13C-NMR (126 MHz, C6D6) δ 147.76, 146.21, 141.24, 
140.83, 135.96, 132.19, 131.72, 131.26, 130.99 (d, J = 9.4 Hz), 129.31, 119.96, 36.52 (d, J 
= 12.4 Hz), 32.67 (d, J = 14.3 Hz), 31.20 (d, J = 4.6 Hz), 27.63 (d, J = 4.6 Hz), 27.52, 
26.53, 21.53. 19F-NMR (282 MHz, C6D6) δ -141.99 (br s). 
31P-NMR (121 MHz, C6D6) δ 36.49 
(d, J = 617.0 Hz). MS (ESI): calcd for C28H34AgBF2N2P (M – Cl) 585.2, found 585.5. (HR-MS 
could not be obtained). 
Synthesis of complex [CuI(12a)] 
To a stirred solution of CuI (2.0 mg, 0.011 mmol) in CH3CN (1 ml) 
the BODIPY-phosphine 12a (5.0 mg, 0.011 mmol) dissolved in 1 ml 
of CH3CN was added. Stirring was continued for 1 h. After 
evaporation of the solvent under reduced pressure, product was 
obtained as a deep purple powder (7.0 mg, >95% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.72 (br s, 1H), 7.61 (br s, 4H), 7.45 
(d, J = 8.0 Hz, 2H), 7.40–7.30 (m, 8H), 6.90 (d, J = 4.1 Hz, 1H), 
6.81 (d, J = 3.9 Hz, 1H), 6.46 (d, J = 2.9 Hz, 1H), 6.11 (d, J = 4.0 
Hz, 1H), 2.46 (s, 3H). 13C-NMR (126 MHz, CDCl3) δ 146.96, 141.49, 139.24, 135.76, 134.55 
(d, J = 17.2 Hz), 132.40, 132.09, 131.30, 130.85, 129.88, 129.36, 128.66 (d, J = 8.3 Hz), 
125.60, 119.39, 21.69. 19F-NMR (282 MHz, CDCl3) δ -142.92 (br s). 
31P-NMR (121 MHz, 
CDCl3) δ -18.42 (br s). MS (ESI): calcd for C28H22BCuF2N2P (M – I) 529.1, found 529.5. (HR-
MS could not be obtained). 
Synthesis of silver salt 14·Ag 
Tetramethyl-meso-(p-tolyl)-BODIPY (100 mg, 0.296 mmol, 1.0 eq) 
was loaded into 10 mL flame-dried Schlenk flask equipped with a 
stirring bar, followed by addition of DCM (4 mL). The obtained 
solution was cooled down to -78 °C and 1 M solution of 
chlorosulfonic acid in acetonitrile (355 µL, 0.355 mmol, 1.2 eq) was 
added dropwise. After stirring for 30 min the cooling bath was 
removed and the stirring was continued at room temperature for 
additional 1 h. The content of the flask was diluted with methanol 
(4 ml) and silver carbonate was added (82 mg, 0.296 mmol, 2.0 
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eq). The reaction mixture was stirred overnight protected from light. The excess of silver 
carbonate was removed by filtration. The filtrate was centrifuged and filtered again for 
complete removal of silver carbonate. After evaporation of the solvents under reduced 
pressure, the crude residue was dissolved in minimum amount of DCM. Excess addition of 
diethyl ether (5 mL) caused the precipitation of the pure silver salt, which was collected by 
filtration as an orange powder (85 mg, 55% yield). 
1H-NMR (500 MHz, CD3OD) δ 7.39 (d, J = 7.7 Hz, 2H), 7.19 (d, J = 8.0 Hz, 2H), 6.15 (s, 
1H), 2.76 (s, 3H), 2.51 (s, 3H), 2.45 (s, 3H), 1.68 (s, 3H), 1.42 (s, 3H). 13C-NMR (126 MHz, 
CD3OD) δ 159.92, 153.56, 147.04, 145.39, 141.35, 140.98, 134.29, 133.17, 131.50, 131.46, 
131.29, 130.73, 129.20, 123.72, 21.53, 15.05, 14.88, 14.30, 13.37. HRMS (ESI, negative 
mode): m/z calcd. for C20H20BF2N2O3S [M-Ag]
- 417.12612, found 417.12675. 
Synthesis of complex [AuIPr(14)] 
BODIPY silver sulfonate (8.5 mg, 0.016 mmol, 1.0 eq) and 
IPrAuCl (10.0 mg, 0.016 mmol, 1.0 eq) were loaded into flame-
dried Schlenk flask equipped with a stirring bar, followed by 
addition of DCM (2 mL). The reaction mixture was vigorously 
stirred overnight. The insoluble materials were removed by 
filtration. After evaporation of solvent the product was obtained 
as an orange powder in quantitative yield. 
1H-NMR (500 MHz, CDCl3) δ 7.48 (t, J = 7.8 Hz, 2H), 7.29 (d, J 
= 7.7 Hz, 2H), 7.27 (d, J = 7.0 Hz, 4H), 7.20 (s, 2H), 7.08 (d, J 
= 7.7 Hz, 2H), 6.02 (s, 1H), 2.56 (s, 3H), 2.51–2.43 (m, 10H), 1.37 (s, 6H), 1.30 (d, J = 6.9 
Hz, 12H), 1.21 (d, J = 6.9 Hz, 12H). 
Synthesis of compound 15·NBu4 
Sodium 3-formylbenzenesulfonate (2.8 g, 13.4 mmol) was dissolved in 
distilled water (10 mL) and to the obtained solution was added the 
solution of tetrabutylammonium bromide (3.6 g, 11.1 mmol) in 
dichloromethane (20 mL). The two-phase mixture was vigorously stirred 
for 2 h and transferred into a separatory funnel. The mixture was 
repeatedly shaken few times. The organic layer was separated and water phase washed few 
times with dichloromethane. The combined extracts were washed with brine and dried over 
magnesium sulfate. After evaporation of the solvent, the residue was purified by column 
chromatography (silica, acetone:dichloromethane, 1:10) affording the product as a colorless 
viscous oil (3.72 g, 78% yield). 
1H NMR (500 MHz, CDCl3) δ 9.98 (s, 1H, CHO), 8.37 (t, J = 1.7 Hz, 1H, HAr), 8.17 – 8.14 (m, 
2H, HAr), 7.81 (dt, J = 7.7, 1.4 Hz, 1H, HAr), 7.46 (t, J = 7.6 Hz, 1H,HAr), 3.27 – 3.21 (m, 8H, 
NCH2), 1.64 – 1.55 (m, 8H, CH2), 1.37 (sex, J = 7.4 Hz, 8H, CH2), 0.93 (t, J = 7.3 Hz, 12H, 
CH3). 
13C NMR (126 MHz, CDCl3) δ 192.19 (CHO), 148.62, 136.18, 132.33, 129.16, 128.76, 
128.59, 58.91 (NCH2), 24.09 (CH2), 19.80 (CH2), 13.72 (CH3). HR-MS (ESI, positive mode): 
m/z calcd. for C16H36N
+ [M]+ 242.2842, found 242.2843. HR-MS (ESI, negative mode): m/z 
calcd. for C7H5O4S
- [M]- 184.9914, found 184.9914. 
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Synthesis of BODIPY sulfonate 16·NBu4(EtiPr2NH) 
Compound 15·NBu4 (990 mg, 2.31 mmol), 3-ethyl-2,4-
dimethylpyrrole (624.7 µL, 4.63 mmol) were dissolved in 
dichloromethane (100 mL) under nitrogen atmosphere. 
Trifluoroacetic acid (3 drops) was added and the mixture 
stirred overnight at RT in a dark. Next, DDQ (525.7 mg, 2.31 
mmol) was added and the mixture stirred for 1.5 h at RT. 
After this the mixture was cooled to 0 °C and N,N-
diisopropylethylamine (2.01 mL, 11.5 mmol) was added 
dropwise. After few minutes boron trifluoride diethyl 
etherate (2.0 mL, 16.1 mmol) was added dropwise and the mixture stirred for 1 h at r.t. Next, 
the mixture was washed with water, the organic layer was separated, dried over magnesium 
sulfate and the solvent evaporated under reduced pressure. The residue was purified by 
column chromatography (silica, acetone:dichloromethane, 1:1 to 2:1) affording the dye 
16·NBu4(EtiPr2NH) with mixed cations (448.5 mg, 30% yield). 
1H NMR (500 MHz, CDCl3) δ 8.04 (d, J = 7.8 Hz, 1H, HAr), 7.83 (s, 1H, HAr), 7.48 (t, J = 7.7 
Hz, 1H, HAr), 7.26 (d, J = 8.3 Hz, 1H, HAr), 3.69 (hept, J = 6.6 Hz, 1H, iPr2CH), 3.34 – 3.27 
(m, 2H, NCH2, NBu4), 3.11 (q, J = 7.5 Hz, 1H, NCH2, iPr2NEt), 2.52 (s, 6H, CH3, bodipy), 
2.28 (q, J = 7.5 Hz, 4H, CH2, bodipy), 1.70 – 1.61 (m, 4H, CH2, NBu4), 1.50 – 1.36 (m, 12H), 
1.30 (s, 6H, CH3, bodipy), 1.00 – 0.93 (m, 12H, CH3, bodipy+NBu4). 
13C NMR (126 MHz, 
CDCl3) δ 153.68, 147.80, 139.95, 138.74, 135.30, 132.79, 130.90, 129.14, 128.89, 126.76, 
126.15, 59.00, 54.35, 42.67, 29.41, 24.16, 19.85, 18.77, 17.51, 17.15, 14.72, 13.74, 12.60, 
12.34, 12.24. 19F NMR (471 MHz, CDCl3) δ -148.61 – -149.00 (m). HR-MS (ESI, positive 
mode): m/z calcd. for C16H36N
+ [M]+ 242.2842, found 242.2838; m/z calcd. for C8H20N
+ 
[M]+ 130.1590, found 130.1587. HR-MS (ESI, negative mode): m/z calcd. for 
C23H26BF2N2O3S
- [M]- 459.1730, found 459.1733.  
Synthesis of BODIPY sulfonic acid 16·H 
BODIPY sulfonate 16·NBu4(EtiPr2NH) (100 mg, 0.22 mmol) was 
dissolved in methanol and the solution was passed through 
Amberlite IR-120 hydrogen form cation exchange resin. The solvent 
was evaporated under reduced pressure and the residue purified by 
flash chromatography (silica, methanol:dichloromethane, 1:5) 
affording acid 16·H (54.2 mg, 76% yield). 
1H NMR (500 MHz, DMSO-d6) δ 7.77 (dt, J = 7.8, 1.3 Hz, 1H, HAr), 
7.53 (t, J = 7.7 Hz, 1H, HAr), 7.49 (t, J = 1.7 Hz, 1H, HAr), 7.31 (dt, 
J = 7.5, 1.5 Hz, 1H, HAr), 2.44 (s, 6H, CH3), 2.30 (q, J = 7.5 Hz, 4H, CH2), 1.25 (s, 6H, CH3), 
0.95 (t, J = 7.5 Hz, 6H, CH3). 
13C NMR (126 MHz, DMSO-d6) δ 153.22, 149.43, 140.06, 
137.92, 133.94, 132.64, 129.86, 128.74, 127.98, 126.05, 125.00, 16.36, 14.46, 12.22, 11.51. 
19F NMR (471 MHz, DMSO-d6) δ -145.01 – -145.49 (m). 
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Synthesis of complex [(17)-O-IPrAu(OAc)] 
Silver acetate (4.4 mg, 0.027 mmol, 1 eq) and the respective 
complex [(17)-O-IPrAuCl] (30.0 mg, 0.027 mmol, 1 eq) were 
loaded into a 10 mL Schlenk flask equipped with a stirring bar, 
followed by addition of CH2Cl2 (3 mL). The mixture was stirred 
for 3 h at room temperature protected from light. Formed 
precipitate of silver chloride was separated by centrifuge and the 
solvent was evaporated under reduced pressure. Obtained 
material was carefully washed with pentane and dried. The 
product was obtained in a quantitative yield as a deep blue 
powder. 
1H NMR (500 MHz, CDCl3) δ 8.73 (d, J = 8.0 Hz, 2H), 7.48 (q, J = 7.6 Hz, 2H), 7.39 (t, J = 
7.6 Hz, 2H), 7.30–7.22 (m, 8H, overlapped with solvent residual peak), 6.42 (s, 1H), 4.01 (t, 
J = 6.2 Hz, 2H), 3.12–3.01 (m, 2H), 2.89 (t, J = 7.0 Hz, 4H), 2.68–2.56 (m, 8H), 2.33 (s, 
6H), 1.81–1.72 (m, 2H), 1.76 (s, 3H), 1.70–1.62 (m, 2H), 1.53–1.49 (s, 2H), 1.38 (d, J = 6.9 
Hz, 6H), 1.36 (d, J = 6.9 Hz, 6H), 1.24 (d, J = 6.9 Hz, 6H), 1.20 (d, J = 6.9 Hz, 6H). 13C 
NMR (126 MHz, CDCl3) δ 176.50, 163.61, 149.85, 148.67, 146.36, 145.99, 143.77, 140.57, 
135.01, 134.26, 133.22, 132.25, 130.87, 130.77, 130.63, 129.45, 128.77, 128.56, 128.19, 
127.48, 124.41, 124.22, 99.55, 72.33, 32.04, 30.79, 29.36, 29.07, 28.80, 26.40, 24.83, 24.46, 
24.29, 24.11, 23.97, 20.89, 14.15. 
Synthesis of NHC-gold(I) sulfonato complexes [IPrAu(16)] and [(17)-O-IPrAu(16)] 
General procedure. Corresponding NHC-gold(I) acetate complex (1 eq) and acid 16·H (1 eq) 
were dissolved in DCM and stirred at room temperature overnight. The solvent was removed 
under reduced pressure and the residue was washed with pentane to give a pure product. 
Complex [IPrAu(16)] was quantitatively obtained from [IPrAu(OAc)] (10 
mg, 0.016 mmol) and acid 16·H (7 mg, 0.016 mmol). 
1H NMR (500 MHz, CDCl3) δ 7.69 (d, J = 5.4 Hz, 1H), 7.52 (br s, 1H), 
7.42–7.33 (m, 4H), 7.25 (d, J = 7.8 Hz, 4H), 7.22 (s, 2H), 2.56 (s, 6H), 
2.48 (hept, J = 6.7 Hz, 4H), 2.30 (q, J = 7.5 Hz, 4H), 1.28 (d, J = 6.8 Hz, 
12H), 1.19 (d, J = 6.9 Hz, 12H), 1.16 (s, 6H), 1.00 (t, J = 7.5 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 164.38, 154.06, 145.77, 144.47, 139.28, 
138.85, 135.84, 133.82, 133.03, 131.15, 130.96, 130.53, 129.01, 126.99, 
126.58, 124.51, 123.66, 29.09, 24.47, 24.30, 17.28, 14.87, 12.74, 12.25. 
Complex [(17)-O-IPrAu(16)] was quantitatively obtained from 
[(17)-O-IPrAu(OAc)] (20 mg, 0.017 mmol) and acid 16·H (8 mg, 
0.017 mmol). 
1H NMR (500 MHz, CD2Cl2) δ 8.68 (d, J = 8.0 Hz, 2H), 7.57 (d, J 
= 7.4 Hz, 1H), 7.44–7.35 (m, 6H), 7.33–7.25 (m, 9H), 6.53 (s, 
1H), 4.05 (t, J = 6.2 Hz, 2H), 3.14–3.06 (m, 2H), 2.92 (t, J = 7.0 
Hz, 4H), 2.69–2.55 (m, 8H), 2.53 (s, 6H), 2.36 (s, 6H), 2.33 (q, J 
= 7.6 Hz, 4H), 1.83–1.75 (m, 2H), 1.72–1.64 (m, 2H), 1.58–1.50 
(m, 2H), 1.29 (d, J = 7.0 Hz, 6H), 1.27 (d, J = 6.9 Hz, 6H), 1.23 
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(d, J = 6.8 Hz, 6H), 1.19 (d, J = 6.9 Hz, 6H), 1.17 (s, 6H), 1.01 (t, J = 7.5 Hz, 6H). 13C NMR 
(126 MHz, CD2Cl2) δ 165.99, 158.36, 154.41, 149.84, 149.26, 146.84, 146.43, 145.03, 
144.85, 141.37, 139.74, 139.28, 136.18, 135.10, 134.62, 134.31, 133.60, 132.79, 131.39, 
131.29, 130.99, 130.78, 129.81, 129.58, 128.90, 128.83, 128.74, 127.52, 127.06, 126.86, 
124.80, 124.67, 100.60, 73.11, 32.32, 31.11, 29.68, 29.38, 29.26, 26.74, 24.90, 24.51, 24.36, 
24.05, 21.18, 17.57, 15.03, 14.33, 12.88, 12.40. 19F NMR (471 MHz, CD2Cl2) δ -136.23 – -
136.82 (m, 1F), -138.69 – -139.33 (m, 1F), -147.22 – -148.15 (m, 2F). 
Synthesis of compound 18·K 
Biphenyl-4-carboxaldehyde (1.0 g, 5.48 mmol) was added portion wise to the 
stirred oleum (2.5 mL) at RT. The obtained solution was stirred at 40 °C overnight, 
cooled to RT and poured into ice. The obtained suspension was warmed to RT and 
to the obtained solution was added an excess of solid potassium chloride. The 
obtained white precipitate of the product was collected by filtration, washed with 
water and with a small amount of methanol. After drying in vacuo for 12 h at 50 
°C, the product was obtained as white powder (1.51 g, 92% yield). 
1H NMR (500 MHz, DMSO-d6) δ 10.06 (s, 1H, CHO), 8.00 (d, J = 8.3 Hz, 2H, 
HAr), 7.92 (d, J = 8.2 Hz, 2H, HAr), 7.73 (s, 4H, HAr). 
13C NMR (126 MHz, DMSO-
d6) δ 192.68 (CHO), 148.44, 145.39, 138.66, 135.11, 130.10, 127.36, 126.50, 
126.27. 
Synthesis of compound 18·NBu4 
Potassium salt 18·K (1.5 g, 5 mmol) was suspended in a mixture of water (20 
mL) and dichloromethane (40 mL) and tetra-n-butylammonium bromide (1.61 
g, 5 mmol) was added. The mixture was intensively shaken until insoluble salt 
18·K completely disappeared. Next, the organic layer was separated, dried 
over magnesium sulfate and solvent evaporated affording the title compound 
as colorless oil (2.4 g, 96% yield). 
1H NMR (500 MHz, CDCl3) δ 10.00 (s, 1H, CHO), 7.95 (d, J = 8.1 Hz, 2H, 
HAr), 7.89 (d, J = 8.2 Hz, 2H, HAr), 7.68 (d, J = 8.3 Hz, 2H, HAr), 7.55 (d, J = 
8.2 Hz, 2H, HAr), 3.25–3.17 (m, 8H, NCH2), 1.60–1.52 (m, 8H, CH2), 1.39–
1.30 (m, 8H, CH2), 0.91 (t, J = 7.3 Hz, 12H, CH3). 
13C NMR (126 MHz, 
CDCl3) δ 191.95 (CHO), 147.40, 146.75, 140.14, 135.29, 130.24, 127.69, 126.87, 58.70 
(NCH2), 23.96 (CH2), 19.68 (CH2), 13.65 (CH3). HR-MS (ESI, positive mode): m/z calcd. for 
C16H36N
+ [M]+ 242.2842, found 242.2843. HR-MS (ESI, negative mode): m/z calcd. for 
C13H9O4S
- [M]- 261.0227, found 261.0231. 
Synthesis of BODIPY biphenyl sulfonates 19a·EtiPr2NH and 19b·NBu4 
General procedure. Compound 18·NBu4 (1 eq) and respective pyrrole (2 eq) were dissolved in 
dichloromethane (100 mL) under a nitrogen atmosphere. Trifluoroacetic acid (4 drops) was 
added and the mixture stirred overnight at RT in a dark. Next, chloranil (1 eq) was added and 
the stirring was continued for another 1.5 h. The reaction mixture was cooled to 0 °C and 
N,N-diisopropylethylamine (5 eq) was added dropwise. After few minutes boron trifluoride 
diethyl etherate (7 eq) was added dropwise and the mixture stirred for 1 h at RT. Next, the 
mixture was washed with water, the organic layer was separated, dried over magnesium 
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sulfate and the solvent was evaporated under reduced pressure. The residue was purified by 
silica column chromatography (acetone:dichloromethane, 1:1 to 2:1) affording the pure 
products. 
Compound 19a·EtiPr2NH was obtained as a dark red material 
(1.37 g, 58% yield) from compound 18·NBu4 (1.78 g, 3.53 
mmol), 3-ethyl-2,4-dimethylpyrrole (953.6 µL, 7.06 mmol), 
chloranil (868.8 mg, 3.53 mmol), N,N-diisopropylethylamine 
(3.13 mL, 18 mmol) and boron trifluoride diethyl etherate (3.1 
mL, 25 mmol). 
1H NMR (300 MHz, DMSO-d6) δ 8.19 (s, 1H, iPr2NHEt), 7.90 (d, 
J = 8.3 Hz, 2H, HAr), 7.78–7.69 (m, 4H, HAr), 7.44 (d, J = 8.2 
Hz, 2H, HAr), 3.68–3.55 (m, 2H), 3.19–3.09 (m, 2H), 2.45 (s, 
6H, CH3, bodipy), 2.30 (q, J = 7.4 Hz, 4H, CH2CH3, bodipy), 
1.34 (s, 6H, CH3, bodipy), 1.29–1.21 (m, 15H, CH3, cation), 0.95 
(t, J = 7.5 Hz, 6H, CH2CH3, bodipy). 
13C NMR (75 MHz, DMSO-
d6) δ 153.16, 147.96, 140.19, 140.11, 138.86, 138.09, 133.86, 132.59, 129.95, 128.68, 
127.22, 126.24, 125.98, 53.59, 41.82, 18.05, 16.70, 16.37, 14.45, 12.41, 12.21, 11.49. 19F 
NMR (282 MHz, CDCl3/DMSO-d6) δ -148.45 (1:1:1:1 pattern, J = 32.4 Hz). HR-MS (ESI, 
positive mode): m/z calcd. for C8H20N
+ [M]+ 130.1590, found 130.1590. HR-MS (ESI, 
negative mode): m/z calcd. for C29H30BF2N2O3S
- [M]- 535.2044, found 535.2055. 
Compound 19b·NBu4 was obtained as a dark red material (0.99 
g, 45% yield) from compound 18·NBu4 (1.24 g, 2.46 mmol), 3-
hexyl-2,4-dimethylpyrrole (885 mg, 4.94 mmol), chloranil (610 
mg, 2.48 mmol), N,N-diisopropylethylamine (2.15 mL, 12.34 
mmol) and boron trifluoride diethyl etherate (2.13 mL, 17.26 
mmol). 
1H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 8.1 Hz, 2H), 7.70 (d, J 
= 8.1 Hz, 2H), 7.63 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.1 Hz, 
2H), 3.36–3.28 (m, 8H), 2.52 (s, 6H), 2.26 (t, J = 7.4 Hz, 4H), 
1.71–1.63 (m, 8H), 1.45 (h, J = 7.3 Hz, 8H), 1.33 (s, 6H), 1.32–
1.20 (m, 16H), 1.00 (t, J = 7.3 Hz, 12H), 0.86 (t, J = 6.7 Hz, 
6H). 
 
6.2. Quantum yields determination 
Quantum yields were determined according to the literature procedure[225] using rhodamine 
6G or rhodamine 101 (from Sigma-Aldrich, BioReagent, suitable for fluorescence) as the 
standards. Absorption and emission spectra for all fluorescent compounds were obtained in 
1,2-dichloroethane over a range of concentrations (250 nM to 1.0 μM) where a linear 
correlation between concentration and absorption was observed and the absorbance was 
within the range from 0.01 to 0.1. The quantum yield was calculated according to the 
equation        (
     
      
) (
  
   
)
 
 where the subscripts st and x denote standard and test 
respectively, Φ is the fluorescence quantum yield, Grad the gradient from the plot of 
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integrated fluorescence intensity vs absorbance, and η the refractive index of the solvent. For 
rhodamine 6G Φst = 0.95 in EtOH; for rhodamine 101 Φst = 1.00 in EtOH. 
6.3. Monitoring of the reaction of BODIPY-tagged gold(I) complexes with thiols 
General conditions. All experiments were carried out in quartz cuvettes with a path length of 
10.00 mm equipped with a stirring bar. The temperature (298 K) was adjusted using a 
thermostat and controlled with a thermometer over the course of measurements. 
General procedure of measurements. The following general procedure was applied in all 
experiments with thiols. The cuvette was filled with 2 ml of 1 µM solution of the respective 
gold complex in 1,2-dichloroethane. The measurement was started and the fluorescence 
intensity at emission maximum was observed. After approximately 1 min 10 µl of 0.02 M 
solution of N,N-diisopropylethylamine (Hünig base) in 1,2-dichloroethane (100 eq) was 
added, followed by the addition of 10 µl of the corresponding para-substituted thiophenol 
solution in 1,2-dichloroethane (0.02 M solution of thiophenol was used to add 100 eq, 0.1 M 
– to add 500 eq). The dilution, caused by the addition of reagents, was recalculated on the 
final curves. 
6.4. Monitoring of the reaction of BODIPY-tagged phosphine-gold(I) complex with 
silver salt and acetylenes 
Purification of the solvent. 1 L flame-dried Schlenk flask was filled with 500 ml of 1,2-
dichloroethane (99+%, for spectroscopy ACS, Acros Organics), followed by addition of ca. 50 
g of alumina powder (previously preactivated by keeping under vacuum at 200 °C overnight). 
The obtained suspension was shaken for two days at room temperature. The solvent was 
distilled under nitrogen into another Schlenk flask and ca. 10 g of CaH2 powder was added. 
The suspension was stirred for two days at room temperature and the solvent was distilled 
under nitrogen. Purified 1,2-dichloroethane was kept under an inert atmosphere. 
Preparation of stock solution of silver salt. Silver nonaflate (1-1.5 mg) was weighed in a small 
vial, dissolved in a minimum amount of methanol and transferred into 10 ml flame-dried 
Schlenk flask. After careful evaporation of methanol, the flask was kept under vacuum at 50 
°C overnight. To get 10-3 M solution of silver salt the respective amount of 1,2-dichloroethane 
(2.457 ml for 1 mg of AgONf) was added, the flask was tightly closed and immersed into an 
ultrasonic bath for 5-10 min, until all silver salt was dissolved. The obtained silver nonaflate 
solution was used within 12 hours to avoid the formation of triflic acid. 
Preparation of stock solution of BODIPY-tagged phosphine-gold(I) complex. [(12b)AuCl] (< 1 
mg) was weighed in a small vial and transferred with dichloromethane into 25 ml flame-dried 
Schlenk flask. After evaporation of DCM, the gold complex was dried under vacuum for 
several hours. The necessary amount of 1,2-dichloroethane was added to obtain a 10-4 M 
solution. The stock solution was kept under an inert atmosphere and was used within 24 h. 
Preparation of other stock solutions. Stock solutions (0.3 M) of different phenylacetylenes and 
N,N-diisopropylethylamine (Hünig base) were prepared by dissolving the respective amount 
of the substance in 1,2-dichloroethane. Solutions were kept under an inert atmosphere and 
used within 24 h. 
General procedure of fluorescence time measurements. 1 µM solution of [(12b)AuCl] was 
prepared directly in a cuvette by dilution of 30 µl of 10-4 M stock solution in 2.970 ml of 1,2-
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dichloroethane. After measurement was started the necessary amount of silver salt stock 
solution was added (1 eq = 3 µl), followed by addition of 10 µl (1000 eq) of the respective 
phenylacetylene solution. Prior to the addition of phenylacetylene 50-150 eq of N,N-
diisopropylethylamine were added. This didn’t have any significant influence on the 
fluorescence intensity but enhanced the evolution of fluorescence signal after addition of 
phenylacetylene and (more importantly) enables reproducible measurements. 
6.5. Measurements of FRET efficiency 
Different solvents. In a cuvette containing 1.5 ml of 1 µM solution of [(17)-O-IPrAu(16)] in 
toluene different amount of solvents (either acetonitrile or 1,2-dichloroethane) were added 
stepwise. After each addition, the cuvette was shaken and the emission spectrum was 
measured. The process was continued until the overall amount of added solvent has reached 2 
ml. The volumes of aliquots were chosen with intent to obtain the most accurate and 
complete dependence of FRET efficiency on solvent content and were different for every 
solvent at each step. To measure the intensity of donor fluorophore in the absence of the 
acceptor, completely the same experiments were carried out with [IPrAu(16)]. 
Alkyne substrate. 15 ml of 1 µM solution of [(17)-O-IPrAu(16)] in toluene were loaded into a 
flame dried glass reactor under a nitrogen atmosphere. The fluorescence emission was 
monitored by an immersion probe (Hellma Analytics; Serial No. 13316). Approximately one 
minute after the start of measurements 75 µL of 0.2 M phenyl acetylene solution (1000 eq) in 
toluene were added. The measurement was continued until no changes in the signal intensity 
of both donor and acceptor fluorophores were observed. 
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7. List of Abbreviations 
Ac    acetyl 
Ar    aryl 
BArF    tetrakis(3,5-bis(trifluoromethyl)phenyl)borate 
BODIPY   4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 
Bu    butyl 
cod    cis,cis-1,5-cyclooctadiene 
Cy    cyclohexyl 
dba    dibenzylideneacetone 
DCE    1,2-dichloroethane 
DCM    dichloromethane 
DDQ    2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DFT    density functional theory 
DMAP    4-dimethylaminopyridine 
DMSO    dimethyl sulfoxide 
EDG    electron-donating group 
Et    ethyl 
EWG    electron-withdrawing group 
FMO    frontier molecular orbital 
FRET    fluorescence or Förster resonance energy transfer 
Hex    hexyl 
hfa    hexafluoroacetylacetonat 
HOESY   heteronuclear Overhauser effect spectroscopy 
HOMO    highest occupied molecular orbital 
IC    internal conversion 
iPr    isopropyl 
ISC    intersystem crossing 
ISIP    inner-sphere ion pair 
LUMO    lowest unoccupied molecular orbital 
Me    methyl 
Mes    mesityl 
MLCT    metal-to-ligand charge transfer 
NCS    N-chlorosuccinimide 
Nf    nonafluorobutanesulfonyl 
NHC    N-heterocyclic carbene 
NMR    nuclear magnetic resonance 
NOESY   nuclear Overhauser effect spectroscopy 
OSIP    outer-sphere ion pair 
PDT    photodynamic therapy 
PET    photoinduced electron transfer 
PGSE    pulsed field gradient spin-echo 
Ph    phenyl 
phen  phenantroline 
pip  piperidine 
PM-FTIRRAS polarization-modulation Fourier transform IR reflection-
absorption spectroscopy 
PS    photosensitizer 
py    pyridine 
RET    resonance energy transfer 
RNS    reactive nitrogen species 
RT, rt    room temperature 
SIMes    1,3-bis(2,4,6-trimethylphenyl)imidazolin-2-ylidene 
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SIPr    1,3-bis(2,6-diisopropylphenyl)imidazolin-2-ylidene 
SMFM    single-molecule fluorescence microscopy 
SPECT    single-photon emission computed tomography 
terpy    terpyridine 
Tf    trifluoromethanesulfonyl 
TFA    trifluoroacetic acid 
THF    tetrahydrofuran 
tht    tetrahydrothiophene 
TIRF    total internal reflectance fluorescence 
Ts    p-toluenesulfonyl 
TTA    triplet-triplet annihilation 
TTET    triplet-triplet energy transfer 
UV-Vis    ultraviolet-visible spectroscopy 
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